| 13517946 | CV488183 | variation | DNMT3A, ARG822CYS | Acute myeloid leukemia [RCV000590990]|Tatton-Brown-rahman syndrome [RCV000590987] | pathogenic | | | | Human | | name |
| 150473826 | CV1281607 | single nucleotide variant | NM_022552.5(DNMT3A):c.-6G>A | not provided [RCV001713593] | benign|likely benign | 2 | 25313990 | 25313990 | Human | | name |
| 405276217 | CV3193288 | single nucleotide variant | NM_022552.5(DNMT3A):c.-4C>T | DNMT3A-related disorder [RCV003974455]|not provided [RCV005220812] | likely benign|uncertain significance | 2 | 25313988 | 25313988 | Human | | name , trait , alternate_id |
| 405273081 | CV3197647 | single nucleotide variant | NM_022552.5(DNMT3A):c.-9G>A | DNMT3A-related disorder [RCV003901615] | likely benign | 2 | 25313993 | 25313993 | Human | | name , trait , alternate_id |
| 405266853 | CV3220166 | single nucleotide variant | NM_022552.5(DNMT3A):c.-7C>T | DNMT3A-related disorder [RCV003969429] | likely benign | 2 | 25313991 | 25313991 | Human | | name , trait , alternate_id |
| 405149427 | CV2877237 | single nucleotide variant | NM_022552.5(DNMT3A):c.73-8G>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003585516] | likely benign | 2 | 25300251 | 25300251 | Human | 1 | name |
| 597893193 | CV3785407 | single nucleotide variant | NM_022552.5(DNMT3A):c.72+4A>G | Tatton-Brown-Rahman overgrowth syndrome [RCV005125993] | uncertain significance | 2 | 25313909 | 25313909 | Human | 1 | name |
| 13216419 | CV428051 | single nucleotide variant | NM_022552.5(DNMT3A):c.72+9C>T | DNMT3A-related disorder [RCV003935283]|Tatton-Brown-Rahman overgrowth syndrome [RCV000964665]|not specified [RCV000503737] | likely benign | 2 | 25313904 | 25313904 | Human | 1 | name , trait , alternate_id |
| 15141946 | CV695137 | single nucleotide variant | NM_175629.2(DNMT3A):c.-786T>C | Tatton-Brown-Rahman overgrowth syndrome [RCV001521676] | benign | 2 | 25343038 | 25343038 | Human | 1 | name |
| 150485240 | CV1222665 | single nucleotide variant | NM_022552.5(DNMT3A):c.73-84A>G | not provided [RCV001617668] | benign | 2 | 25300327 | 25300327 | Human | | name |
| 150468738 | CV1257094 | single nucleotide variant | NM_022552.5(DNMT3A):c.639+6G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003746595]|not provided [RCV001670740] | benign|likely benign | 2 | 25274935 | 25274935 | Human | 1 | name |
| 150453399 | CV1275435 | single nucleotide variant | NM_022552.5(DNMT3A):c.855+1G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV001706950] | likely pathogenic | 2 | 25248036 | 25248036 | Human | 1 | name |
| 150535850 | CV1307137 | single nucleotide variant | NM_022552.5(DNMT3A):c.178-9C>G | not provided [RCV001759192] | uncertain significance | 2 | 25282720 | 25282720 | Human | | name |
| 152102573 | CV1523922 | single nucleotide variant | NM_022552.5(DNMT3A):c.73-18C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002133451] | likely benign | 2 | 25300261 | 25300261 | Human | 1 | name |
| 156050530 | CV2091412 | single nucleotide variant | NM_022552.5(DNMT3A):c.855+7G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV002886146] | likely benign | 2 | 25248030 | 25248030 | Human | 1 | name |
| 156318996 | CV2155247 | single nucleotide variant | NM_022552.5(DNMT3A):c.72+10G>C | Tatton-Brown-Rahman overgrowth syndrome [RCV003011567] | likely benign | 2 | 25313903 | 25313903 | Human | 1 | name |
| 401937485 | CV2815588 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+8C>G | not provided [RCV003415520] | uncertain significance | 2 | 25282433 | 25282433 | Human | | name |
| 405150120 | CV2869337 | single nucleotide variant | NM_022552.5(DNMT3A):c.639+7C>T | DNMT3A-related disorder [RCV003966484]|Tatton-Brown-Rahman overgrowth syndrome [RCV003585577] | likely benign | 2 | 25274934 | 25274934 | Human | 1 | name , trait , alternate_id |
| 405249104 | CV2972500 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-5C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003746990] | likely benign | 2 | 25248257 | 25248257 | Human | 1 | name |
| 405249879 | CV2993153 | single nucleotide variant | NM_022552.5(DNMT3A):c.856-7G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003747313] | likely benign | 2 | 25247756 | 25247756 | Human | 1 | name |
| 405247452 | CV3049895 | single nucleotide variant | NM_022552.5(DNMT3A):c.855+6C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003746376] | uncertain significance | 2 | 25248031 | 25248031 | Human | 1 | name |
| 405270094 | CV3198040 | single nucleotide variant | NM_022552.5(DNMT3A):c.178-9C>T | DNMT3A-related disorder [RCV003899850] | likely benign | 2 | 25282720 | 25282720 | Human | | name , trait , alternate_id |
| 407457511 | CV3416178 | single nucleotide variant | NM_022552.5(DNMT3A):c.449-4A>G | not provided [RCV004599056] | uncertain significance | 2 | 25275547 | 25275547 | Human | | name |
| 408373880 | CV3513257 | single nucleotide variant | NM_022552.5(DNMT3A):c.178-6T>G | DNMT3A-related disorder [RCV004745813] | likely benign | 2 | 25282717 | 25282717 | Human | | name , trait , alternate_id |
| 408374009 | CV3513919 | single nucleotide variant | NM_022552.5(DNMT3A):c.639+3G>A | DNMT3A-related disorder [RCV004745905] | likely benign | 2 | 25274938 | 25274938 | Human | | name , trait , alternate_id |
| 408374334 | CV3515582 | single nucleotide variant | NM_022552.5(DNMT3A):c.177+7G>T | DNMT3A-related disorder [RCV004746651] | likely benign | 2 | 25300132 | 25300132 | Human | | name , trait , alternate_id |
| 597899616 | CV3854698 | single nucleotide variant | NM_022552.5(DNMT3A):c.856-4C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV005201806] | likely benign | 2 | 25247753 | 25247753 | Human | 1 | name |
| 598126258 | CV3881839 | single nucleotide variant | NM_022552.5(DNMT3A):c.639+5G>A | not provided [RCV005233391] | uncertain significance | 2 | 25274936 | 25274936 | Human | | name |
| 598218782 | CV3895558 | single nucleotide variant | NM_022552.5(DNMT3A):c.855+2T>C | Acute myeloid leukemia [RCV005360410] | uncertain significance | 2 | 25248035 | 25248035 | Human | 2 | name |
| 13624532 | CV518001 | single nucleotide variant | NM_022552.5(DNMT3A):c.72+10G>A | DNMT3A-related disorder [RCV003928131]|Tatton-Brown-Rahman overgrowth syndrome [RCV000652292]|not specified [RCV001816636] | benign|likely benign | 2 | 25313903 | 25313903 | Human | 1 | name , trait , alternate_id |
| 14736134 | CV650948 | single nucleotide variant | NM_022552.5(DNMT3A):c.639+6G>C | DNMT3A-related disorder [RCV003928284]|Tatton-Brown-Rahman overgrowth syndrome [RCV000819867]|not provided [RCV001776038] | likely benign|uncertain significance | 2 | 25274935 | 25274935 | Human | 1 | name , trait , alternate_id |
| 15115800 | CV743919 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+7C>T | DNMT3A-related disorder [RCV003950451]|Tatton-Brown-Rahman overgrowth syndrome [RCV003584776] | likely benign|uncertain significance | 2 | 25282434 | 25282434 | Human | 1 | name , trait , alternate_id |
| 40889710 | CV975035 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+1G>A | not provided [RCV001268146] | likely pathogenic | 2 | 25282440 | 25282440 | Human | | name |
| 127235378 | CV1059270 | single nucleotide variant | NM_022552.5(DNMT3A):c.856-10G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV001382387] | pathogenic | 2 | 25247759 | 25247759 | Human | 1 | name |
| 127318491 | CV1154098 | single nucleotide variant | NM_022552.5(DNMT3A):c.1122+7G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV001521674]|not provided [RCV001725222] | benign | 2 | 25247044 | 25247044 | Human | 1 | name |
| 150422328 | CV1179502 | single nucleotide variant | NM_022552.5(DNMT3A):c.492+55G>C | not provided [RCV001552507] | likely benign | 2 | 25275445 | 25275445 | Human | | name |
| 150429467 | CV1189194 | single nucleotide variant | NM_022552.5(DNMT3A):c.1851+3G>C | Tatton-Brown-Rahman overgrowth syndrome [RCV001563649] | likely pathogenic | 2 | 25244152 | 25244152 | Human | 1 | name |
| 150411640 | CV1196881 | single nucleotide variant | NM_022552.5(DNMT3A):c.73-234G>C | not provided [RCV001574084] | likely benign | 2 | 25300477 | 25300477 | Human | | name |
| 150436996 | CV1200907 | single nucleotide variant | NM_022552.5(DNMT3A):c.2478+1G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV005094823]|not provided [RCV001582987] | pathogenic|likely pathogenic | 2 | 25236935 | 25236935 | Human | 1 | name |
| 150481931 | CV1209877 | single nucleotide variant | NM_022552.5(DNMT3A):c.72+162G>A | not provided [RCV001590575] | likely benign | 2 | 25313751 | 25313751 | Human | | name |
| 150470083 | CV1219182 | deletion | NM_022552.5(DNMT3A):c.640-49del | not provided [RCV001614934] | benign | 2 | 25248301 | 25248301 | Human | | name |
| 150530924 | CV1310312 | single nucleotide variant | NM_022552.5(DNMT3A):c.1555-1G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV001775240] | pathogenic | 2 | 25244653 | 25244653 | Human | 1 | name |
| 150540435 | CV1314560 | single nucleotide variant | NM_022552.5(DNMT3A):c.1554+1G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003832391] | likely pathogenic | 2 | 25245252 | 25245252 | Human | 1 | name |
| 150540436 | CV1314561 | single nucleotide variant | NM_022552.5(DNMT3A):c.2173+1G>A | not provided [RCV001780993] | likely pathogenic | 2 | 25240639 | 25240639 | Human | | name |
| 151234417 | CV1320909 | single nucleotide variant | NM_022552.5(DNMT3A):c.2322+1G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV001801261] | pathogenic | 2 | 25240301 | 25240301 | Human | 1 | name |
| 151351586 | CV1324943 | single nucleotide variant | NM_022552.5(DNMT3A):c.1668-1G>A | not provided [RCV001810521] | not provided | 2 | 25244339 | 25244339 | Human | | name |
| 151728041 | CV1335118 | single nucleotide variant | NM_022552.5(DNMT3A):c.1851+2T>C | not provided [RCV001844436] | not provided | 2 | 25244153 | 25244153 | Human | | name |
| 151788909 | CV1394126 | single nucleotide variant | NM_022552.5(DNMT3A):c.2409-1G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV002046908] | likely pathogenic | 2 | 25237006 | 25237006 | Human | 1 | name |
| 151829541 | CV1491513 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+3A>G | Tatton-Brown-Rahman overgrowth syndrome [RCV002030662] | uncertain significance | 2 | 25235704 | 25235704 | Human | 1 | name |
| 152089547 | CV1580677 | single nucleotide variant | NM_022552.5(DNMT3A):c.2598-7C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002093977] | likely benign | 2 | 25234427 | 25234427 | Human | 1 | name |
| 152155248 | CV1668253 | single nucleotide variant | NM_022552.5(DNMT3A):c.2478+2T>G | not provided [RCV002221989] | not provided | 2 | 25236934 | 25236934 | Human | | name |
| 155641694 | CV1709909 | single nucleotide variant | NM_022552.5(DNMT3A):c.1555-1G>T | not provided [RCV002293009] | pathogenic | 2 | 25244653 | 25244653 | Human | | name |
| 156413353 | CV1887849 | single nucleotide variant | NM_022552.5(DNMT3A):c.1122+9C>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003073256] | likely benign | 2 | 25247042 | 25247042 | Human | 1 | name |
| 156264625 | CV1910155 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+7G>A | DNMT3A-related disorder [RCV003973692]|Tatton-Brown-Rahman overgrowth syndrome [RCV002627882] | likely benign | 2 | 25235700 | 25235700 | Human | 1 | name , trait , alternate_id |
| 156365298 | CV1912954 | single nucleotide variant | NM_022552.5(DNMT3A):c.1475-4C>G | DNMT3A-related disorder [RCV003918914]|Tatton-Brown-Rahman overgrowth syndrome [RCV002602784] | likely benign | 2 | 25245336 | 25245336 | Human | 1 | name , trait , alternate_id |
| 156418569 | CV1922337 | deletion | NM_022552.5(DNMT3A):c.1015-3del | Tatton-Brown-Rahman overgrowth syndrome [RCV002611768] | benign | 2 | 25247161 | 25247161 | Human | 1 | name |
| 156125321 | CV2046679 | single nucleotide variant | NM_022552.5(DNMT3A):c.1852-9A>G | Tatton-Brown-Rahman overgrowth syndrome [RCV002800393] | likely benign | 2 | 25243991 | 25243991 | Human | 1 | name |
| 156202345 | CV2076540 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-17G>C | Tatton-Brown-Rahman overgrowth syndrome [RCV002852512] | likely benign | 2 | 25248269 | 25248269 | Human | 1 | name |
| 155977396 | CV2100161 | single nucleotide variant | NM_022552.5(DNMT3A):c.1555-8C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002881768] | likely benign|uncertain significance | 2 | 25244660 | 25244660 | Human | 1 | name |
| 155949599 | CV2123400 | single nucleotide variant | NM_022552.5(DNMT3A):c.1123-4C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002971786] | likely benign | 2 | 25246780 | 25246780 | Human | 1 | name |
| 155932751 | CV2290862 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+48C>G | DNMT3A-related disorder [RCV003404171]|Inborn genetic diseases [RCV002861219] | uncertain significance | 2 | 25282393 | 25282393 | Human | 1 | name , trait , alternate_id |
| 243053235 | CV2418160 | single nucleotide variant | NM_022552.5(DNMT3A):c.2479-1G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003153226] | likely pathogenic | 2 | 25235826 | 25235826 | Human | 1 | name |
| 329847922 | CV2524636 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+1G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003227565] | pathogenic | 2 | 25235706 | 25235706 | Human | 1 | name |
| 401722986 | CV2737764 | single nucleotide variant | NM_022552.5(DNMT3A):c.1667+5G>A | not provided [RCV003314936] | uncertain significance | 2 | 25244535 | 25244535 | Human | | name |
| 401741983 | CV2738883 | single nucleotide variant | NM_022552.5(DNMT3A):c.1123-2A>G | not provided [RCV003318277] | uncertain significance | 2 | 25246778 | 25246778 | Human | | name |
| 401937484 | CV2815587 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+40C>A | not provided [RCV003415519] | uncertain significance | 2 | 25282401 | 25282401 | Human | | name |
| 401964030 | CV2843466 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+48C>A | DNMT3A-related disorder [RCV004747299]|not specified [RCV003479808] | likely benign|uncertain significance | 2 | 25282393 | 25282393 | Human | | name , trait , alternate_id |
| 405149003 | CV2855484 | single nucleotide variant | NM_022552.5(DNMT3A):c.493-14T>G | Tatton-Brown-Rahman overgrowth syndrome [RCV003585478] | likely benign | 2 | 25275101 | 25275101 | Human | 1 | name |
| 405139927 | CV2882014 | single nucleotide variant | NM_022552.5(DNMT3A):c.1852-5C>T | DNMT3A-related disorder [RCV003919286]|Tatton-Brown-Rahman overgrowth syndrome [RCV003584036] | likely benign | 2 | 25243987 | 25243987 | Human | 1 | name , trait , alternate_id |
| 405140409 | CV2882604 | single nucleotide variant | NM_022552.5(DNMT3A):c.1667+1G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003584060] | likely pathogenic | 2 | 25244539 | 25244539 | Human | 1 | name |
| 405150632 | CV2885044 | single nucleotide variant | NM_022552.5(DNMT3A):c.1015-9T>C | Tatton-Brown-Rahman overgrowth syndrome [RCV003585622] | likely benign | 2 | 25247167 | 25247167 | Human | 1 | name |
| 405141126 | CV2899506 | single nucleotide variant | NM_022552.5(DNMT3A):c.856-14C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003584128] | likely benign | 2 | 25247763 | 25247763 | Human | 1 | name |
| 405142000 | CV2909066 | single nucleotide variant | NM_022552.5(DNMT3A):c.1667+3G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003584243] | uncertain significance | 2 | 25244537 | 25244537 | Human | 1 | name |
| 405248772 | CV2963712 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-10G>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003746905] | likely benign | 2 | 25248262 | 25248262 | Human | 1 | name |
| 405249896 | CV3003489 | single nucleotide variant | NM_022552.5(DNMT3A):c.1015-8C>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003747320] | likely benign | 2 | 25247166 | 25247166 | Human | 1 | name |
| 405247256 | CV3035425 | single nucleotide variant | NM_022552.5(DNMT3A):c.1123-9A>G | Tatton-Brown-Rahman overgrowth syndrome [RCV003746301] | likely benign | 2 | 25246785 | 25246785 | Human | 1 | name |
| 405247605 | CV3044650 | single nucleotide variant | NM_022552.5(DNMT3A):c.493-15G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003746436] | likely benign | 2 | 25275102 | 25275102 | Human | 1 | name |
| 405090059 | CV3167835 | single nucleotide variant | NM_022552.5(DNMT3A):c.177+10A>G | Tatton-Brown-Rahman overgrowth syndrome [RCV003852225] | likely benign | 2 | 25300129 | 25300129 | Human | 1 | name |
| 405287088 | CV3193022 | single nucleotide variant | NM_022552.5(DNMT3A):c.2173+9C>T | DNMT3A-related disorder [RCV003981696] | likely benign | 2 | 25240631 | 25240631 | Human | | name , trait , alternate_id |
| 405261890 | CV3194319 | single nucleotide variant | NM_022552.5(DNMT3A):c.1014+7T>C | DNMT3A-related disorder [RCV003896352] | likely benign | 2 | 25247584 | 25247584 | Human | | name , trait , alternate_id |
| 405259801 | CV3195243 | single nucleotide variant | NM_022552.5(DNMT3A):c.1015-4C>G | DNMT3A-related disorder [RCV003894438]|Tatton-Brown-Rahman overgrowth syndrome [RCV005101620] | likely benign | 2 | 25247162 | 25247162 | Human | 1 | name , trait , alternate_id |
| 405264955 | CV3201420 | single nucleotide variant | NM_022552.5(DNMT3A):c.2479-7C>A | DNMT3A-related disorder [RCV003897178] | likely benign | 2 | 25235832 | 25235832 | Human | | name , trait , alternate_id |
| 405269658 | CV3201782 | single nucleotide variant | NM_022552.5(DNMT3A):c.1936+3G>A | DNMT3A-related disorder [RCV003899687]|Tatton-Brown-Rahman overgrowth syndrome [RCV005064754] | likely benign|uncertain significance | 2 | 25243895 | 25243895 | Human | 1 | name , trait , alternate_id |
| 405279051 | CV3217336 | single nucleotide variant | NM_022552.5(DNMT3A):c.1936+8G>A | DNMT3A-related disorder [RCV003976774]|Tatton-Brown-Rahman overgrowth syndrome [RCV005103092] | likely benign | 2 | 25243890 | 25243890 | Human | 1 | name , trait , alternate_id |
| 405278734 | CV3220366 | single nucleotide variant | NM_022552.5(DNMT3A):c.2479-6A>G | DNMT3A-related disorder [RCV003976588] | likely benign | 2 | 25235831 | 25235831 | Human | | name , trait , alternate_id |
| 408368141 | CV3224481 | single nucleotide variant | NM_022552.5(DNMT3A):c.1430-1G>C | Tatton-Brown-Rahman overgrowth syndrome [RCV004723560] | likely pathogenic | 2 | 25246065 | 25246065 | Human | 1 | name |
| 405709749 | CV3225680 | single nucleotide variant | NM_022552.5(DNMT3A):c.2598-1G>C | Tatton-Brown-Rahman overgrowth syndrome [RCV003990738] | likely pathogenic | 2 | 25234421 | 25234421 | Human | 1 | name |
| 407480672 | CV3415321 | single nucleotide variant | NM_022552.5(DNMT3A):c.2409-2A>T | Tatton-Brown-Rahman overgrowth syndrome [RCV004596031] | pathogenic | 2 | 25237007 | 25237007 | Human | 1 | name |
| 407502728 | CV3495708 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+1G>T | not provided [RCV004697548] | likely pathogenic | 2 | 25235706 | 25235706 | Human | | name |
| 408375225 | CV3510578 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+6C>T | DNMT3A-related disorder [RCV004747867] | likely benign | 2 | 25235701 | 25235701 | Human | | name , trait , alternate_id |
| 408375313 | CV3511466 | single nucleotide variant | NM_022552.5(DNMT3A):c.1554+5G>A | DNMT3A-related disorder [RCV004747992] | likely benign | 2 | 25245248 | 25245248 | Human | | name , trait , alternate_id |
| 408373881 | CV3513266 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+17A>T | DNMT3A-related disorder [RCV004745814] | likely benign | 2 | 25282424 | 25282424 | Human | | name , trait , alternate_id |
| 408373921 | CV3513457 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+50C>G | DNMT3A-related disorder [RCV004745850] | likely benign | 2 | 25282391 | 25282391 | Human | | name , trait , alternate_id |
| 408374160 | CV3515145 | single nucleotide variant | NM_022552.5(DNMT3A):c.1429+9C>G | DNMT3A-related disorder [RCV004746078] | likely benign | 2 | 25246151 | 25246151 | Human | | name , trait , alternate_id |
| 408374301 | CV3515557 | single nucleotide variant | NM_022552.5(DNMT3A):c.1015-7C>T | DNMT3A-related disorder [RCV004746648] | likely benign | 2 | 25247165 | 25247165 | Human | | name , trait , alternate_id |
| 596920379 | CV3534562 | single nucleotide variant | NM_022552.5(DNMT3A):c.2082+3A>G | not specified [RCV004782123] | uncertain significance | 2 | 25241559 | 25241559 | Human | | name |
| 596939863 | CV3543124 | single nucleotide variant | NM_022552.5(DNMT3A):c.2408+2T>C | Tatton-Brown-Rahman overgrowth syndrome [RCV004798996] | likely pathogenic | 2 | 25239128 | 25239128 | Human | 1 | name |
| 597907119 | CV3781432 | single nucleotide variant | NM_022552.5(DNMT3A):c.2083-7C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV005128120] | likely benign | 2 | 25240737 | 25240737 | Human | 1 | name |
| 597974020 | CV3801697 | single nucleotide variant | NM_022552.5(DNMT3A):c.2174-7C>G | Tatton-Brown-Rahman overgrowth syndrome [RCV005143686] | uncertain significance | 2 | 25240457 | 25240457 | Human | 1 | name |
| 597882495 | CV3803137 | single nucleotide variant | NM_022552.5(DNMT3A):c.1555-3T>C | Tatton-Brown-Rahman overgrowth syndrome [RCV005149988] | uncertain significance | 2 | 25244655 | 25244655 | Human | 1 | name |
| 597887696 | CV3804348 | single nucleotide variant | NM_022552.5(DNMT3A):c.492+13C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV005150799] | likely benign | 2 | 25275487 | 25275487 | Human | 1 | name |
| 597944532 | CV3812479 | single nucleotide variant | NM_022552.5(DNMT3A):c.639+15G>C | Tatton-Brown-Rahman overgrowth syndrome [RCV005159689] | likely benign | 2 | 25274926 | 25274926 | Human | 1 | name |
| 597866413 | CV3834457 | single nucleotide variant | NM_022552.5(DNMT3A):c.2598-1G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV005175824] | uncertain significance | 2 | 25234421 | 25234421 | Human | 1 | name |
| 597902641 | CV3835927 | single nucleotide variant | NM_022552.5(DNMT3A):c.1015-6C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV005181462] | likely benign | 2 | 25247164 | 25247164 | Human | 1 | name |
| 597946993 | CV3841787 | single nucleotide variant | NM_022552.5(DNMT3A):c.1015-3C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV005189221] | uncertain significance | 2 | 25247161 | 25247161 | Human | 1 | name |
| 597922453 | CV3843251 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+20G>T | Tatton-Brown-Rahman overgrowth syndrome [RCV005184543] | likely benign | 2 | 25282421 | 25282421 | Human | 1 | name |
| 597945276 | CV3844194 | single nucleotide variant | NM_022552.5(DNMT3A):c.449-17T>C | Tatton-Brown-Rahman overgrowth syndrome [RCV005188803] | likely benign | 2 | 25275560 | 25275560 | Human | 1 | name |
| 597951247 | CV3847130 | single nucleotide variant | NM_022552.5(DNMT3A):c.639+19T>A | Tatton-Brown-Rahman overgrowth syndrome [RCV005190302] | likely benign | 2 | 25274922 | 25274922 | Human | 1 | name |
| 597932309 | CV3863231 | single nucleotide variant | NM_022552.5(DNMT3A):c.1474+4A>T | Tatton-Brown-Rahman overgrowth syndrome [RCV005206757] | uncertain significance | 2 | 25246016 | 25246016 | Human | 1 | name |
| 12893981 | CV405693 | single nucleotide variant | NM_022552.5(DNMT3A):c.1015-2A>G | not provided [RCV000481026] | likely pathogenic | 2 | 25247160 | 25247160 | Human | | name |
| 13213064 | CV428045 | single nucleotide variant | NM_022552.5(DNMT3A):c.2598-3C>T | DNMT3A-related disorder [RCV003900041]|Tatton-Brown-Rahman overgrowth syndrome [RCV002527239]|not specified [RCV000499457] | likely benign|uncertain significance | 2 | 25234423 | 25234423 | Human | 1 | name , trait , alternate_id |
| 13213878 | CV428049 | single nucleotide variant | NM_022552.5(DNMT3A):c.1015-4C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003746529]|not specified [RCV000500562] | likely benign|uncertain significance | 2 | 25247162 | 25247162 | Human | 1 | name |
| 13473187 | CV443219 | single nucleotide variant | NM_022552.5(DNMT3A):c.2478+1G>T | not provided [RCV000519319] | likely pathogenic | 2 | 25236935 | 25236935 | Human | | name |
| 15179645 | CV777287 | single nucleotide variant | NM_022552.5(DNMT3A):c.1280-7C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV000951567]|not provided [RCV001683697] | benign | 2 | 25246316 | 25246316 | Human | 1 | name |
| 26907543 | CV851412 | single nucleotide variant | NM_022552.5(DNMT3A):c.1122+3G>A | DNMT3A-related disorder [RCV003898044]|Tatton-Brown-Rahman overgrowth syndrome [RCV001038011] | likely benign|uncertain significance | 2 | 25247048 | 25247048 | Human | 1 | name , trait , alternate_id |
| 28907546 | CV859152 | single nucleotide variant | NM_022552.5(DNMT3A):c.1851+1G>C | not provided [RCV001093355] | pathogenic | 2 | 25244154 | 25244154 | Human | | name |
| 40816433 | CV967263 | single nucleotide variant | NM_022552.5(DNMT3A):c.1937-2A>G | Tatton-Brown-Rahman overgrowth syndrome [RCV001258351]|not provided [RCV001560963] | pathogenic | 2 | 25241709 | 25241709 | Human | 1 | name |
| 8577090 | CV111460 | single nucleotide variant | NM_175629.2(DNMT3A):c.72+4863A>C | Lung cancer [RCV000091983] | uncertain significance | 2 | 25309050 | 25309050 | Human | | name |
| 150331117 | CV1168907 | single nucleotide variant | NM_022552.5(DNMT3A):c.177+213C>T | not provided [RCV001536340] | benign | 2 | 25299926 | 25299926 | Human | | name |
| 150334718 | CV1170942 | single nucleotide variant | NM_022552.5(DNMT3A):c.493-111G>T | not provided [RCV001540201] | likely benign | 2 | 25275198 | 25275198 | Human | | name |
| 150422444 | CV1179500 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-155T>C | not provided [RCV001552642] | likely benign | 2 | 25248407 | 25248407 | Human | | name |
| 150419523 | CV1179501 | duplication | NM_022552.5(DNMT3A):c.493-181dup | not provided [RCV001551100] | likely benign | 2 | 25275261 | 25275262 | Human | | name |
| 150423831 | CV1183153 | single nucleotide variant | NM_022552.5(DNMT3A):c.2598-62G>A | not provided [RCV001555857] | likely benign | 2 | 25234482 | 25234482 | Human | | name |
| 150423557 | CV1183154 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+78T>C | not provided [RCV001555488] | likely benign | 2 | 25235629 | 25235629 | Human | | name |
| 150423913 | CV1183158 | single nucleotide variant | NM_022552.5(DNMT3A):c.177+339C>T | not provided [RCV001555961] | likely benign | 2 | 25299800 | 25299800 | Human | | name |
| 150426720 | CV1186422 | single nucleotide variant | NM_022552.5(DNMT3A):c.493-171C>G | not provided [RCV001559933] | likely benign | 2 | 25275258 | 25275258 | Human | | name |
| 150409298 | CV1189862 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+104G>A | not provided [RCV001565618] | likely benign | 2 | 25282337 | 25282337 | Human | | name |
| 150406349 | CV1189863 | single nucleotide variant | NM_022552.5(DNMT3A):c.178-300G>A | not provided [RCV001564659] | likely benign | 2 | 25283011 | 25283011 | Human | | name |
| 150503569 | CV1212509 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+30G>A | not provided [RCV001595384] | benign | 2 | 25235677 | 25235677 | Human | | name |
| 150508024 | CV1213921 | single nucleotide variant | NM_022552.5(DNMT3A):c.1279+18G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV002072362]|not provided [RCV001596442] | benign|likely benign | 2 | 25246602 | 25246602 | Human | 1 | name |
| 150498219 | CV1224100 | single nucleotide variant | NM_022552.5(DNMT3A):c.178-213A>G | not provided [RCV001620212] | benign | 2 | 25282924 | 25282924 | Human | | name |
| 150494814 | CV1224964 | single nucleotide variant | NM_022552.5(DNMT3A):c.2173+26C>T | not provided [RCV001619442] | benign | 2 | 25240614 | 25240614 | Human | 1 | name |
| 150463265 | CV1235030 | single nucleotide variant | NM_022552.5(DNMT3A):c.1852-37C>A | not provided [RCV001649612] | benign | 2 | 25244019 | 25244019 | Human | | name |
| 150459508 | CV1268353 | single nucleotide variant | NM_022552.5(DNMT3A):c.1430-13C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002073238]|not provided [RCV001693350] | benign | 2 | 25246077 | 25246077 | Human | 1 | name |
| 150449401 | CV1275666 | single nucleotide variant | NM_022552.5(DNMT3A):c.448+118G>C | not provided [RCV001708121] | benign | 2 | 25282323 | 25282323 | Human | | name |
| 150492890 | CV1281489 | single nucleotide variant | NM_022552.5(DNMT3A):c.449-153G>C | not provided [RCV001716898] | benign | 2 | 25275696 | 25275696 | Human | | name |
| 152036748 | CV1521755 | single nucleotide variant | NM_022552.5(DNMT3A):c.1122+17G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV002187629] | likely benign | 2 | 25247034 | 25247034 | Human | 1 | name |
| 152069545 | CV1526570 | single nucleotide variant | NM_022552.5(DNMT3A):c.2478+13G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV002074911] | likely benign | 2 | 25236923 | 25236923 | Human | 1 | name |
| 152133007 | CV1585178 | single nucleotide variant | NM_022552.5(DNMT3A):c.2083-20C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002083125] | likely benign | 2 | 25240750 | 25240750 | Human | 1 | name |
| 152082692 | CV1589624 | single nucleotide variant | NM_022552.5(DNMT3A):c.2083-19G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV002112970] | likely benign | 2 | 25240749 | 25240749 | Human | 1 | name |
| 152037652 | CV1605679 | single nucleotide variant | NM_022552.5(DNMT3A):c.1555-13C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002087482] | likely benign | 2 | 25244665 | 25244665 | Human | 1 | name |
| 156187170 | CV1882507 | single nucleotide variant | NM_022552.5(DNMT3A):c.1014+19C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003083753] | likely benign | 2 | 25247572 | 25247572 | Human | 1 | name |
| 156292767 | CV1883823 | single nucleotide variant | NM_022552.5(DNMT3A):c.2478+12C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003087555] | likely benign | 2 | 25236924 | 25236924 | Human | 1 | name |
| 156288494 | CV1885020 | single nucleotide variant | NM_022552.5(DNMT3A):c.1429+17T>C | Tatton-Brown-Rahman overgrowth syndrome [RCV003061348] | likely benign | 2 | 25246143 | 25246143 | Human | 1 | name |
| 156101519 | CV1907136 | single nucleotide variant | NM_022552.5(DNMT3A):c.2082+20C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003080619] | likely benign | 2 | 25241542 | 25241542 | Human | 1 | name |
| 156151881 | CV1929393 | single nucleotide variant | NM_022552.5(DNMT3A):c.1123-10C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002624033] | likely benign | 2 | 25246786 | 25246786 | Human | 1 | name |
| 156394206 | CV2002705 | single nucleotide variant | NM_022552.5(DNMT3A):c.1474+19A>C | Tatton-Brown-Rahman overgrowth syndrome [RCV002681075] | likely benign | 2 | 25246001 | 25246001 | Human | 1 | name |
| 156382185 | CV2004894 | single nucleotide variant | NM_022552.5(DNMT3A):c.2323-16G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV002653739] | likely benign | 2 | 25239231 | 25239231 | Human | 1 | name |
| 155952921 | CV2033218 | single nucleotide variant | NM_022552.5(DNMT3A):c.2479-15C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002730777] | likely benign | 2 | 25235840 | 25235840 | Human | 1 | name |
| 156233601 | CV2093939 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+12G>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002894647] | likely benign | 2 | 25235695 | 25235695 | Human | 1 | name |
| 156183956 | CV2102583 | single nucleotide variant | NM_022552.5(DNMT3A):c.1123-14G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV002917236] | likely benign | 2 | 25246790 | 25246790 | Human | 1 | name |
| 156091374 | CV2102686 | single nucleotide variant | NM_022552.5(DNMT3A):c.1668-12G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV002913050] | likely benign | 2 | 25244350 | 25244350 | Human | 1 | name |
| 156238440 | CV2108998 | single nucleotide variant | NM_022552.5(DNMT3A):c.1279+13A>C | Tatton-Brown-Rahman overgrowth syndrome [RCV002933111] | likely benign | 2 | 25246607 | 25246607 | Human | 1 | name |
| 155908212 | CV2130945 | single nucleotide variant | NM_022552.5(DNMT3A):c.1851+20C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV002967849] | likely benign | 2 | 25244135 | 25244135 | Human | 1 | name |
| 156161961 | CV2136862 | single nucleotide variant | NM_022552.5(DNMT3A):c.2408+14C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003005097] | likely benign | 2 | 25239116 | 25239116 | Human | 1 | name |
| 405149369 | CV2860044 | duplication | NM_022552.5(DNMT3A):c.2323-19dup | Tatton-Brown-Rahman overgrowth syndrome [RCV003585511] | likely benign | 2 | 25239233 | 25239234 | Human | 1 | name |
| 405148428 | CV2864125 | single nucleotide variant | NM_022552.5(DNMT3A):c.1123-15C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003585430] | uncertain significance | 2 | 25246791 | 25246791 | Human | 1 | name |
| 405149996 | CV2868628 | single nucleotide variant | NM_022552.5(DNMT3A):c.1430-14T>C | Tatton-Brown-Rahman overgrowth syndrome [RCV003585566] | likely benign | 2 | 25246078 | 25246078 | Human | 1 | name |
| 405149459 | CV2873966 | single nucleotide variant | NM_022552.5(DNMT3A):c.1667+16C>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003585519] | likely benign | 2 | 25244524 | 25244524 | Human | 1 | name |
| 405149640 | CV2878155 | single nucleotide variant | NM_022552.5(DNMT3A):c.1554+12C>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003585535] | likely benign | 2 | 25245241 | 25245241 | Human | 1 | name |
| 405141279 | CV2895914 | single nucleotide variant | NM_022552.5(DNMT3A):c.2323-17C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003584145] | likely benign | 2 | 25239232 | 25239232 | Human | 1 | name |
| 405141407 | CV2906647 | single nucleotide variant | NM_022552.5(DNMT3A):c.2174-10G>A | DNMT3A-related disorder [RCV004747326]|Tatton-Brown-Rahman overgrowth syndrome [RCV003584158] | likely benign | 2 | 25240460 | 25240460 | Human | 1 | name , trait , alternate_id |
| 405247706 | CV3038871 | single nucleotide variant | NM_022552.5(DNMT3A):c.1123-12G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003746326] | likely benign | 2 | 25246788 | 25246788 | Human | 1 | name |
| 405247684 | CV3048551 | single nucleotide variant | NM_022552.5(DNMT3A):c.1122+15T>A | Tatton-Brown-Rahman overgrowth syndrome [RCV003746467] | likely benign | 2 | 25247036 | 25247036 | Human | 1 | name |
| 405250299 | CV3060633 | single nucleotide variant | NM_022552.5(DNMT3A):c.2083-19G>C | Tatton-Brown-Rahman overgrowth syndrome [RCV003747467] | likely benign | 2 | 25240749 | 25240749 | Human | 1 | name |
| 405250340 | CV3064442 | single nucleotide variant | NM_022552.5(DNMT3A):c.1475-19C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003747484] | likely benign | 2 | 25245351 | 25245351 | Human | 1 | name |
| 405239110 | CV3165834 | single nucleotide variant | NM_022552.5(DNMT3A):c.1851+19G>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003866846] | likely benign | 2 | 25244136 | 25244136 | Human | 1 | name |
| 402466693 | CV3177696 | single nucleotide variant | NM_022552.5(DNMT3A):c.2174-11C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV003873134] | likely benign | 2 | 25240461 | 25240461 | Human | 1 | name |
| 405277838 | CV3190980 | single nucleotide variant | NM_022552.5(DNMT3A):c.2479-10C>T | DNMT3A-related disorder [RCV003904702]|Tatton-Brown-Rahman overgrowth syndrome [RCV005064794] | likely benign | 2 | 25235835 | 25235835 | Human | 1 | name , trait , alternate_id |
| 408373758 | CV3512390 | single nucleotide variant | NM_022552.5(DNMT3A):c.2082+10T>C | DNMT3A-related disorder [RCV004745689]|Tatton-Brown-Rahman overgrowth syndrome [RCV005059846] | likely benign | 2 | 25241552 | 25241552 | Human | 1 | name , trait , alternate_id |
| 597870735 | CV3749953 | single nucleotide variant | NM_022552.5(DNMT3A):c.1936+14G>T | Tatton-Brown-Rahman overgrowth syndrome [RCV005068634] | likely benign | 2 | 25243884 | 25243884 | Human | 1 | name |
| 597959372 | CV3752289 | single nucleotide variant | NM_022552.5(DNMT3A):c.2408+12C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV005081239] | likely benign | 2 | 25239118 | 25239118 | Human | 1 | name |
| 597953562 | CV3776445 | single nucleotide variant | NM_022552.5(DNMT3A):c.2173+18C>T | Tatton-Brown-Rahman overgrowth syndrome [RCV005121573] | likely benign | 2 | 25240622 | 25240622 | Human | 1 | name |
| 597944612 | CV3776642 | single nucleotide variant | NM_022552.5(DNMT3A):c.2174-19T>G | Tatton-Brown-Rahman overgrowth syndrome [RCV005119498] | likely benign | 2 | 25240469 | 25240469 | Human | 1 | name |
| 597901878 | CV3779164 | single nucleotide variant | NM_022552.5(DNMT3A):c.2083-15C>G | Tatton-Brown-Rahman overgrowth syndrome [RCV005127241] | uncertain significance | 2 | 25240745 | 25240745 | Human | 1 | name |
| 597869100 | CV3803436 | single nucleotide variant | NM_022552.5(DNMT3A):c.1936+10G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV005148033] | likely benign | 2 | 25243888 | 25243888 | Human | 1 | name |
| 597898748 | CV3826671 | single nucleotide variant | NM_022552.5(DNMT3A):c.1015-20G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV005180804] | likely benign | 2 | 25247178 | 25247178 | Human | 1 | name |
| 597907597 | CV3843029 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+12G>A | Tatton-Brown-Rahman overgrowth syndrome [RCV005182337] | likely benign | 2 | 25235695 | 25235695 | Human | 1 | name |
| 597933068 | CV3844598 | single nucleotide variant | NM_022552.5(DNMT3A):c.1852-20C>A | Tatton-Brown-Rahman overgrowth syndrome [RCV005186104] | likely benign | 2 | 25244002 | 25244002 | Human | 1 | name |
| 597915457 | CV3851252 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+15C>A | Tatton-Brown-Rahman overgrowth syndrome [RCV005204220] | likely benign | 2 | 25235692 | 25235692 | Human | 1 | name |
| 150330609 | CV1170940 | single nucleotide variant | NM_022552.5(DNMT3A):c.2408+223T>C | not provided [RCV001538178] | likely benign | 2 | 25238907 | 25238907 | Human | | name |
| 150337525 | CV1170941 | single nucleotide variant | NM_022552.5(DNMT3A):c.2083-272G>A | not provided [RCV001541706] | benign | 2 | 25241002 | 25241002 | Human | 1 | name |
| 150337525 | CV1170941 | single nucleotide variant | NM_022552.5(DNMT3A):c.2083-272G>A | not provided [RCV001541706] | benign | 2 | 25241002 | 25241003 | Human | 1 | name |
| 150414111 | CV1176137 | duplication | NM_022552.5(DNMT3A):c.2479-258dup | not provided [RCV001548000] | likely benign | 2 | 25236067 | 25236068 | Human | | name |
| 150422429 | CV1179498 | single nucleotide variant | NM_022552.5(DNMT3A):c.2322+118G>A | not provided [RCV001552622] | likely benign | 2 | 25240184 | 25240184 | Human | | name |
| 150424790 | CV1183155 | single nucleotide variant | NM_022552.5(DNMT3A):c.2409-253C>T | not provided [RCV001557129] | likely benign | 2 | 25237258 | 25237258 | Human | | name |
| 150424740 | CV1183157 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3916G>T | not provided [RCV001557061] | likely benign | 2 | 25252168 | 25252168 | Human | | name |
| 150406438 | CV1193123 | single nucleotide variant | NM_022552.5(DNMT3A):c.2409-172C>T | not provided [RCV001572022] | likely benign | 2 | 25237177 | 25237177 | Human | | name |
| 150465716 | CV1201123 | single nucleotide variant | NM_022552.5(DNMT3A):c.-177-158G>A | not provided [RCV001587603] | likely benign | 2 | 25314319 | 25314319 | Human | | name |
| 150438405 | CV1201398 | single nucleotide variant | NM_022552.5(DNMT3A):c.1279+143G>A | not provided [RCV001583210] | likely benign | 2 | 25246477 | 25246477 | Human | | name |
| 150462534 | CV1206603 | single nucleotide variant | NM_022552.5(DNMT3A):c.2409-127G>C | not provided [RCV001587004] | likely benign | 2 | 25237132 | 25237132 | Human | | name |
| 150481106 | CV1209728 | single nucleotide variant | NM_022552.5(DNMT3A):c.2409-290T>C | not provided [RCV001590425] | likely benign | 2 | 25237295 | 25237295 | Human | | name |
| 150475673 | CV1216700 | single nucleotide variant | NM_022552.5(DNMT3A):c.1554+255A>T | not provided [RCV001615993] | benign | 2 | 25244998 | 25244998 | Human | | name |
| 150457349 | CV1269477 | single nucleotide variant | NM_022552.5(DNMT3A):c.2479-159T>C | not provided [RCV001693017] | benign | 2 | 25235984 | 25235984 | Human | | name |
| 150485104 | CV1280648 | single nucleotide variant | NM_022552.5(DNMT3A):c.2322+183C>T | not provided [RCV001715520] | benign | 2 | 25240119 | 25240119 | Human | | name |
| 150504691 | CV1286008 | single nucleotide variant | NM_022552.5(DNMT3A):c.2597+197C>T | not provided [RCV001719431] | benign | 2 | 25235510 | 25235510 | Human | | name |
| 150504827 | CV1286035 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1663G>A | not provided [RCV001719458] | benign | 2 | 25249915 | 25249915 | Human | | name |
| 150504857 | CV1286041 | single nucleotide variant | NM_022552.5(DNMT3A):c.2323-243G>C | not provided [RCV001719464] | benign | 2 | 25239458 | 25239458 | Human | | name |
| 156265588 | CV2299232 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1461C>T | Inborn genetic diseases [RCV002855699] | uncertain significance | 2 | 25249713 | 25249713 | Human | 1 | name |
| 401908917 | CV2798905 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3760T>C | DNMT3A-related disorder [RCV003397688] | uncertain significance | 2 | 25252012 | 25252012 | Human | | name , trait , alternate_id |
| 401916414 | CV2799662 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3841T>A | DNMT3A-related disorder [RCV003429072] | uncertain significance | 2 | 25252093 | 25252093 | Human | | name , trait , alternate_id |
| 401911595 | CV2800350 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3749G>A | DNMT3A-related disorder [RCV003399589] | uncertain significance | 2 | 25252001 | 25252001 | Human | | name , trait , alternate_id |
| 401934903 | CV2800672 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1408T>A | DNMT3A-related disorder [RCV003412340] | uncertain significance | 2 | 25249660 | 25249660 | Human | | name , trait , alternate_id |
| 401931751 | CV2801488 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3659G>A | DNMT3A-related disorder [RCV003408466] | uncertain significance | 2 | 25251911 | 25251911 | Human | | name , trait , alternate_id |
| 401910886 | CV2815585 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3676C>G | DNMT3A-related disorder [RCV003938972]|not provided [RCV003425532] | benign|likely benign | 2 | 25251928 | 25251928 | Human | | name , trait , alternate_id |
| 401929384 | CV2815586 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3791G>A | not provided [RCV003407175] | benign | 2 | 25252043 | 25252043 | Human | | name |
| 405282559 | CV3191088 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3717G>A | DNMT3A-related disorder [RCV003921505] | likely benign | 2 | 25251969 | 25251969 | Human | | name , trait , alternate_id |
| 405292571 | CV3192860 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1471G>A | DNMT3A-related disorder [RCV003964622] | likely benign | 2 | 25249723 | 25249723 | Human | | name , trait , alternate_id |
| 405259145 | CV3194510 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1438C>T | DNMT3A-related disorder [RCV003893907] | likely benign | 2 | 25249690 | 25249690 | Human | | name , trait , alternate_id |
| 405289676 | CV3218337 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3764C>A | DNMT3A-related disorder [RCV003983739] | uncertain significance | 2 | 25252016 | 25252016 | Human | | name , trait , alternate_id |
| 405278827 | CV3220476 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3830C>G | DNMT3A-related disorder [RCV003976668] | uncertain significance | 2 | 25252082 | 25252082 | Human | | name , trait , alternate_id |
| 408371240 | CV3503705 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1404G>A | DNMT3A-related disorder [RCV004724590] | uncertain significance | 2 | 25249656 | 25249656 | Human | | name , trait , alternate_id |
| 408382368 | CV3504530 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3803G>A | DNMT3A-related disorder [RCV004729831] | uncertain significance | 2 | 25252055 | 25252055 | Human | | name , trait , alternate_id |
| 408378502 | CV3505289 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1449A>G | DNMT3A-related disorder [RCV004727995] | uncertain significance | 2 | 25249701 | 25249701 | Human | | name , trait , alternate_id |
| 408375772 | CV3506478 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3667G>C | DNMT3A-related disorder [RCV004726319] | uncertain significance | 2 | 25251919 | 25251919 | Human | | name , trait , alternate_id |
| 408374924 | CV3508644 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3766G>C | DNMT3A-related disorder [RCV004747624] | uncertain significance | 2 | 25252018 | 25252018 | Human | | name , trait , alternate_id |
| 408374986 | CV3508685 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3746C>T | DNMT3A-related disorder [RCV004747627] | uncertain significance | 2 | 25251998 | 25251998 | Human | | name , trait , alternate_id |
| 408375031 | CV3509076 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1426C>A | DNMT3A-related disorder [RCV004747679] | uncertain significance | 2 | 25249678 | 25249678 | Human | | name , trait , alternate_id |
| 408375089 | CV3509510 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3690G>A | DNMT3A-related disorder [RCV004747733] | likely benign | 2 | 25251942 | 25251942 | Human | | name , trait , alternate_id |
| 408375136 | CV3510236 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3832G>A | DNMT3A-related disorder [RCV004747828] | uncertain significance | 2 | 25252084 | 25252084 | Human | | name , trait , alternate_id |
| 408375240 | CV3510678 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3813G>T | DNMT3A-related disorder [RCV004747883] | likely benign | 2 | 25252065 | 25252065 | Human | | name , trait , alternate_id |
| 408373745 | CV3512115 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1437G>A | DNMT3A-related disorder [RCV004745672] | uncertain significance | 2 | 25249689 | 25249689 | Human | | name , trait , alternate_id |
| 408373792 | CV3512685 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3774G>A | DNMT3A-related disorder [RCV004745727] | likely benign | 2 | 25252026 | 25252026 | Human | | name , trait , alternate_id |
| 408373814 | CV3512834 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3947T>C | DNMT3A-related disorder [RCV004745749] | likely benign | 2 | 25252199 | 25252199 | Human | | name , trait , alternate_id |
| 408373891 | CV3513049 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3811C>G | DNMT3A-related disorder [RCV004745779] | uncertain significance | 2 | 25252063 | 25252063 | Human | | name , trait , alternate_id |
| 408373845 | CV3513053 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3800C>T | DNMT3A-related disorder [RCV004745780] | uncertain significance | 2 | 25252052 | 25252052 | Human | | name , trait , alternate_id |
| 408373862 | CV3513149 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3827G>A | DNMT3A-related disorder [RCV004745797] | uncertain significance | 2 | 25252079 | 25252079 | Human | | name , trait , alternate_id |
| 408373944 | CV3513643 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1417C>T | DNMT3A-related disorder [RCV004745871] | likely benign | 2 | 25249669 | 25249669 | Human | | name , trait , alternate_id |
| 408373996 | CV3513767 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3678G>C | DNMT3A-related disorder [RCV004745887] | likely benign | 2 | 25251930 | 25251930 | Human | | name , trait , alternate_id |
| 408374007 | CV3513884 | duplication | NM_022552.5(DNMT3A):c.640-3735dup | DNMT3A-related disorder [RCV004745899] | uncertain significance | 2 | 25251986 | 25251987 | Human | | name , trait , alternate_id |
| 408374694 | CV3518030 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-3848T>G | DNMT3A-related disorder [RCV004747020] | likely benign | 2 | 25252100 | 25252100 | Human | | name , trait , alternate_id |
| 39456405 | CV965476 | single nucleotide variant | NM_022552.5(DNMT3A):c.640-1439G>A | DNMT3A-related disorder [RCV003953611]|not provided [RCV001254995] | likely benign|uncertain significance | 2 | 25249691 | 25249691 | Human | | name , trait , alternate_id |
| 8577091 | CV111461 | single nucleotide variant | NM_175629.2(DNMT3A):c.-178+8586G>A | Lung cancer [RCV000091984] | uncertain significance | 2 | 25333844 | 25333844 | Human | | name |
| 401830843 | CV2419800 | deletion | NM_022552.5(DNMT3A):c.1012_1014+3del | Heyn-Sproul-Jackson syndrome [RCV003330113] | pathogenic | 2 | 25247588 | 25247593 | Human | 1 | name |
| 127318494 | CV1154099 | single nucleotide variant | NM_022552.5(DNMT3A):c.27C>T (p.Pro9=) | Tatton-Brown-Rahman overgrowth syndrome [RCV001521675]|not provided [RCV001724335] | benign | 2 | 25313958 | 25313958 | Human | 1 | name |
| 405248730 | CV2952616 | single nucleotide variant | NM_022552.5(DNMT3A):c.21C>T (p.Ser7=) | DNMT3A-related disorder [RCV003956454]|Tatton-Brown-Rahman overgrowth syndrome [RCV003746892] | likely benign | 2 | 25313964 | 25313964 | Human | 1 | name , trait , alternate_id |
| 127307632 | CV1112622 | single nucleotide variant | NM_022552.5(DNMT3A):c.51G>A (p.Ala17=) | DNMT3A-related disorder [RCV003900595]|Tatton-Brown-Rahman overgrowth syndrome [RCV001463094] | likely benign | 2 | 25313934 | 25313934 | Human | 1 | name , trait , alternate_id |
| 156377057 | CV1930597 | single nucleotide variant | NM_022552.5(DNMT3A):c.7G>A (p.Ala3Thr) | DNMT3A-related disorder [RCV003984337]|Tatton-Brown-Rahman overgrowth syndrome [RCV002633926] | uncertain significance | 2 | 25313978 | 25313978 | Human | 1 | name , trait , alternate_id |
| 156012908 | CV2123022 | single nucleotide variant | NM_022552.5(DNMT3A):c.75C>T (p.Asp25=) | DNMT3A-related disorder [RCV003926618]|Tatton-Brown-Rahman overgrowth syndrome [RCV002975743] | likely benign | 2 | 25300241 | 25300241 | Human | 1 | name , trait , alternate_id |
| 405141418 | CV2906657 | single nucleotide variant | NM_022552.5(DNMT3A):c.96G>A (p.Pro32=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584159] | likely benign | 2 | 25300220 | 25300220 | Human | 1 | name |
| 405269241 | CV3201535 | microsatellite | NM_022552.5(DNMT3A):c.2174-4_2174-3del | DNMT3A-related disorder [RCV003899449] | likely benign | 2 | 25240453 | 25240454 | Human | | name , trait , alternate_id |
| 405261884 | CV3219986 | single nucleotide variant | NM_022552.5(DNMT3A):c.66C>T (p.Asp22=) | DNMT3A-related disorder [RCV003967138] | likely benign | 2 | 25313919 | 25313919 | Human | | name , trait , alternate_id |
| 408371394 | CV3503839 | microsatellite | NM_022552.5(DNMT3A):c.1851+2_1851+3del | DNMT3A-related disorder [RCV004724678] | uncertain significance | 2 | 25244152 | 25244153 | Human | | name , trait , alternate_id |
| 408374913 | CV3508581 | single nucleotide variant | NM_022552.5(DNMT3A):c.48T>C (p.Ala16=) | DNMT3A-related disorder [RCV004747614] | likely benign | 2 | 25313937 | 25313937 | Human | | name , trait , alternate_id |
| 408374065 | CV3514175 | single nucleotide variant | NM_022552.5(DNMT3A):c.93G>A (p.Glu31=) | DNMT3A-related disorder [RCV004745945] | likely benign | 2 | 25300223 | 25300223 | Human | | name , trait , alternate_id |
| 15167647 | CV747502 | single nucleotide variant | NM_022552.5(DNMT3A):c.36C>T (p.Thr12=) | Tatton-Brown-Rahman overgrowth syndrome [RCV001488436] | likely benign | 2 | 25313949 | 25313949 | Human | 1 | name |
| 15173460 | CV788680 | single nucleotide variant | NM_022552.5(DNMT3A):c.7G>T (p.Ala3Ser) | Multiple myeloma [RCV000984105] | likely pathogenic | 2 | 25313978 | 25313978 | Human | 2 | name |
| 150534024 | CV1307542 | single nucleotide variant | NM_022552.5(DNMT3A):c.12G>C (p.Met4Ile) | not provided [RCV001755679] | uncertain significance | 2 | 25313973 | 25313973 | Human | | name |
| 152028497 | CV1655262 | single nucleotide variant | NM_022552.5(DNMT3A):c.270T>C (p.Asn90=) | Tatton-Brown-Rahman overgrowth syndrome [RCV002105253] | likely benign | 2 | 25282619 | 25282619 | Human | 1 | name |
| 156437532 | CV1947537 | single nucleotide variant | NM_022552.5(DNMT3A):c.237C>A (p.Ala79=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003107071] | likely benign | 2 | 25282652 | 25282652 | Human | 1 | name |
| 156362142 | CV2016751 | single nucleotide variant | NM_022552.5(DNMT3A):c.19A>G (p.Ser7Gly) | Tatton-Brown-Rahman overgrowth syndrome [RCV002720937] | uncertain significance | 2 | 25313966 | 25313966 | Human | 1 | name |
| 156333072 | CV2172000 | single nucleotide variant | NM_022552.5(DNMT3A):c.267C>T (p.Pro89=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003029878] | likely benign | 2 | 25282622 | 25282622 | Human | 1 | name |
| 401945464 | CV2839607 | single nucleotide variant | NM_022552.5(DNMT3A):c.102C>T (p.Gly34=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003458183] | not provided | 2 | 25300214 | 25300214 | Human | | name |
| 405248898 | CV2960852 | deletion | NM_022552.5(DNMT3A):c.27del (p.Asp11fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746821] | pathogenic | 2 | 25313958 | 25313958 | Human | 1 | name |
| 405249060 | CV2965398 | single nucleotide variant | NM_022552.5(DNMT3A):c.147G>T (p.Gly49=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746975] | uncertain significance | 2 | 25300169 | 25300169 | Human | 1 | name |
| 405249712 | CV2991458 | single nucleotide variant | NM_022552.5(DNMT3A):c.249C>T (p.Gly83=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747243] | likely benign | 2 | 25282640 | 25282640 | Human | 1 | name |
| 405247014 | CV3029745 | single nucleotide variant | NM_022552.5(DNMT3A):c.174C>T (p.Pro58=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746202] | likely benign | 2 | 25300142 | 25300142 | Human | 1 | name |
| 405250450 | CV3059548 | single nucleotide variant | NM_022552.5(DNMT3A):c.186C>T (p.Ser62=) | DNMT3A-related disorder [RCV004747363]|Tatton-Brown-Rahman overgrowth syndrome [RCV003747534] | likely benign | 2 | 25282703 | 25282703 | Human | 1 | name , trait , alternate_id |
| 405250688 | CV3077641 | single nucleotide variant | NM_022552.5(DNMT3A):c.13C>T (p.Pro5Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747657] | uncertain significance | 2 | 25313972 | 25313972 | Human | 1 | name |
| 405138647 | CV3130742 | single nucleotide variant | NM_022552.5(DNMT3A):c.228A>G (p.Pro76=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003838976] | likely benign | 2 | 25282661 | 25282661 | Human | 1 | name |
| 402511943 | CV3178422 | single nucleotide variant | NM_022552.5(DNMT3A):c.162G>A (p.Lys54=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003879039] | likely benign | 2 | 25300154 | 25300154 | Human | 1 | name |
| 405260803 | CV3204364 | single nucleotide variant | NM_022552.5(DNMT3A):c.249C>A (p.Gly83=) | DNMT3A-related disorder [RCV003944193] | likely benign | 2 | 25282640 | 25282640 | Human | | name , trait , alternate_id |
| 408382337 | CV3504463 | single nucleotide variant | NM_022552.5(DNMT3A):c.213G>C (p.Val71=) | DNMT3A-related disorder [RCV004729781] | likely benign | 2 | 25282676 | 25282676 | Human | | name , trait , alternate_id |
| 408375712 | CV3506529 | single nucleotide variant | NM_022552.5(DNMT3A):c.14C>T (p.Pro5Leu) | DNMT3A-related disorder [RCV004726353] | uncertain significance | 2 | 25313971 | 25313971 | Human | | name , trait , alternate_id |
| 408375202 | CV3510696 | single nucleotide variant | NM_022552.5(DNMT3A):c.243C>T (p.Asp81=) | DNMT3A-related disorder [RCV004747886] | likely benign | 2 | 25282646 | 25282646 | Human | | name , trait , alternate_id |
| 408391274 | CV3523131 | duplication | NM_022552.5(DNMT3A):c.27dup (p.Gly10fs) | not provided [RCV004770503] | pathogenic | 2 | 25313957 | 25313958 | Human | | name |
| 597975767 | CV3828688 | single nucleotide variant | NM_022552.5(DNMT3A):c.195G>A (p.Thr65=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005169317] | likely benign | 2 | 25282694 | 25282694 | Human | 1 | name |
| 597907925 | CV3829833 | single nucleotide variant | NM_022552.5(DNMT3A):c.177G>A (p.Pro59=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005182402] | uncertain significance | 2 | 25300139 | 25300139 | Human | 1 | name |
| 15145981 | CV691111 | single nucleotide variant | NM_022552.5(DNMT3A):c.120G>A (p.Glu40=) | Acute myeloid leukemia [RCV002495331]|DNMT3A-related disorder [RCV003920472]|Tatton-Brown-Rahman overgrowth syndrome [RCV000878472]|not provided [RCV001585853] | benign|likely benign | 2 | 25300196 | 25300196 | Human | 4 | name , trait , alternate_id |
| 15168382 | CV697502 | single nucleotide variant | NM_022552.5(DNMT3A):c.16T>G (p.Ser6Ala) | DNMT3A-related disorder [RCV003970695]|Tatton-Brown-Rahman overgrowth syndrome [RCV000949244]|not provided [RCV001545677] | likely benign | 2 | 25313969 | 25313969 | Human | 1 | name , trait , alternate_id |
| 15202837 | CV747501 | single nucleotide variant | NM_022552.5(DNMT3A):c.210G>A (p.Ala70=) | DNMT3A-related disorder [RCV003913042]|Tatton-Brown-Rahman overgrowth syndrome [RCV000913570]|not provided [RCV001563018] | likely benign | 2 | 25282679 | 25282679 | Human | 1 | name , trait , alternate_id |
| 26900894 | CV826116 | single nucleotide variant | NM_022552.5(DNMT3A):c.240G>A (p.Gln80=) | Tatton-Brown-Rahman overgrowth syndrome [RCV001071421] | likely benign|uncertain significance | 2 | 25282649 | 25282649 | Human | 1 | name |
| 127294343 | CV1112621 | single nucleotide variant | NM_022552.5(DNMT3A):c.765C>T (p.Ser255=) | DNMT3A-related disorder [RCV004746394]|Inborn genetic diseases [RCV005330842]|Tatton-Brown-Rahman overgrowth syndrome [RCV001452219] | likely benign | 2 | 25248127 | 25248127 | Human | 2 | name , trait , alternate_id |
| 150337657 | CV1170943 | duplication | NM_022552.5(DNMT3A):c.176dup (p.Val60fs) | not provided [RCV001541787] | pathogenic | 2 | 25300139 | 25300140 | Human | | name |
| 150414591 | CV1176141 | single nucleotide variant | NM_022552.5(DNMT3A):c.76G>A (p.Gly26Arg) | DNMT3A-related disorder [RCV003900789]|Tatton-Brown-Rahman overgrowth syndrome [RCV003584975]|not provided [RCV001548200] | likely benign|uncertain significance | 2 | 25300240 | 25300240 | Human | 1 | name , trait , alternate_id |
| 150414985 | CV1196880 | single nucleotide variant | NM_022552.5(DNMT3A):c.558G>A (p.Pro186=) | DNMT3A-related disorder [RCV003931216]|Tatton-Brown-Rahman overgrowth syndrome [RCV002568483]|not provided [RCV001575199] | likely benign | 2 | 25275022 | 25275022 | Human | 1 | name , trait , alternate_id |
| 150541862 | CV1308382 | single nucleotide variant | NM_022552.5(DNMT3A):c.64G>A (p.Asp22Asn) | not provided [RCV001768222] | uncertain significance | 2 | 25313921 | 25313921 | Human | | name |
| 151866718 | CV1358638 | single nucleotide variant | NM_022552.5(DNMT3A):c.98G>A (p.Arg33His) | Tatton-Brown-Rahman overgrowth syndrome [RCV001939245]|not provided [RCV003329424] | uncertain significance | 2 | 25300218 | 25300218 | Human | 1 | name |
| 8688712 | CV137721 | single nucleotide variant | NM_022552.5(DNMT3A):c.89A>C (p.Glu30Ala) | DNMT3A-related disorder [RCV003935147]|Tatton-Brown-Rahman overgrowth syndrome [RCV000986598]|not provided [RCV000513872]|not specified [RCV000120651] | benign|likely benign|not provided | 2 | 25300227 | 25300227 | Human | 1 | name , trait , alternate_id |
| 151872350 | CV1435252 | single nucleotide variant | NM_022552.5(DNMT3A):c.576G>A (p.Ala192=) | DNMT3A-related disorder [RCV004746504]|Tatton-Brown-Rahman overgrowth syndrome [RCV001939981] | likely benign|uncertain significance | 2 | 25275004 | 25275004 | Human | 1 | name , trait , alternate_id |
| 152124828 | CV1580567 | single nucleotide variant | NM_022552.5(DNMT3A):c.768C>T (p.Pro256=) | Tatton-Brown-Rahman overgrowth syndrome [RCV002082065] | likely benign | 2 | 25248124 | 25248124 | Human | 1 | name |
| 152107328 | CV1605259 | single nucleotide variant | NM_022552.5(DNMT3A):c.609G>C (p.Arg203=) | Tatton-Brown-Rahman overgrowth syndrome [RCV002196323] | likely benign | 2 | 25274971 | 25274971 | Human | 1 | name |
| 156238144 | CV1882261 | single nucleotide variant | NM_022552.5(DNMT3A):c.309G>A (p.Glu103=) | DNMT3A-related disorder [RCV004747194]|Tatton-Brown-Rahman overgrowth syndrome [RCV003085642] | likely benign | 2 | 25282580 | 25282580 | Human | 1 | name , trait , alternate_id |
| 156295115 | CV1904561 | single nucleotide variant | NM_022552.5(DNMT3A):c.50C>T (p.Ala17Val) | Tatton-Brown-Rahman overgrowth syndrome [RCV002598914] | uncertain significance | 2 | 25313935 | 25313935 | Human | 1 | name |
| 155944985 | CV1911229 | single nucleotide variant | NM_022552.5(DNMT3A):c.696G>A (p.Gly232=) | Inborn genetic diseases [RCV004978683]|Tatton-Brown-Rahman overgrowth syndrome [RCV002615878] | likely benign | 2 | 25248196 | 25248196 | Human | 2 | name |
| 156221229 | CV1925079 | single nucleotide variant | NM_022552.5(DNMT3A):c.55C>T (p.Arg19Trp) | Tatton-Brown-Rahman overgrowth syndrome [RCV002644415]|not provided [RCV003491262] | uncertain significance | 2 | 25313930 | 25313930 | Human | 1 | name |
| 156263485 | CV1977644 | single nucleotide variant | NM_022552.5(DNMT3A):c.993C>T (p.Phe331=) | Inborn genetic diseases [RCV005333269]|Tatton-Brown-Rahman overgrowth syndrome [RCV002597859] | likely benign | 2 | 25247612 | 25247612 | Human | 2 | name |
| 156319343 | CV2025225 | single nucleotide variant | NM_022552.5(DNMT3A):c.660C>A (p.Val220=) | Tatton-Brown-Rahman overgrowth syndrome [RCV002716990] | likely benign | 2 | 25248232 | 25248232 | Human | 1 | name |
| 156002610 | CV2045658 | single nucleotide variant | NM_022552.5(DNMT3A):c.68G>A (p.Arg23Gln) | Tatton-Brown-Rahman overgrowth syndrome [RCV002756282] | uncertain significance | 2 | 25313917 | 25313917 | Human | 1 | name |
| 156025376 | CV2078039 | single nucleotide variant | NM_022552.5(DNMT3A):c.669A>T (p.Gly223=) | Tatton-Brown-Rahman overgrowth syndrome [RCV002866811] | likely benign | 2 | 25248223 | 25248223 | Human | 1 | name |
| 156205754 | CV2110264 | single nucleotide variant | NM_022552.5(DNMT3A):c.480C>T (p.Ser160=) | DNMT3A-related disorder [RCV004747155]|Tatton-Brown-Rahman overgrowth syndrome [RCV002957547] | likely benign | 2 | 25275512 | 25275512 | Human | 1 | name , trait , alternate_id |
| 156049609 | CV2169037 | single nucleotide variant | NM_022552.5(DNMT3A):c.840C>T (p.Asp280=) | DNMT3A-related disorder [RCV003943718]|Inborn genetic diseases [RCV005333428]|Tatton-Brown-Rahman overgrowth syndrome [RCV003019351] | likely benign | 2 | 25248052 | 25248052 | Human | 2 | name , trait , alternate_id |
| 156280438 | CV2295039 | single nucleotide variant | NM_022552.5(DNMT3A):c.639G>A (p.Glu213=) | Inborn genetic diseases [RCV002896482] | likely pathogenic | 2 | 25274941 | 25274941 | Human | 1 | name |
| 401924067 | CV2801035 | single nucleotide variant | NM_022552.5(DNMT3A):c.71A>C (p.Lys24Thr) | DNMT3A-related disorder [RCV003404624] | uncertain significance | 2 | 25313914 | 25313914 | Human | | name , trait , alternate_id |
| 401929387 | CV2815589 | single nucleotide variant | NM_022552.5(DNMT3A):c.95C>T (p.Pro32Leu) | not provided [RCV003407176] | uncertain significance | 2 | 25300221 | 25300221 | Human | | name |
| 405149293 | CV2856272 | single nucleotide variant | NM_022552.5(DNMT3A):c.336C>T (p.Gly112=) | DNMT3A-related disorder [RCV003929210]|Tatton-Brown-Rahman overgrowth syndrome [RCV003585504] | likely benign | 2 | 25282553 | 25282553 | Human | 1 | name , trait , alternate_id |
| 405149330 | CV2856459 | single nucleotide variant | NM_022552.5(DNMT3A):c.801C>G (p.Ser267=) | Inborn genetic diseases [RCV005333612]|Tatton-Brown-Rahman overgrowth syndrome [RCV003585507] | likely benign | 2 | 25248091 | 25248091 | Human | 2 | name |
| 405140073 | CV2885903 | single nucleotide variant | NM_022552.5(DNMT3A):c.474C>T (p.Ile158=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584051] | likely benign | 2 | 25275518 | 25275518 | Human | 1 | name |
| 405143155 | CV2928984 | deletion | NM_022552.5(DNMT3A):c.1555-37_1555-18del | Tatton-Brown-Rahman overgrowth syndrome [RCV003584360] | uncertain significance | 2 | 25244670 | 25244689 | Human | 1 | name |
| 405249581 | CV2979860 | single nucleotide variant | NM_022552.5(DNMT3A):c.300G>A (p.Gln100=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747187] | likely benign | 2 | 25282589 | 25282589 | Human | 1 | name |
| 405247196 | CV3030717 | single nucleotide variant | NM_022552.5(DNMT3A):c.999C>T (p.Asp333=) | DNMT3A-related disorder [RCV003909092]|Inborn genetic diseases [RCV004980935]|Tatton-Brown-Rahman overgrowth syndrome [RCV003746253] | likely benign | 2 | 25247606 | 25247606 | Human | 2 | name , trait , alternate_id |
| 405247199 | CV3030821 | single nucleotide variant | NM_022552.5(DNMT3A):c.89A>G (p.Glu30Gly) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746254]|not specified [RCV005240871] | uncertain significance | 2 | 25300227 | 25300227 | Human | 1 | name |
| 405247229 | CV3040760 | single nucleotide variant | NM_022552.5(DNMT3A):c.699C>T (p.Pro233=) | DNMT3A-related disorder [RCV003901287]|Tatton-Brown-Rahman overgrowth syndrome [RCV003746290] | likely benign | 2 | 25248193 | 25248193 | Human | 1 | name , trait , alternate_id |
| 405247434 | CV3053255 | single nucleotide variant | NM_022552.5(DNMT3A):c.582C>T (p.Asp194=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746369] | likely benign | 2 | 25274998 | 25274998 | Human | 1 | name |
| 405250269 | CV3057170 | single nucleotide variant | NM_022552.5(DNMT3A):c.97C>T (p.Arg33Cys) | DNMT3A-related disorder [RCV004747356]|Tatton-Brown-Rahman overgrowth syndrome [RCV003747455] | uncertain significance | 2 | 25300219 | 25300219 | Human | 1 | name , trait , alternate_id |
| 405250578 | CV3076141 | single nucleotide variant | NM_022552.5(DNMT3A):c.834C>T (p.Gly278=) | DNMT3A-related disorder [RCV004747368]|Tatton-Brown-Rahman overgrowth syndrome [RCV003747588] | uncertain significance | 2 | 25248058 | 25248058 | Human | 1 | name , trait , alternate_id |
| 405085621 | CV3137730 | single nucleotide variant | NM_022552.5(DNMT3A):c.468C>T (p.Thr156=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003834439] | likely benign | 2 | 25275524 | 25275524 | Human | 1 | name |
| 405182579 | CV3147687 | single nucleotide variant | NM_022552.5(DNMT3A):c.324G>A (p.Gly108=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003842589] | likely benign | 2 | 25282565 | 25282565 | Human | 1 | name |
| 405280877 | CV3190607 | single nucleotide variant | NM_022552.5(DNMT3A):c.795G>T (p.Val265=) | DNMT3A-related disorder [RCV003907045] | likely benign | 2 | 25248097 | 25248097 | Human | | name , trait , alternate_id |
| 405279172 | CV3217399 | single nucleotide variant | NM_022552.5(DNMT3A):c.429A>T (p.Arg143=) | DNMT3A-related disorder [RCV003976824] | likely benign | 2 | 25282460 | 25282460 | Human | | name , trait , alternate_id |
| 405272897 | CV3220606 | single nucleotide variant | NM_022552.5(DNMT3A):c.948G>C (p.Thr316=) | DNMT3A-related disorder [RCV003972299]|Inborn genetic diseases [RCV004981154]|Tatton-Brown-Rahman overgrowth syndrome [RCV005103067] | likely benign | 2 | 25247657 | 25247657 | Human | 2 | name , trait , alternate_id |
| 407502755 | CV3495711 | deletion | NM_022552.5(DNMT3A):c.241del (p.Asp81fs) | not provided [RCV004697551] | likely pathogenic | 2 | 25282648 | 25282648 | Human | | name |
| 408382482 | CV3503349 | single nucleotide variant | NM_022552.5(DNMT3A):c.348A>G (p.Ala116=) | DNMT3A-related disorder [RCV004729924] | likely benign | 2 | 25282541 | 25282541 | Human | | name , trait , alternate_id |
| 408382605 | CV3503507 | single nucleotide variant | NM_022552.5(DNMT3A):c.65A>T (p.Asp22Val) | DNMT3A-related disorder [RCV004730022] | uncertain significance | 2 | 25313920 | 25313920 | Human | | name , trait , alternate_id |
| 408379471 | CV3506906 | single nucleotide variant | NM_022552.5(DNMT3A):c.702G>C (p.Gly234=) | DNMT3A-related disorder [RCV004728407] | likely benign | 2 | 25248190 | 25248190 | Human | | name , trait , alternate_id |
| 408374968 | CV3508981 | single nucleotide variant | NM_022552.5(DNMT3A):c.954G>C (p.Arg318=) | DNMT3A-related disorder [RCV004747665] | likely benign | 2 | 25247651 | 25247651 | Human | | name , trait , alternate_id |
| 408374970 | CV3509013 | single nucleotide variant | NM_022552.5(DNMT3A):c.966T>C (p.Ala322=) | DNMT3A-related disorder [RCV004747667] | likely benign | 2 | 25247639 | 25247639 | Human | | name , trait , alternate_id |
| 408375038 | CV3509484 | single nucleotide variant | NM_022552.5(DNMT3A):c.28G>A (p.Gly10Arg) | DNMT3A-related disorder [RCV004747730] | uncertain significance | 2 | 25313957 | 25313957 | Human | | name , trait , alternate_id |
| 408373826 | CV3512593 | single nucleotide variant | NM_022552.5(DNMT3A):c.624A>C (p.Ala208=) | DNMT3A-related disorder [RCV004745714] | likely benign | 2 | 25274956 | 25274956 | Human | | name , trait , alternate_id |
| 408373832 | CV3512976 | single nucleotide variant | NM_022552.5(DNMT3A):c.402T>C (p.Asn134=) | DNMT3A-related disorder [RCV004745766] | likely benign | 2 | 25282487 | 25282487 | Human | | name , trait , alternate_id |
| 408373911 | CV3513401 | single nucleotide variant | NM_022552.5(DNMT3A):c.327G>A (p.Gly109=) | DNMT3A-related disorder [RCV004745841] | likely benign | 2 | 25282562 | 25282562 | Human | | name , trait , alternate_id |
| 408374062 | CV3514528 | single nucleotide variant | NM_022552.5(DNMT3A):c.783G>A (p.Thr261=) | DNMT3A-related disorder [RCV004745985]|Inborn genetic diseases [RCV004981194] | likely benign | 2 | 25248109 | 25248109 | Human | 1 | name , trait , alternate_id |
| 408374377 | CV3516080 | single nucleotide variant | NM_022552.5(DNMT3A):c.417C>T (p.Pro139=) | DNMT3A-related disorder [RCV004746725] | likely benign | 2 | 25282472 | 25282472 | Human | | name , trait , alternate_id |
| 597649429 | CV3659343 | single nucleotide variant | NM_022552.5(DNMT3A):c.972C>T (p.Gly324=) | Inborn genetic diseases [RCV004974374] | likely benign | 2 | 25247633 | 25247633 | Human | 1 | name |
| 597889164 | CV3739351 | single nucleotide variant | NM_022552.5(DNMT3A):c.783G>T (p.Thr261=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005070898] | likely benign | 2 | 25248109 | 25248109 | Human | 1 | name |
| 597899433 | CV3740938 | single nucleotide variant | NM_022552.5(DNMT3A):c.858C>T (p.Asp286=) | Inborn genetic diseases [RCV005325973]|Tatton-Brown-Rahman overgrowth syndrome [RCV005072101] | likely benign | 2 | 25247747 | 25247747 | Human | 2 | name |
| 597949248 | CV3772308 | single nucleotide variant | NM_022552.5(DNMT3A):c.408C>T (p.Cys136=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005120627] | likely benign | 2 | 25282481 | 25282481 | Human | 1 | name |
| 597890291 | CV3784826 | single nucleotide variant | NM_022552.5(DNMT3A):c.780C>T (p.Thr260=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005125605] | likely benign | 2 | 25248112 | 25248112 | Human | 1 | name |
| 597944009 | CV3847813 | single nucleotide variant | NM_022552.5(DNMT3A):c.807T>C (p.Ala269=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005188541] | likely benign | 2 | 25248085 | 25248085 | Human | 1 | name |
| 598164900 | CV3964253 | single nucleotide variant | NM_022552.5(DNMT3A):c.897A>G (p.Lys299=) | Inborn genetic diseases [RCV005329598] | likely benign | 2 | 25247708 | 25247708 | Human | 1 | name |
| 598164903 | CV3964254 | single nucleotide variant | NM_022552.5(DNMT3A):c.705G>A (p.Glu235=) | Inborn genetic diseases [RCV005329599] | likely benign | 2 | 25248187 | 25248187 | Human | 1 | name |
| 598164943 | CV3964262 | single nucleotide variant | NM_022552.5(DNMT3A):c.798G>A (p.Gly266=) | Inborn genetic diseases [RCV005329607] | likely benign | 2 | 25248094 | 25248094 | Human | 1 | name |
| 598164976 | CV3964270 | single nucleotide variant | NM_022552.5(DNMT3A):c.798G>T (p.Gly266=) | Inborn genetic diseases [RCV005329615] | likely benign | 2 | 25248094 | 25248094 | Human | 1 | name |
| 598165050 | CV3964285 | single nucleotide variant | NM_022552.5(DNMT3A):c.726C>T (p.Ala242=) | Inborn genetic diseases [RCV005329630] | likely benign | 2 | 25248166 | 25248166 | Human | 1 | name |
| 598165079 | CV3964291 | single nucleotide variant | NM_022552.5(DNMT3A):c.978C>T (p.Arg326=) | Inborn genetic diseases [RCV005329636] | likely benign | 2 | 25247627 | 25247627 | Human | 1 | name |
| 598165091 | CV3964293 | single nucleotide variant | NM_022552.5(DNMT3A):c.966T>G (p.Ala322=) | Inborn genetic diseases [RCV005329638] | likely benign | 2 | 25247639 | 25247639 | Human | 1 | name |
| 598165155 | CV3964307 | single nucleotide variant | NM_022552.5(DNMT3A):c.699C>G (p.Pro233=) | Inborn genetic diseases [RCV005329652] | likely benign | 2 | 25248193 | 25248193 | Human | 1 | name |
| 598165176 | CV3964311 | single nucleotide variant | NM_022552.5(DNMT3A):c.789G>A (p.Glu263=) | Inborn genetic diseases [RCV005329656] | likely benign | 2 | 25248103 | 25248103 | Human | 1 | name |
| 598165236 | CV3964325 | single nucleotide variant | NM_022552.5(DNMT3A):c.729C>T (p.Ser243=) | Inborn genetic diseases [RCV005329670] | likely benign | 2 | 25248163 | 25248163 | Human | 1 | name |
| 13214531 | CV428050 | single nucleotide variant | NM_022552.5(DNMT3A):c.759C>T (p.Pro253=) | DNMT3A-related disorder [RCV003915372]|Inborn genetic diseases [RCV004975588]|Tatton-Brown-Rahman overgrowth syndrome [RCV000652290]|not provided [RCV001584213]|not specified [RCV000501387] | benign|likely benign | 2 | 25248133 | 25248133 | Human | 2 | name , trait , alternate_id |
| 13492385 | CV450758 | single nucleotide variant | NM_022552.5(DNMT3A):c.447G>A (p.Ala149=) | Tatton-Brown-Rahman overgrowth syndrome [RCV000534914] | uncertain significance | 2 | 25282442 | 25282442 | Human | 1 | name |
| 13624454 | CV518136 | single nucleotide variant | NM_022552.5(DNMT3A):c.801C>T (p.Ser267=) | Inborn genetic diseases [RCV004972825]|Tatton-Brown-Rahman overgrowth syndrome [RCV000652291]|not provided [RCV001683624] | benign|likely benign | 2 | 25248091 | 25248091 | Human | 2 | name |
| 14706729 | CV629756 | single nucleotide variant | NM_022552.5(DNMT3A):c.855G>A (p.Glu285=) | Tatton-Brown-Rahman overgrowth syndrome [RCV000792086]|not provided [RCV002305538] | uncertain significance | 2 | 25248037 | 25248037 | Human | 1 | name |
| 15123961 | CV733375 | single nucleotide variant | NM_022552.5(DNMT3A):c.792C>T (p.Pro264=) | Inborn genetic diseases [RCV005328429]|Tatton-Brown-Rahman overgrowth syndrome [RCV001502320] | likely benign | 2 | 25248100 | 25248100 | Human | 2 | name |
| 15141921 | CV747500 | single nucleotide variant | NM_022552.5(DNMT3A):c.774G>C (p.Val258=) | DNMT3A-related disorder [RCV003895607]|Inborn genetic diseases [RCV005328436]|not provided [RCV000921921] | likely benign | 2 | 25248118 | 25248118 | Human | 1 | name , trait , alternate_id |
| 15133896 | CV763125 | single nucleotide variant | NM_022552.5(DNMT3A):c.852C>T (p.Tyr284=) | Inborn genetic diseases [RCV005328444]|Tatton-Brown-Rahman overgrowth syndrome [RCV000942648] | likely benign | 2 | 25248040 | 25248040 | Human | 2 | name |
| 21066913 | CV795204 | single nucleotide variant | NM_022552.5(DNMT3A):c.58G>A (p.Glu20Lys) | Tatton-Brown-Rahman overgrowth syndrome [RCV005093009]|not provided [RCV000997084] | uncertain significance | 2 | 25313927 | 25313927 | Human | 1 | name |
| 40815014 | CV970740 | single nucleotide variant | NM_022552.5(DNMT3A):c.67C>T (p.Arg23Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV001262399] | likely benign | 2 | 25313918 | 25313918 | Human | 1 | name |
| 126744898 | CV1016040 | single nucleotide variant | NM_022552.5(DNMT3A):c.230C>T (p.Ser77Phe) | Tatton-Brown-Rahman overgrowth syndrome [RCV001330537] | uncertain significance | 2 | 25282659 | 25282659 | Human | 1 | name |
| 127294107 | CV1154097 | single nucleotide variant | NM_022552.5(DNMT3A):c.1266G>A (p.Leu422=) | Tatton-Brown-Rahman overgrowth syndrome [RCV001511617]|not provided [RCV001534983] | benign | 2 | 25246633 | 25246633 | Human | 1 | name |
| 150408537 | CV1176139 | single nucleotide variant | NM_022552.5(DNMT3A):c.1344C>T (p.Tyr448=) | DNMT3A-related disorder [RCV003956232]|Inborn genetic diseases [RCV004980589]|Tatton-Brown-Rahman overgrowth syndrome [RCV002568961]|not provided [RCV001545941] | likely benign | 2 | 25246245 | 25246245 | Human | 2 | name , trait , alternate_id |
| 150413351 | CV1189861 | single nucleotide variant | NM_022552.5(DNMT3A):c.1194C>T (p.Ala398=) | DNMT3A-related disorder [RCV004746429]|Inborn genetic diseases [RCV005330892]|Tatton-Brown-Rahman overgrowth syndrome [RCV002570760]|not provided [RCV001567167] | likely benign | 2 | 25246705 | 25246705 | Human | 2 | name , trait , alternate_id |
| 150478804 | CV1240563 | single nucleotide variant | NM_022552.5(DNMT3A):c.1443C>T (p.Tyr481=) | DNMT3A-related disorder [RCV003968425]|Inborn genetic diseases [RCV004980617]|Tatton-Brown-Rahman overgrowth syndrome [RCV002539584]|not provided [RCV001652438] | benign|likely benign | 2 | 25246051 | 25246051 | Human | 2 | name , trait , alternate_id |
| 150461105 | CV1253200 | insertion | NM_022552.5(DNMT3A):c.639+125_639+126insG | not provided [RCV001669529] | benign | 2 | 25274815 | 25274816 | Human | | name |
| 150533890 | CV1305992 | single nucleotide variant | NM_022552.5(DNMT3A):c.2601A>C (p.Val867=) | Inborn genetic diseases [RCV004980677]|Tatton-Brown-Rahman overgrowth syndrome [RCV003746602]|not provided [RCV001755395] | likely benign | 2 | 25234417 | 25234417 | Human | 2 | name |
| 150535821 | CV1307118 | single nucleotide variant | NM_022552.5(DNMT3A):c.233T>C (p.Met78Thr) | Inborn genetic diseases [RCV004980679]|Tatton-Brown-Rahman overgrowth syndrome [RCV005095073]|not provided [RCV001759173] | uncertain significance | 2 | 25282656 | 25282656 | Human | 2 | name |
| 151353895 | CV1327447 | single nucleotide variant | NM_022552.5(DNMT3A):c.2145C>T (p.Ile715=) | Inborn genetic diseases [RCV005330917]|not specified [RCV001817391] | likely benign|uncertain significance | 2 | 25240668 | 25240668 | Human | 1 | name |
| 151662538 | CV1333183 | single nucleotide variant | NM_022552.5(DNMT3A):c.113G>A (p.Arg38His) | DNMT3A-related disorder [RCV003416488]|Tatton-Brown-Rahman overgrowth syndrome [RCV001837416] | uncertain significance | 2 | 25300203 | 25300203 | Human | 1 | name , trait , alternate_id |
| 151712425 | CV1334422 | single nucleotide variant | NM_022552.5(DNMT3A):c.149G>A (p.Arg50Gln) | not provided [RCV001840896] | uncertain significance | 2 | 25300167 | 25300167 | Human | | name |
| 8688713 | CV137722 | single nucleotide variant | NM_022552.5(DNMT3A):c.131C>T (p.Thr44Met) | DNMT3A-related disorder [RCV003407510]|Tatton-Brown-Rahman overgrowth syndrome [RCV000700793]|not specified [RCV000120652] | likely benign|uncertain significance|not provided | 2 | 25300185 | 25300185 | Human | 1 | name , trait , alternate_id |
| 151738850 | CV1428882 | single nucleotide variant | NM_022552.5(DNMT3A):c.287G>A (p.Arg96Gln) | Acute myeloid leukemia [RCV005017001]|DNMT3A-related disorder [RCV004746563]|Tatton-Brown-Rahman overgrowth syndrome [RCV002022118] | uncertain significance | 2 | 25282602 | 25282602 | Human | 4 | name , trait , alternate_id |
| 152164165 | CV1543451 | single nucleotide variant | NM_022552.5(DNMT3A):c.2659A>C (p.Arg887=) | Inborn genetic diseases [RCV004973337]|Tatton-Brown-Rahman overgrowth syndrome [RCV002123748] | likely benign | 2 | 25234359 | 25234359 | Human | 2 | name |
| 152054988 | CV1581996 | single nucleotide variant | NM_022552.5(DNMT3A):c.1074G>T (p.Thr358=) | Inborn genetic diseases [RCV005333145]|Tatton-Brown-Rahman overgrowth syndrome [RCV002089597] | likely benign | 2 | 25247099 | 25247099 | Human | 2 | name |
| 152047797 | CV1591438 | single nucleotide variant | NM_022552.5(DNMT3A):c.2538G>A (p.Gln846=) | Tatton-Brown-Rahman overgrowth syndrome [RCV002189029] | likely benign | 2 | 25235766 | 25235766 | Human | 1 | name |
| 153348628 | CV1692672 | single nucleotide variant | NM_022552.5(DNMT3A):c.289A>C (p.Ser97Arg) | not provided [RCV002274527] | uncertain significance | 2 | 25282600 | 25282600 | Human | | name |
| 153349655 | CV1693764 | single nucleotide variant | NM_022552.5(DNMT3A):c.1929C>T (p.Ile643=) | Inborn genetic diseases [RCV004973396]|not provided [RCV002276071] | likely benign | 2 | 25243905 | 25243905 | Human | 1 | name |
| 153348043 | CV1695092 | single nucleotide variant | NM_022552.5(DNMT3A):c.265C>T (p.Pro89Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746613]|not provided [RCV002279023] | uncertain significance | 2 | 25282624 | 25282624 | Human | 1 | name |
| 155714692 | CV1780332 | single nucleotide variant | NM_022552.5(DNMT3A):c.206C>T (p.Pro69Leu) | not provided [RCV002305936] | uncertain significance | 2 | 25282683 | 25282683 | Human | | name |
| 155799521 | CV1862525 | single nucleotide variant | NM_022552.5(DNMT3A):c.148C>T (p.Arg50Trp) | Tatton-Brown-Rahman overgrowth syndrome [RCV002471932] | uncertain significance | 2 | 25300168 | 25300168 | Human | 1 | name |
| 156189466 | CV1867289 | single nucleotide variant | NM_022552.5(DNMT3A):c.1935A>T (p.Thr645=) | not provided [RCV002508991] | not provided | 2 | 25243899 | 25243899 | Human | | name |
| 156378998 | CV1876791 | single nucleotide variant | NM_022552.5(DNMT3A):c.2181T>C (p.Thr727=) | DNMT3A-related disorder [RCV004747190]|Inborn genetic diseases [RCV005333462]|Tatton-Brown-Rahman overgrowth syndrome [RCV003067000] | likely benign | 2 | 25240443 | 25240443 | Human | 2 | name , trait , alternate_id |
| 156406998 | CV1878541 | single nucleotide variant | NM_022552.5(DNMT3A):c.1305G>A (p.Val435=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003070687] | likely benign | 2 | 25246284 | 25246284 | Human | 1 | name |
| 156403574 | CV1885838 | single nucleotide variant | NM_022552.5(DNMT3A):c.1587C>T (p.Asp529=) | Inborn genetic diseases [RCV004978559]|Tatton-Brown-Rahman overgrowth syndrome [RCV003069503] | likely benign | 2 | 25244620 | 25244620 | Human | 2 | name |
| 156411655 | CV1889493 | single nucleotide variant | NM_022552.5(DNMT3A):c.209C>T (p.Ala70Val) | DNMT3A-related disorder [RCV004747198]|Tatton-Brown-Rahman overgrowth syndrome [RCV003072568]|not provided [RCV003427560] | uncertain significance | 2 | 25282680 | 25282680 | Human | 1 | name , trait , alternate_id |
| 156152854 | CV1896070 | single nucleotide variant | NM_022552.5(DNMT3A):c.1776C>T (p.Tyr592=) | Inborn genetic diseases [RCV005333488]|Tatton-Brown-Rahman overgrowth syndrome [RCV003082609] | likely benign | 2 | 25244230 | 25244230 | Human | 2 | name |
| 156361071 | CV1898956 | single nucleotide variant | NM_022552.5(DNMT3A):c.128C>T (p.Thr43Ile) | Tatton-Brown-Rahman overgrowth syndrome [RCV003091713] | uncertain significance | 2 | 25300188 | 25300188 | Human | 1 | name |
| 156019924 | CV1909428 | single nucleotide variant | NM_022552.5(DNMT3A):c.1059G>A (p.Ala353=) | Inborn genetic diseases [RCV005333521]|Tatton-Brown-Rahman overgrowth syndrome [RCV002619343] | likely benign | 2 | 25247114 | 25247114 | Human | 2 | name |
| 156417731 | CV1910044 | single nucleotide variant | NM_022552.5(DNMT3A):c.2211C>G (p.Leu737=) | Inborn genetic diseases [RCV004978656]|Tatton-Brown-Rahman overgrowth syndrome [RCV002610894] | likely benign | 2 | 25240413 | 25240413 | Human | 2 | name |
| 156303581 | CV1916250 | single nucleotide variant | NM_022552.5(DNMT3A):c.1611C>T (p.Cys537=) | DNMT3A-related disorder [RCV004725541]|Inborn genetic diseases [RCV004978642]|Tatton-Brown-Rahman overgrowth syndrome [RCV002599291]|not provided [RCV003883882] | likely benign | 2 | 25244596 | 25244596 | Human | 2 | name , trait , alternate_id |
| 156371110 | CV1920259 | single nucleotide variant | NM_022552.5(DNMT3A):c.1110C>T (p.Tyr370=) | DNMT3A-related disorder [RCV003898841]|Inborn genetic diseases [RCV004978650]|Tatton-Brown-Rahman overgrowth syndrome [RCV002603182]|not provided [RCV003883884] | likely benign | 2 | 25247063 | 25247063 | Human | 2 | name , trait , alternate_id |
| 156032912 | CV1921211 | single nucleotide variant | NM_022552.5(DNMT3A):c.1989G>A (p.Ser663=) | Inborn genetic diseases [RCV005333527]|Tatton-Brown-Rahman overgrowth syndrome [RCV002619931] | likely benign | 2 | 25241655 | 25241655 | Human | 2 | name |
| 156179711 | CV1924413 | single nucleotide variant | NM_022552.5(DNMT3A):c.1242C>T (p.Phe414=) | DNMT3A-related disorder [RCV003898900]|Inborn genetic diseases [RCV004978725]|Tatton-Brown-Rahman overgrowth syndrome [RCV002624998] | likely benign | 2 | 25246657 | 25246657 | Human | 2 | name , trait , alternate_id |
| 156308443 | CV1928140 | single nucleotide variant | NM_022552.5(DNMT3A):c.1593C>T (p.Asp531=) | DNMT3A-related disorder [RCV004747231]|Inborn genetic diseases [RCV004978741]|Tatton-Brown-Rahman overgrowth syndrome [RCV002648017] | likely benign | 2 | 25244614 | 25244614 | Human | 2 | name , trait , alternate_id |
| 156419394 | CV1932744 | single nucleotide variant | NM_022552.5(DNMT3A):c.250G>A (p.Ala84Thr) | DNMT3A-related disorder [RCV004747221]|Tatton-Brown-Rahman overgrowth syndrome [RCV002612626] | uncertain significance | 2 | 25282639 | 25282639 | Human | 1 | name , trait , alternate_id |
| 156448937 | CV1948247 | single nucleotide variant | NM_022552.5(DNMT3A):c.1899C>T (p.Pro633=) | DNMT3A-related disorder [RCV004747263]|Inborn genetic diseases [RCV004978756]|Tatton-Brown-Rahman overgrowth syndrome [RCV003121044] | likely benign | 2 | 25243935 | 25243935 | Human | 2 | name , trait , alternate_id |
| 156407106 | CV1963906 | single nucleotide variant | NM_022552.5(DNMT3A):c.248G>A (p.Gly83Asp) | Tatton-Brown-Rahman overgrowth syndrome [RCV002586123] | uncertain significance | 2 | 25282641 | 25282641 | Human | 1 | name |
| 156147524 | CV1963924 | single nucleotide variant | NM_022552.5(DNMT3A):c.185G>A (p.Ser62Asn) | Tatton-Brown-Rahman overgrowth syndrome [RCV002572791] | uncertain significance | 2 | 25282704 | 25282704 | Human | 1 | name |
| 156327531 | CV1982299 | single nucleotide variant | NM_022552.5(DNMT3A):c.2013G>A (p.Thr671=) | DNMT3A-related disorder [RCV004725336]|Tatton-Brown-Rahman overgrowth syndrome [RCV002649640] | likely benign | 2 | 25241631 | 25241631 | Human | 1 | name , trait , alternate_id |
| 155997461 | CV1986980 | single nucleotide variant | NM_022552.5(DNMT3A):c.2412G>C (p.Pro804=) | Inborn genetic diseases [RCV005333280]|Tatton-Brown-Rahman overgrowth syndrome [RCV002618293] | likely benign | 2 | 25237002 | 25237002 | Human | 2 | name |
| 155923880 | CV1987647 | single nucleotide variant | NM_022552.5(DNMT3A):c.1149G>A (p.Leu383=) | DNMT3A-related disorder [RCV004747100]|Inborn genetic diseases [RCV005333286]|Tatton-Brown-Rahman overgrowth syndrome [RCV002614682] | likely benign | 2 | 25246750 | 25246750 | Human | 2 | name , trait , alternate_id |
| 156136571 | CV2006409 | single nucleotide variant | NM_022552.5(DNMT3A):c.2067C>T (p.Ser689=) | Tatton-Brown-Rahman overgrowth syndrome [RCV002663412] | likely benign | 2 | 25241577 | 25241577 | Human | 1 | name |
| 156322000 | CV2014611 | single nucleotide variant | NM_022552.5(DNMT3A):c.1758C>T (p.Cys586=) | Inborn genetic diseases [RCV004973564]|Tatton-Brown-Rahman overgrowth syndrome [RCV002672260] | likely benign | 2 | 25244248 | 25244248 | Human | 2 | name |
| 156005742 | CV2015014 | single nucleotide variant | NM_022552.5(DNMT3A):c.1140G>C (p.Ala380=) | DNMT3A-related disorder [RCV003973465]|Inborn genetic diseases [RCV004973567]|Tatton-Brown-Rahman overgrowth syndrome [RCV002690262] | likely benign | 2 | 25246759 | 25246759 | Human | 2 | name , trait , alternate_id |
| 156116135 | CV2016933 | single nucleotide variant | NM_022552.5(DNMT3A):c.1581G>A (p.Gln527=) | Tatton-Brown-Rahman overgrowth syndrome [RCV002740020] | likely benign | 2 | 25244626 | 25244626 | Human | 1 | name |
| 156120833 | CV2039856 | single nucleotide variant | NM_022552.5(DNMT3A):c.1231C>T (p.Leu411=) | Inborn genetic diseases [RCV005333343]|Tatton-Brown-Rahman overgrowth syndrome [RCV002785784] | likely benign | 2 | 25246668 | 25246668 | Human | 2 | name |
| 156282625 | CV2071223 | single nucleotide variant | NM_022552.5(DNMT3A):c.1143G>A (p.Gly381=) | Inborn genetic diseases [RCV005333357]|Tatton-Brown-Rahman overgrowth syndrome [RCV002856439]|not provided [RCV003491155] | likely benign|uncertain significance | 2 | 25246756 | 25246756 | Human | 2 | name |
| 156080978 | CV2083681 | single nucleotide variant | NM_022552.5(DNMT3A):c.2412G>A (p.Pro804=) | DNMT3A-related disorder [RCV003973502]|Inborn genetic diseases [RCV004973668]|Tatton-Brown-Rahman overgrowth syndrome [RCV002847383] | likely benign | 2 | 25237002 | 25237002 | Human | 2 | name , trait , alternate_id |
| 156014704 | CV2086898 | single nucleotide variant | NM_022552.5(DNMT3A):c.2115T>C (p.Ile705=) | Inborn genetic diseases [RCV005333361]|Tatton-Brown-Rahman overgrowth syndrome [RCV002866291] | likely benign | 2 | 25240698 | 25240698 | Human | 2 | name |
| 156331445 | CV2094835 | single nucleotide variant | NM_022552.5(DNMT3A):c.1827C>T (p.Phe609=) | Inborn genetic diseases [RCV004973684]|Tatton-Brown-Rahman overgrowth syndrome [RCV002899948]|not provided [RCV005242281] | likely benign | 2 | 25244179 | 25244179 | Human | 2 | name |
| 156155419 | CV2098699 | single nucleotide variant | NM_022552.5(DNMT3A):c.269A>G (p.Asn90Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV002890795] | uncertain significance | 2 | 25282620 | 25282620 | Human | 1 | name |
| 156191654 | CV2099014 | single nucleotide variant | NM_022552.5(DNMT3A):c.1047G>A (p.Ser349=) | Inborn genetic diseases [RCV005333372]|Tatton-Brown-Rahman overgrowth syndrome [RCV002917468] | likely benign | 2 | 25247126 | 25247126 | Human | 2 | name |
| 156023243 | CV2105903 | single nucleotide variant | NM_022552.5(DNMT3A):c.2373C>T (p.Ala791=) | Tatton-Brown-Rahman overgrowth syndrome [RCV002923170] | likely benign | 2 | 25239165 | 25239165 | Human | 1 | name |
| 156311038 | CV2107468 | single nucleotide variant | NM_022552.5(DNMT3A):c.2643C>T (p.Ser881=) | Inborn genetic diseases [RCV005333383]|Tatton-Brown-Rahman overgrowth syndrome [RCV002937165] | likely benign | 2 | 25234375 | 25234375 | Human | 2 | name |
| 156032766 | CV2117742 | single nucleotide variant | NM_022552.5(DNMT3A):c.2682C>T (p.Ser894=) | DNMT3A-related disorder [RCV003906369]|Inborn genetic diseases [RCV004973754]|Tatton-Brown-Rahman overgrowth syndrome [RCV002923587] | likely benign | 2 | 25234336 | 25234336 | Human | 2 | name , trait , alternate_id |
| 156211195 | CV2117746 | single nucleotide variant | NM_022552.5(DNMT3A):c.113G>T (p.Arg38Leu) | Tatton-Brown-Rahman overgrowth syndrome [RCV002957751] | uncertain significance | 2 | 25300203 | 25300203 | Human | 1 | name |
| 156349273 | CV2125367 | single nucleotide variant | NM_022552.5(DNMT3A):c.1956C>T (p.Asp652=) | DNMT3A-related disorder [RCV004747161]|Tatton-Brown-Rahman overgrowth syndrome [RCV002966173] | likely benign | 2 | 25241688 | 25241688 | Human | 1 | name , trait , alternate_id |
| 156161867 | CV2136854 | single nucleotide variant | NM_022552.5(DNMT3A):c.2647T>C (p.Leu883=) | Inborn genetic diseases [RCV005333421]|Tatton-Brown-Rahman overgrowth syndrome [RCV003005093] | likely benign | 2 | 25234371 | 25234371 | Human | 2 | name |
| 156263761 | CV2138820 | single nucleotide variant | NM_022552.5(DNMT3A):c.1545A>G (p.Gln515=) | DNMT3A-related disorder [RCV004747169]|Inborn genetic diseases [RCV004978432]|Tatton-Brown-Rahman overgrowth syndrome [RCV002988563] | likely benign | 2 | 25245262 | 25245262 | Human | 2 | name , trait , alternate_id |
| 155994909 | CV2171508 | single nucleotide variant | NM_022552.5(DNMT3A):c.232A>G (p.Met78Val) | Tatton-Brown-Rahman overgrowth syndrome [RCV003034500] | uncertain significance | 2 | 25282657 | 25282657 | Human | 1 | name |
| 156331410 | CV2171825 | single nucleotide variant | NM_022552.5(DNMT3A):c.2730G>A (p.Ala910=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003029789] | likely benign | 2 | 25234288 | 25234288 | Human | 1 | name |
| 156123558 | CV2179679 | single nucleotide variant | NM_022552.5(DNMT3A):c.1116C>T (p.Val372=) | Inborn genetic diseases [RCV005333435]|Tatton-Brown-Rahman overgrowth syndrome [RCV003039414] | likely benign | 2 | 25247057 | 25247057 | Human | 2 | name |
| 329352929 | CV2476783 | single nucleotide variant | NM_022552.5(DNMT3A):c.203A>G (p.Asp68Gly) | not provided [RCV003223015] | uncertain significance | 2 | 25282686 | 25282686 | Human | | name |
| 401798767 | CV2742561 | single nucleotide variant | NM_022552.5(DNMT3A):c.1935A>G (p.Thr645=) | not provided [RCV003325005] | uncertain significance | 2 | 25243899 | 25243899 | Human | | name |
| 401912054 | CV2796043 | single nucleotide variant | NM_022552.5(DNMT3A):c.164G>A (p.Arg55His) | DNMT3A-related disorder [RCV003399739]|Tatton-Brown-Rahman overgrowth syndrome [RCV003585389] | uncertain significance | 2 | 25300152 | 25300152 | Human | 1 | name , trait , alternate_id |
| 401910885 | CV2815584 | single nucleotide variant | NM_022552.5(DNMT3A):c.1152C>T (p.Phe384=) | Inborn genetic diseases [RCV005333604]|Tatton-Brown-Rahman overgrowth syndrome [RCV003585393]|not provided [RCV003425531] | likely benign | 2 | 25246747 | 25246747 | Human | 2 | name |
| 401917398 | CV2829842 | single nucleotide variant | NM_022552.5(DNMT3A):c.163C>T (p.Arg55Cys) | not provided [RCV003443886] | uncertain significance | 2 | 25300153 | 25300153 | Human | | name |
| 405149828 | CV2878796 | single nucleotide variant | NM_022552.5(DNMT3A):c.120G>T (p.Glu40Asp) | Tatton-Brown-Rahman overgrowth syndrome [RCV003585552] | uncertain significance | 2 | 25300196 | 25300196 | Human | 1 | name |
| 405140388 | CV2882446 | single nucleotide variant | NM_022552.5(DNMT3A):c.1716C>G (p.Ala572=) | DNMT3A-related disorder [RCV003901172]|Inborn genetic diseases [RCV004980874]|Tatton-Brown-Rahman overgrowth syndrome [RCV003584058] | likely benign | 2 | 25244290 | 25244290 | Human | 2 | name , trait , alternate_id |
| 405140819 | CV2883414 | single nucleotide variant | NM_022552.5(DNMT3A):c.112C>T (p.Arg38Cys) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584095] | uncertain significance | 2 | 25300204 | 25300204 | Human | 1 | name |
| 405150624 | CV2888305 | single nucleotide variant | NM_022552.5(DNMT3A):c.2037G>C (p.Gly679=) | DNMT3A-related disorder [RCV004747312]|Tatton-Brown-Rahman overgrowth syndrome [RCV003585621] | likely benign | 2 | 25241607 | 25241607 | Human | 1 | name , trait , alternate_id |
| 405141320 | CV2900101 | single nucleotide variant | NM_022552.5(DNMT3A):c.1395C>T (p.Pro465=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584149] | likely benign | 2 | 25246194 | 25246194 | Human | 1 | name |
| 405141463 | CV2903333 | single nucleotide variant | NM_022552.5(DNMT3A):c.1521C>T (p.Pro507=) | Inborn genetic diseases [RCV005333626]|Tatton-Brown-Rahman overgrowth syndrome [RCV003584163] | likely benign | 2 | 25245286 | 25245286 | Human | 2 | name |
| 405143952 | CV2909598 | single nucleotide variant | NM_022552.5(DNMT3A):c.2703C>G (p.Leu901=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584264] | likely benign | 2 | 25234315 | 25234315 | Human | 1 | name |
| 405248823 | CV2974105 | single nucleotide variant | NM_022552.5(DNMT3A):c.296C>T (p.Pro99Leu) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746922] | uncertain significance | 2 | 25282593 | 25282593 | Human | 1 | name |
| 405250122 | CV3012474 | single nucleotide variant | NM_022552.5(DNMT3A):c.194C>T (p.Thr65Met) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747415] | uncertain significance | 2 | 25282695 | 25282695 | Human | 1 | name |
| 405246480 | CV3013241 | single nucleotide variant | NM_022552.5(DNMT3A):c.158G>A (p.Arg53Lys) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746011] | uncertain significance | 2 | 25300158 | 25300158 | Human | 1 | name |
| 405247077 | CV3023690 | single nucleotide variant | NM_022552.5(DNMT3A):c.1245G>A (p.Gln415=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746228] | likely benign | 2 | 25246654 | 25246654 | Human | 1 | name |
| 405247497 | CV3046677 | single nucleotide variant | NM_022552.5(DNMT3A):c.1383A>G (p.Thr461=) | Inborn genetic diseases [RCV004980954]|Tatton-Brown-Rahman overgrowth syndrome [RCV003746393] | likely benign | 2 | 25246206 | 25246206 | Human | 2 | name |
| 405247545 | CV3047057 | single nucleotide variant | NM_022552.5(DNMT3A):c.2310G>A (p.Ser770=) | Inborn genetic diseases [RCV004980962]|Tatton-Brown-Rahman overgrowth syndrome [RCV003746412] | likely benign | 2 | 25240314 | 25240314 | Human | 2 | name |
| 405250301 | CV3057414 | single nucleotide variant | NM_022552.5(DNMT3A):c.1584C>T (p.Tyr528=) | Inborn genetic diseases [RCV005325798]|Tatton-Brown-Rahman overgrowth syndrome [RCV003747468] | likely benign | 2 | 25244623 | 25244623 | Human | 2 | name |
| 405250407 | CV3062302 | single nucleotide variant | NM_022552.5(DNMT3A):c.1632T>G (p.Arg544=) | Inborn genetic diseases [RCV005325809]|Tatton-Brown-Rahman overgrowth syndrome [RCV003747514] | likely benign | 2 | 25244575 | 25244575 | Human | 2 | name |
| 405250344 | CV3064525 | single nucleotide variant | NM_022552.5(DNMT3A):c.1854C>T (p.Asp618=) | Inborn genetic diseases [RCV005325802]|Tatton-Brown-Rahman overgrowth syndrome [RCV003747486] | likely benign | 2 | 25243980 | 25243980 | Human | 2 | name |
| 405250776 | CV3072243 | single nucleotide variant | NM_022552.5(DNMT3A):c.2738A>G (p.Ter913=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747641] | likely benign | 2 | 25234280 | 25234280 | Human | 1 | name |
| 405250762 | CV3072254 | single nucleotide variant | NM_022552.5(DNMT3A):c.2622T>C (p.Tyr874=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747643] | likely benign | 2 | 25234396 | 25234396 | Human | 1 | name |
| 405161324 | CV3125003 | single nucleotide variant | NM_022552.5(DNMT3A):c.1137C>T (p.Arg379=) | Inborn genetic diseases [RCV005325832]|Tatton-Brown-Rahman overgrowth syndrome [RCV003818274] | likely benign | 2 | 25246762 | 25246762 | Human | 2 | name |
| 405239804 | CV3166022 | single nucleotide variant | NM_022552.5(DNMT3A):c.1311G>A (p.Thr437=) | DNMT3A-related disorder [RCV004747395]|Inborn genetic diseases [RCV005325873]|Tatton-Brown-Rahman overgrowth syndrome [RCV003867034] | likely benign | 2 | 25246278 | 25246278 | Human | 2 | name , trait , alternate_id |
| 405252362 | CV3177929 | single nucleotide variant | NM_022552.5(DNMT3A):c.1860A>G (p.Pro620=) | Inborn genetic diseases [RCV004981117]|Tatton-Brown-Rahman overgrowth syndrome [RCV003870709] | likely benign | 2 | 25243974 | 25243974 | Human | 2 | name |
| 402503467 | CV3181068 | single nucleotide variant | NM_022552.5(DNMT3A):c.1596C>A (p.Gly532=) | Tatton-Brown-Rahman overgrowth syndrome [RCV003878085] | likely benign | 2 | 25244611 | 25244611 | Human | 1 | name |
| 405259650 | CV3195147 | single nucleotide variant | NM_022552.5(DNMT3A):c.1590C>T (p.Asp530=) | DNMT3A-related disorder [RCV003894344]|Inborn genetic diseases [RCV004981138] | likely benign | 2 | 25244617 | 25244617 | Human | 1 | name , trait , alternate_id |
| 405265047 | CV3201475 | single nucleotide variant | NM_022552.5(DNMT3A):c.2625T>C (p.Thr875=) | DNMT3A-related disorder [RCV003897233]|Inborn genetic diseases [RCV005325887]|Tatton-Brown-Rahman overgrowth syndrome [RCV005101578] | likely benign | 2 | 25234393 | 25234393 | Human | 2 | name , trait , alternate_id |
| 405271866 | CV3203024 | single nucleotide variant | NM_022552.5(DNMT3A):c.2103C>T (p.Phe701=) | DNMT3A-related disorder [RCV003914076]|Inborn genetic diseases [RCV004981142] | likely benign | 2 | 25240710 | 25240710 | Human | 1 | name , trait , alternate_id |
| 405294020 | CV3203395 | single nucleotide variant | NM_022552.5(DNMT3A):c.1041G>A (p.Leu347=) | DNMT3A-related disorder [RCV003933941]|Inborn genetic diseases [RCV004981145] | likely benign | 2 | 25247132 | 25247132 | Human | 1 | name , trait , alternate_id |
| 407502747 | CV3495710 | deletion | NM_022552.5(DNMT3A):c.417del (p.Lys140fs) | not provided [RCV004697550] | pathogenic | 2 | 25282472 | 25282472 | Human | | name |
| 408382414 | CV3504484 | single nucleotide variant | NM_022552.5(DNMT3A):c.2055G>A (p.Gly685=) | DNMT3A-related disorder [RCV004729798]|Inborn genetic diseases [RCV005325913]|Tatton-Brown-Rahman overgrowth syndrome [RCV005103632] | likely benign | 2 | 25241589 | 25241589 | Human | 2 | name , trait , alternate_id |
| 408379463 | CV3506989 | single nucleotide variant | NM_022552.5(DNMT3A):c.1386G>A (p.Ala462=) | DNMT3A-related disorder [RCV004728469]|Inborn genetic diseases [RCV005325916] | likely benign | 2 | 25246203 | 25246203 | Human | 1 | name , trait , alternate_id |
| 408379507 | CV3507037 | deletion | NM_022552.5(DNMT3A):c.940del (p.Trp314fs) | DNMT3A-related disorder [RCV004728498] | likely pathogenic | 2 | 25247665 | 25247665 | Human | | name , trait , alternate_id |
| 408374780 | CV3507214 | single nucleotide variant | NM_022552.5(DNMT3A):c.1440G>A (p.Val480=) | DNMT3A-related disorder [RCV004747455] | likely benign | 2 | 25246054 | 25246054 | Human | | name , trait , alternate_id |
| 408374766 | CV3507252 | single nucleotide variant | NM_022552.5(DNMT3A):c.2016G>T (p.Val672=) | DNMT3A-related disorder [RCV004747462] | likely benign | 2 | 25241628 | 25241628 | Human | | name , trait , alternate_id |
| 408374777 | CV3507481 | single nucleotide variant | NM_022552.5(DNMT3A):c.2388T>G (p.Gly796=) | DNMT3A-related disorder [RCV004747488] | likely benign | 2 | 25239150 | 25239150 | Human | | name , trait , alternate_id |
| 408373730 | CV3511822 | single nucleotide variant | NM_022552.5(DNMT3A):c.1707G>A (p.Pro569=) | DNMT3A-related disorder [RCV004745652]|Inborn genetic diseases [RCV005325919]|Tatton-Brown-Rahman overgrowth syndrome [RCV005103775] | likely benign | 2 | 25244299 | 25244299 | Human | 2 | name , trait , alternate_id |
| 408373783 | CV3512603 | single nucleotide variant | NM_022552.5(DNMT3A):c.2340T>C (p.Ile780=) | DNMT3A-related disorder [RCV004745717] | likely benign | 2 | 25239198 | 25239198 | Human | | name , trait , alternate_id |
| 408373800 | CV3512752 | single nucleotide variant | NM_022552.5(DNMT3A):c.2427G>T (p.Val809=) | DNMT3A-related disorder [RCV004745734] | likely benign | 2 | 25236987 | 25236987 | Human | | name , trait , alternate_id |
| 408373856 | CV3513115 | single nucleotide variant | NM_022552.5(DNMT3A):c.1785G>C (p.Leu595=) | DNMT3A-related disorder [RCV004745791] | likely benign | 2 | 25244221 | 25244221 | Human | | name , trait , alternate_id |
| 408373884 | CV3513281 | single nucleotide variant | NM_022552.5(DNMT3A):c.235G>A (p.Ala79Thr) | DNMT3A-related disorder [RCV004745817] | uncertain significance | 2 | 25282654 | 25282654 | Human | | name , trait , alternate_id |
| 408373938 | CV3513325 | single nucleotide variant | NM_022552.5(DNMT3A):c.2358A>C (p.Ser786=) | DNMT3A-related disorder [RCV004745828] | likely benign | 2 | 25239180 | 25239180 | Human | | name , trait , alternate_id |
| 408373912 | CV3513408 | single nucleotide variant | NM_022552.5(DNMT3A):c.2100A>T (p.Pro700=) | DNMT3A-related disorder [RCV004745842]|Inborn genetic diseases [RCV005325921] | likely benign | 2 | 25240713 | 25240713 | Human | 1 | name , trait , alternate_id |
| 408373946 | CV3513661 | single nucleotide variant | NM_022552.5(DNMT3A):c.2343T>C (p.Asp781=) | DNMT3A-related disorder [RCV004745873] | likely benign | 2 | 25239195 | 25239195 | Human | | name , trait , alternate_id |
| 408373965 | CV3513809 | single nucleotide variant | NM_022552.5(DNMT3A):c.2040G>A (p.Lys680=) | DNMT3A-related disorder [RCV004745892] | likely benign | 2 | 25241604 | 25241604 | Human | | name , trait , alternate_id |
| 408374220 | CV3515232 | single nucleotide variant | NM_022552.5(DNMT3A):c.1500C>T (p.Leu500=) | DNMT3A-related disorder [RCV004746095] | likely benign | 2 | 25245307 | 25245307 | Human | | name , trait , alternate_id |
| 408374242 | CV3515346 | single nucleotide variant | NM_022552.5(DNMT3A):c.1476C>T (p.Asp492=) | DNMT3A-related disorder [RCV004746115] | likely benign | 2 | 25245331 | 25245331 | Human | | name , trait , alternate_id |
| 408374603 | CV3517482 | single nucleotide variant | NM_022552.5(DNMT3A):c.2208C>T (p.Arg736=) | DNMT3A-related disorder [RCV004746936] | likely benign | 2 | 25240416 | 25240416 | Human | | name , trait , alternate_id |
| 596948102 | CV3547697 | single nucleotide variant | NM_022552.5(DNMT3A):c.1488C>T (p.Ser496=) | not provided [RCV004812002] | likely benign | 2 | 25245319 | 25245319 | Human | | name |
| 597649368 | CV3659333 | single nucleotide variant | NM_022552.5(DNMT3A):c.1287G>A (p.Lys429=) | Inborn genetic diseases [RCV004974364] | likely benign | 2 | 25246302 | 25246302 | Human | 1 | name |
| 597649380 | CV3659335 | single nucleotide variant | NM_022552.5(DNMT3A):c.1080C>T (p.Asn360=) | Inborn genetic diseases [RCV004974366] | likely benign | 2 | 25247093 | 25247093 | Human | 1 | name |
| 597649392 | CV3659337 | single nucleotide variant | NM_022552.5(DNMT3A):c.1626G>T (p.Gly542=) | Inborn genetic diseases [RCV004974368] | likely benign | 2 | 25244581 | 25244581 | Human | 1 | name |
| 597649404 | CV3659339 | single nucleotide variant | NM_022552.5(DNMT3A):c.1812G>A (p.Arg604=) | Inborn genetic diseases [RCV004974370] | likely benign | 2 | 25244194 | 25244194 | Human | 1 | name |
| 597649444 | CV3659345 | single nucleotide variant | NM_022552.5(DNMT3A):c.2706C>T (p.Phe902=) | Inborn genetic diseases [RCV004974376] | likely benign | 2 | 25234312 | 25234312 | Human | 1 | name |
| 597649453 | CV3659346 | single nucleotide variant | NM_022552.5(DNMT3A):c.2631C>T (p.Val877=) | Inborn genetic diseases [RCV004974377] | likely benign | 2 | 25234387 | 25234387 | Human | 1 | name |
| 597649462 | CV3659348 | single nucleotide variant | NM_022552.5(DNMT3A):c.1911G>A (p.Leu637=) | Inborn genetic diseases [RCV004974379] | likely benign | 2 | 25243923 | 25243923 | Human | 1 | name |
| 597649475 | CV3659350 | single nucleotide variant | NM_022552.5(DNMT3A):c.1839C>T (p.His613=) | Inborn genetic diseases [RCV004974381] | likely benign | 2 | 25244167 | 25244167 | Human | 1 | name |
| 597649488 | CV3659352 | single nucleotide variant | NM_022552.5(DNMT3A):c.1239C>T (p.Gly413=) | Inborn genetic diseases [RCV004974383] | likely benign | 2 | 25246660 | 25246660 | Human | 1 | name |
| 597649495 | CV3659353 | single nucleotide variant | NM_022552.5(DNMT3A):c.1527C>T (p.Phe509=) | Inborn genetic diseases [RCV004974384] | likely benign | 2 | 25245280 | 25245280 | Human | 1 | name |
| 597649500 | CV3659354 | single nucleotide variant | NM_022552.5(DNMT3A):c.2397C>T (p.Pro799=) | Inborn genetic diseases [RCV004974385] | likely benign | 2 | 25239141 | 25239141 | Human | 1 | name |
| 597649506 | CV3659356 | single nucleotide variant | NM_022552.5(DNMT3A):c.1716C>T (p.Ala572=) | Inborn genetic diseases [RCV004974386] | likely benign | 2 | 25244290 | 25244290 | Human | 1 | name |
| 597649521 | CV3659358 | single nucleotide variant | NM_022552.5(DNMT3A):c.1413T>C (p.Ile471=) | Inborn genetic diseases [RCV004974388] | likely benign | 2 | 25246176 | 25246176 | Human | 1 | name |
| 597649534 | CV3659360 | single nucleotide variant | NM_022552.5(DNMT3A):c.1809C>T (p.Ser603=) | Inborn genetic diseases [RCV004974390] | likely benign | 2 | 25244197 | 25244197 | Human | 1 | name |
| 597958386 | CV3751844 | single nucleotide variant | NM_022552.5(DNMT3A):c.2418A>G (p.Ala806=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005080973] | likely benign | 2 | 25236996 | 25236996 | Human | 1 | name |
| 597894901 | CV3773375 | single nucleotide variant | NM_022552.5(DNMT3A):c.1233G>T (p.Leu411=) | Inborn genetic diseases [RCV005325995]|Tatton-Brown-Rahman overgrowth syndrome [RCV005111282] | likely benign | 2 | 25246666 | 25246666 | Human | 2 | name |
| 597916274 | CV3779342 | single nucleotide variant | NM_022552.5(DNMT3A):c.1293C>T (p.Pro431=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005129483] | likely benign | 2 | 25246296 | 25246296 | Human | 1 | name |
| 597946513 | CV3790149 | single nucleotide variant | NM_022552.5(DNMT3A):c.1569G>A (p.Glu523=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005134850] | likely benign | 2 | 25244638 | 25244638 | Human | 1 | name |
| 597954648 | CV3795823 | single nucleotide variant | NM_022552.5(DNMT3A):c.2058C>T (p.Asp686=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005136833] | likely benign | 2 | 25241586 | 25241586 | Human | 1 | name |
| 597863208 | CV3813995 | single nucleotide variant | NM_022552.5(DNMT3A):c.1017G>A (p.Val339=) | Inborn genetic diseases [RCV005326019]|Tatton-Brown-Rahman overgrowth syndrome [RCV005147064] | likely benign | 2 | 25247156 | 25247156 | Human | 2 | name |
| 597968268 | CV3820879 | single nucleotide variant | NM_022552.5(DNMT3A):c.1713T>G (p.Ala571=) | Inborn genetic diseases [RCV005326030]|Tatton-Brown-Rahman overgrowth syndrome [RCV005165720] | likely benign | 2 | 25244293 | 25244293 | Human | 2 | name |
| 597838460 | CV3824814 | single nucleotide variant | NM_022552.5(DNMT3A):c.1029G>A (p.Lys343=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005171678] | uncertain significance | 2 | 25247144 | 25247144 | Human | 1 | name |
| 597894001 | CV3833516 | single nucleotide variant | NM_022552.5(DNMT3A):c.2172C>T (p.Tyr724=) | Inborn genetic diseases [RCV005326037]|Tatton-Brown-Rahman overgrowth syndrome [RCV005180208] | likely benign|uncertain significance | 2 | 25240641 | 25240641 | Human | 2 | name |
| 597886980 | CV3838979 | single nucleotide variant | NM_022552.5(DNMT3A):c.1780C>T (p.Leu594=) | Inborn genetic diseases [RCV005326041]|Tatton-Brown-Rahman overgrowth syndrome [RCV005179064] | likely benign | 2 | 25244226 | 25244226 | Human | 2 | name |
| 597922314 | CV3843228 | single nucleotide variant | NM_022552.5(DNMT3A):c.2505G>A (p.Thr835=) | Inborn genetic diseases [RCV005326045]|Tatton-Brown-Rahman overgrowth syndrome [RCV005184520] | likely benign | 2 | 25235799 | 25235799 | Human | 2 | name |
| 597953442 | CV3843984 | single nucleotide variant | NM_022552.5(DNMT3A):c.1845G>A (p.Gln615=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005190846] | likely benign | 2 | 25244161 | 25244161 | Human | 1 | name |
| 597965885 | CV3845046 | single nucleotide variant | NM_022552.5(DNMT3A):c.2460G>A (p.Glu820=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005194374] | likely benign | 2 | 25236954 | 25236954 | Human | 1 | name |
| 597871465 | CV3849326 | single nucleotide variant | NM_022552.5(DNMT3A):c.1647C>T (p.Cys549=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005197507] | likely benign | 2 | 25244560 | 25244560 | Human | 1 | name |
| 597926402 | CV3855361 | single nucleotide variant | NM_022552.5(DNMT3A):c.2154T>G (p.Pro718=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005205960] | likely benign | 2 | 25240659 | 25240659 | Human | 1 | name |
| 597892572 | CV3856743 | single nucleotide variant | NM_022552.5(DNMT3A):c.191A>T (p.Asp64Val) | Tatton-Brown-Rahman overgrowth syndrome [RCV005200811] | uncertain significance | 2 | 25282698 | 25282698 | Human | 1 | name |
| 597887333 | CV3859291 | single nucleotide variant | NM_022552.5(DNMT3A):c.175C>T (p.Pro59Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV005199944] | uncertain significance | 2 | 25300141 | 25300141 | Human | 1 | name |
| 597863000 | CV3860635 | single nucleotide variant | NM_022552.5(DNMT3A):c.1023T>C (p.Val341=) | Tatton-Brown-Rahman overgrowth syndrome [RCV005196163] | likely benign | 2 | 25247150 | 25247150 | Human | 1 | name |
| 597863825 | CV3860778 | deletion | NM_022552.5(DNMT3A):c.761del (p.Ala254fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV005196306] | pathogenic | 2 | 25248131 | 25248131 | Human | 1 | name |
| 598175886 | CV3891059 | single nucleotide variant | NM_022552.5(DNMT3A):c.257A>G (p.Glu86Gly) | not provided [RCV005251912] | uncertain significance | 2 | 25282632 | 25282632 | Human | | name |
| 598164873 | CV3964247 | single nucleotide variant | NM_022552.5(DNMT3A):c.2121C>A (p.Gly707=) | Inborn genetic diseases [RCV005329592] | likely benign | 2 | 25240692 | 25240692 | Human | 1 | name |
| 598164886 | CV3964250 | single nucleotide variant | NM_022552.5(DNMT3A):c.2676A>T (p.Ser892=) | Inborn genetic diseases [RCV005329595] | likely benign | 2 | 25234342 | 25234342 | Human | 1 | name |
| 598164890 | CV3964251 | single nucleotide variant | NM_022552.5(DNMT3A):c.1518C>T (p.His506=) | Inborn genetic diseases [RCV005329596] | likely benign | 2 | 25245289 | 25245289 | Human | 1 | name |
| 598164907 | CV3964255 | single nucleotide variant | NM_022552.5(DNMT3A):c.1710G>A (p.Gly570=) | Inborn genetic diseases [RCV005329600] | likely benign | 2 | 25244296 | 25244296 | Human | 1 | name |
| 598164912 | CV3964256 | single nucleotide variant | NM_022552.5(DNMT3A):c.2190C>T (p.Leu730=) | Inborn genetic diseases [RCV005329601] | likely benign | 2 | 25240434 | 25240434 | Human | 1 | name |
| 598164924 | CV3964258 | single nucleotide variant | NM_022552.5(DNMT3A):c.1695C>T (p.Leu565=) | Inborn genetic diseases [RCV005329603] | likely benign | 2 | 25244311 | 25244311 | Human | 1 | name |
| 598164929 | CV3964259 | single nucleotide variant | NM_022552.5(DNMT3A):c.1053C>T (p.Cys351=) | Inborn genetic diseases [RCV005329604] | likely benign | 2 | 25247120 | 25247120 | Human | 1 | name |
| 598164938 | CV3964261 | single nucleotide variant | NM_022552.5(DNMT3A):c.1773C>T (p.Thr591=) | Inborn genetic diseases [RCV005329606] | likely benign | 2 | 25244233 | 25244233 | Human | 1 | name |
| 598164947 | CV3964263 | single nucleotide variant | NM_022552.5(DNMT3A):c.1128C>T (p.Ala376=) | Inborn genetic diseases [RCV005329608] | likely benign | 2 | 25246771 | 25246771 | Human | 1 | name |
| 598164951 | CV3964264 | single nucleotide variant | NM_022552.5(DNMT3A):c.2454T>C (p.Cys818=) | Inborn genetic diseases [RCV005329609] | likely benign | 2 | 25236960 | 25236960 | Human | 1 | name |
| 598164960 | CV3964266 | single nucleotide variant | NM_022552.5(DNMT3A):c.2034G>A (p.Gln678=) | Inborn genetic diseases [RCV005329611] | likely benign | 2 | 25241610 | 25241610 | Human | 1 | name |
| 598164963 | CV3964267 | single nucleotide variant | NM_022552.5(DNMT3A):c.1881A>G (p.Pro627=) | Inborn genetic diseases [RCV005329612] | likely benign | 2 | 25243953 | 25243953 | Human | 1 | name |
| 598164968 | CV3964268 | single nucleotide variant | NM_022552.5(DNMT3A):c.2127C>T (p.Pro709=) | Inborn genetic diseases [RCV005329613] | likely benign | 2 | 25240686 | 25240686 | Human | 1 | name |
| 598164988 | CV3964272 | single nucleotide variant | NM_022552.5(DNMT3A):c.1971G>C (p.Val657=) | Inborn genetic diseases [RCV005329617] | likely benign | 2 | 25241673 | 25241673 | Human | 1 | name |
| 598164994 | CV3964273 | single nucleotide variant | NM_022552.5(DNMT3A):c.1335A>C (p.Ala445=) | Inborn genetic diseases [RCV005329618] | likely benign | 2 | 25246254 | 25246254 | Human | 1 | name |
| 598165016 | CV3964278 | single nucleotide variant | NM_022552.5(DNMT3A):c.1089C>T (p.Pro363=) | Inborn genetic diseases [RCV005329623] | likely benign | 2 | 25247084 | 25247084 | Human | 1 | name |
| 598165029 | CV3964281 | single nucleotide variant | NM_022552.5(DNMT3A):c.1941C>T (p.Leu647=) | Inborn genetic diseases [RCV005329626] | likely benign | 2 | 25241703 | 25241703 | Human | 1 | name |
| 598165035 | CV3964282 | single nucleotide variant | NM_022552.5(DNMT3A):c.1881A>C (p.Pro627=) | Inborn genetic diseases [RCV005329627] | likely benign | 2 | 25243953 | 25243953 | Human | 1 | name |
| 598165047 | CV3964284 | single nucleotide variant | NM_022552.5(DNMT3A):c.1866T>G (p.Val622=) | Inborn genetic diseases [RCV005329629] | likely benign | 2 | 25243968 | 25243968 | Human | 1 | name |
| 598165060 | CV3964287 | single nucleotide variant | NM_022552.5(DNMT3A):c.1185T>C (p.Thr395=) | Inborn genetic diseases [RCV005329632] | likely benign | 2 | 25246714 | 25246714 | Human | 1 | name |
| 598165066 | CV3964288 | single nucleotide variant | NM_022552.5(DNMT3A):c.1263C>T (p.Gly421=) | Inborn genetic diseases [RCV005329633] | likely benign | 2 | 25246636 | 25246636 | Human | 1 | name |
| 598165070 | CV3964289 | single nucleotide variant | NM_022552.5(DNMT3A):c.2181T>G (p.Thr727=) | Inborn genetic diseases [RCV005329634] | likely benign | 2 | 25240443 | 25240443 | Human | 1 | name |
| 598165074 | CV3964290 | single nucleotide variant | NM_022552.5(DNMT3A):c.1005A>G (p.Lys335=) | Inborn genetic diseases [RCV005329635] | likely benign | 2 | 25247600 | 25247600 | Human | 1 | name |
| 598165094 | CV3964294 | single nucleotide variant | NM_022552.5(DNMT3A):c.1479C>T (p.Ile493=) | Inborn genetic diseases [RCV005329639] | likely benign | 2 | 25245328 | 25245328 | Human | 1 | name |
| 598165098 | CV3964295 | single nucleotide variant | NM_022552.5(DNMT3A):c.2235G>A (p.Glu745=) | Inborn genetic diseases [RCV005329640] | likely benign | 2 | 25240389 | 25240389 | Human | 1 | name |
| 598165106 | CV3964297 | single nucleotide variant | NM_022552.5(DNMT3A):c.2673G>T (p.Arg891=) | Inborn genetic diseases [RCV005329642] | likely benign | 2 | 25234345 | 25234345 | Human | 1 | name |
| 598165111 | CV3964298 | single nucleotide variant | NM_022552.5(DNMT3A):c.2166C>A (p.Gly722=) | Inborn genetic diseases [RCV005329643] | likely benign | 2 | 25240647 | 25240647 | Human | 1 | name |
| 598165117 | CV3964299 | single nucleotide variant | NM_022552.5(DNMT3A):c.2157T>C (p.Ala719=) | Inborn genetic diseases [RCV005329644] | likely benign | 2 | 25240656 | 25240656 | Human | 1 | name |
| 598165121 | CV3964300 | single nucleotide variant | NM_022552.5(DNMT3A):c.2154T>C (p.Pro718=) | Inborn genetic diseases [RCV005329645] | likely benign | 2 | 25240659 | 25240659 | Human | 1 | name |
| 598165132 | CV3964302 | single nucleotide variant | NM_022552.5(DNMT3A):c.1731G>A (p.Lys577=) | Inborn genetic diseases [RCV005329647] | likely benign | 2 | 25244275 | 25244275 | Human | 1 | name |
| 598165140 | CV3964304 | single nucleotide variant | NM_022552.5(DNMT3A):c.2244T>C (p.Asp748=) | Inborn genetic diseases [RCV005329649] | likely benign | 2 | 25240380 | 25240380 | Human | 1 | name |
| 598165145 | CV3964305 | single nucleotide variant | NM_022552.5(DNMT3A):c.1059G>C (p.Ala353=) | Inborn genetic diseases [RCV005329650] | likely benign | 2 | 25247114 | 25247114 | Human | 1 | name |
| 598165151 | CV3964306 | single nucleotide variant | NM_022552.5(DNMT3A):c.2169C>T (p.Leu723=) | Inborn genetic diseases [RCV005329651] | likely benign | 2 | 25240644 | 25240644 | Human | 1 | name |
| 598165165 | CV3964309 | single nucleotide variant | NM_022552.5(DNMT3A):c.1113G>A (p.Glu371=) | Inborn genetic diseases [RCV005329654] | likely benign | 2 | 25247060 | 25247060 | Human | 1 | name |
| 598165184 | CV3964313 | single nucleotide variant | NM_022552.5(DNMT3A):c.2671C>A (p.Arg891=) | Inborn genetic diseases [RCV005329658] | likely benign | 2 | 25234347 | 25234347 | Human | 1 | name |
| 598165189 | CV3964314 | single nucleotide variant | NM_022552.5(DNMT3A):c.1626G>A (p.Gly542=) | Inborn genetic diseases [RCV005329659] | likely benign | 2 | 25244581 | 25244581 | Human | 1 | name |
| 598165192 | CV3964315 | single nucleotide variant | NM_022552.5(DNMT3A):c.1056T>C (p.Ser352=) | Inborn genetic diseases [RCV005329660] | likely benign | 2 | 25247117 | 25247117 | Human | 1 | name |
| 598165211 | CV3964319 | single nucleotide variant | NM_022552.5(DNMT3A):c.1137C>A (p.Arg379=) | Inborn genetic diseases [RCV005329664] | likely benign | 2 | 25246762 | 25246762 | Human | 1 | name |
| 598165227 | CV3964323 | single nucleotide variant | NM_022552.5(DNMT3A):c.1524C>T (p.Leu508=) | Inborn genetic diseases [RCV005329668] | likely benign | 2 | 25245283 | 25245283 | Human | 1 | name |
| 12894002 | CV405695 | duplication | NM_022552.5(DNMT3A):c.340dup (p.Ala114fs) | not provided [RCV000481109] | pathogenic | 2 | 25282548 | 25282549 | Human | | name |
| 13215974 | CV428044 | single nucleotide variant | NM_022552.5(DNMT3A):c.2652G>A (p.Ala884=) | DNMT3A-related disorder [RCV003962378]|Inborn genetic diseases [RCV004975586]|Tatton-Brown-Rahman overgrowth syndrome [RCV002060109]|not provided [RCV000920263]|not specified [RCV000503184] | benign|likely benign | 2 | 25234366 | 25234366 | Human | 2 | name , trait , alternate_id |
| 13214642 | CV428046 | single nucleotide variant | NM_022552.5(DNMT3A):c.1491T>C (p.Cys497=) | DNMT3A-related disorder [RCV003915371]|Inborn genetic diseases [RCV005328287]|Tatton-Brown-Rahman overgrowth syndrome [RCV002527240]|not specified [RCV000501518] | likely benign|uncertain significance | 2 | 25245316 | 25245316 | Human | 2 | name , trait , alternate_id |
| 13216322 | CV428047 | single nucleotide variant | NM_022552.5(DNMT3A):c.1155G>A (p.Pro385=) | DNMT3A-related disorder [RCV003960160]|Inborn genetic diseases [RCV004975587]|Tatton-Brown-Rahman overgrowth syndrome [RCV000945500]|not provided [RCV001534819]|not specified [RCV000503622] | likely benign|uncertain significance | 2 | 25246744 | 25246744 | Human | 2 | name , trait , alternate_id |
| 13481777 | CV450751 | single nucleotide variant | NM_022552.5(DNMT3A):c.2151C>T (p.Asn717=) | DNMT3A-related disorder [RCV003935531]|Inborn genetic diseases [RCV004975683]|Tatton-Brown-Rahman overgrowth syndrome [RCV000551582]|not provided [RCV001672862]|not specified [RCV001821633] | benign|likely benign | 2 | 25240662 | 25240662 | Human | 2 | name , trait , alternate_id |
| 13477576 | CV450755 | deletion | NM_022552.5(DNMT3A):c.735del (p.Ala246fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV000549667] | pathogenic | 2 | 25248157 | 25248157 | Human | 1 | name |
| 13473737 | CV450968 | single nucleotide variant | NM_022552.5(DNMT3A):c.1140G>A (p.Ala380=) | Tatton-Brown-Rahman overgrowth syndrome [RCV000547935]|not provided [RCV001536904] | benign | 2 | 25246759 | 25246759 | Human | 1 | name |
| 13516825 | CV490941 | single nucleotide variant | NM_022552.5(DNMT3A):c.2676A>G (p.Ser892=) | DNMT3A-related disorder [RCV003927918]|Inborn genetic diseases [RCV004975698]|Tatton-Brown-Rahman overgrowth syndrome [RCV001088447]|not provided [RCV000596005] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 2 | 25234342 | 25234342 | Human | 2 | name , trait , alternate_id |
| 13523711 | CV492017 | single nucleotide variant | NM_022552.5(DNMT3A):c.2175G>A (p.Glu725=) | not provided [RCV000593348] | uncertain significance | 2 | 25240449 | 25240449 | Human | | name |
| 13624453 | CV518041 | single nucleotide variant | NM_022552.5(DNMT3A):c.2688A>G (p.Pro896=) | DNMT3A-related disorder [RCV003928130]|Inborn genetic diseases [RCV004972824]|Tatton-Brown-Rahman overgrowth syndrome [RCV000652289]|not provided [RCV001653973] | benign|likely benign | 2 | 25234330 | 25234330 | Human | 2 | name , trait , alternate_id |
| 15142026 | CV691110 | single nucleotide variant | NM_022552.5(DNMT3A):c.1038G>A (p.Pro346=) | DNMT3A-related disorder [RCV003930450]|Tatton-Brown-Rahman overgrowth syndrome [RCV000877785] | likely benign | 2 | 25247135 | 25247135 | Human | 1 | name , trait , alternate_id |
| 15176795 | CV697498 | single nucleotide variant | NM_022552.5(DNMT3A):c.2658G>A (p.Gln886=) | DNMT3A-related disorder [RCV003970714]|Inborn genetic diseases [RCV004973195]|Tatton-Brown-Rahman overgrowth syndrome [RCV002066271]|not provided [RCV000950906] | likely benign | 2 | 25234360 | 25234360 | Human | 2 | name , trait , alternate_id |
| 15179215 | CV697499 | single nucleotide variant | NM_022552.5(DNMT3A):c.1677C>T (p.Cys559=) | DNMT3A-related disorder [RCV003915786]|Inborn genetic diseases [RCV004973198]|Tatton-Brown-Rahman overgrowth syndrome [RCV000951468]|not provided [RCV001683696] | benign|likely benign | 2 | 25244329 | 25244329 | Human | 2 | name , trait , alternate_id |
| 15150525 | CV697500 | single nucleotide variant | NM_022552.5(DNMT3A):c.1170C>T (p.Ser390=) | DNMT3A-related disorder [RCV003925853]|Inborn genetic diseases [RCV004973188]|Tatton-Brown-Rahman overgrowth syndrome [RCV000945513]|not provided [RCV001696224] | benign|likely benign | 2 | 25246729 | 25246729 | Human | 2 | name , trait , alternate_id |
| 15153003 | CV697501 | single nucleotide variant | NM_022552.5(DNMT3A):c.1164C>T (p.His388=) | DNMT3A-related disorder [RCV003942988]|Inborn genetic diseases [RCV004973190]|Tatton-Brown-Rahman overgrowth syndrome [RCV002546000] | likely benign | 2 | 25246735 | 25246735 | Human | 2 | name , trait , alternate_id |
| 15131914 | CV708191 | single nucleotide variant | NM_022552.5(DNMT3A):c.187G>A (p.Gly63Ser) | DNMT3A-related disorder [RCV003943135]|Tatton-Brown-Rahman overgrowth syndrome [RCV002547289]|not provided [RCV003886459] | benign|likely benign|uncertain significance | 2 | 25282702 | 25282702 | Human | 1 | name , trait , alternate_id |
| 15158977 | CV733373 | single nucleotide variant | NM_022552.5(DNMT3A):c.2697C>T (p.Arg899=) | Inborn genetic diseases [RCV004973150]|Tatton-Brown-Rahman overgrowth syndrome [RCV000902842]|not provided [RCV001759667] | likely benign | 2 | 25234321 | 25234321 | Human | 2 | name |
| 15139580 | CV733374 | single nucleotide variant | NM_022552.5(DNMT3A):c.1575G>A (p.Ala525=) | DNMT3A-related disorder [RCV003895484]|Inborn genetic diseases [RCV004973145]|Tatton-Brown-Rahman overgrowth syndrome [RCV002540185] | likely benign | 2 | 25244632 | 25244632 | Human | 2 | name , trait , alternate_id |
| 15124036 | CV747496 | single nucleotide variant | NM_022552.5(DNMT3A):c.2628C>T (p.Asp876=) | DNMT3A-related disorder [RCV003970470]|Inborn genetic diseases [RCV004973169]|Tatton-Brown-Rahman overgrowth syndrome [RCV000918918] | likely benign | 2 | 25234390 | 25234390 | Human | 2 | name , trait , alternate_id |
| 15108181 | CV747497 | single nucleotide variant | NM_022552.5(DNMT3A):c.2331T>C (p.Pro777=) | DNMT3A-related disorder [RCV003970427]|Inborn genetic diseases [RCV004973165]|Tatton-Brown-Rahman overgrowth syndrome [RCV001434533] | likely benign | 2 | 25239207 | 25239207 | Human | 2 | name , trait , alternate_id |
| 15170668 | CV747498 | single nucleotide variant | NM_022552.5(DNMT3A):c.1432C>A (p.Arg478=) | DNMT3A-related disorder [RCV003895640]|Inborn genetic diseases [RCV005328438]|not provided [RCV000927746] | likely benign | 2 | 25246062 | 25246062 | Human | 1 | name , trait , alternate_id |
| 15124029 | CV747499 | single nucleotide variant | NM_022552.5(DNMT3A):c.1074G>A (p.Thr358=) | DNMT3A-related disorder [RCV003895584]|Inborn genetic diseases [RCV004973168]|Tatton-Brown-Rahman overgrowth syndrome [RCV002540947]|not provided [RCV000918917] | likely benign | 2 | 25247099 | 25247099 | Human | 2 | name , trait , alternate_id |
| 15174518 | CV763124 | single nucleotide variant | NM_022552.5(DNMT3A):c.2712G>A (p.Pro904=) | DNMT3A-related disorder [RCV003942885]|Inborn genetic diseases [RCV004973177]|Tatton-Brown-Rahman overgrowth syndrome [RCV000928451]|not provided [RCV001593131] | likely benign | 2 | 25234306 | 25234306 | Human | 2 | name , trait , alternate_id |
| 15132527 | CV781268 | single nucleotide variant | NM_022552.5(DNMT3A):c.2232G>A (p.Lys744=) | Inborn genetic diseases [RCV004973223]|Tatton-Brown-Rahman overgrowth syndrome [RCV000981396] | likely benign | 2 | 25240392 | 25240392 | Human | 2 | name |
| 25318988 | CV816445 | single nucleotide variant | NM_022552.5(DNMT3A):c.137G>A (p.Arg46Gln) | Tatton-Brown-Rahman overgrowth syndrome [RCV001028019]|not provided [RCV004761885] | uncertain significance | 2 | 25300179 | 25300179 | Human | 1 | name |
| 38461444 | CV953022 | single nucleotide variant | NM_022552.5(DNMT3A):c.122C>T (p.Pro41Leu) | Tatton-Brown-Rahman overgrowth syndrome [RCV001246960] | uncertain significance | 2 | 25300194 | 25300194 | Human | 1 | name |
| 39457093 | CV965736 | deletion | NM_022552.5(DNMT3A):c.705del (p.Glu235fs) | Intellectual disability [RCV001255352] | likely pathogenic | 2 | 25248187 | 25248187 | Human | 2 | name |
| 126746523 | CV1015414 | single nucleotide variant | NM_022552.5(DNMT3A):c.427C>T (p.Arg143Ter) | Intellectual disability [RCV001328488]|Tatton-Brown-Rahman overgrowth syndrome [RCV003584898] | pathogenic|likely pathogenic | 2 | 25282462 | 25282462 | Human | 3 | name |
| 126773988 | CV1024328 | single nucleotide variant | NM_022552.5(DNMT3A):c.386C>T (p.Ser129Leu) | Tatton-Brown-Rahman overgrowth syndrome [RCV001346704] | uncertain significance | 2 | 25282503 | 25282503 | Human | 1 | name |
| 127248063 | CV1059269 | duplication | NM_022552.5(DNMT3A):c.1711dup (p.Ala571fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV001384839] | pathogenic|likely pathogenic | 2 | 25244294 | 25244295 | Human | 1 | name |
| 127230420 | CV1087033 | deletion | NM_022552.5(DNMT3A):c.1299del (p.Glu434fs) | See cases [RCV001420316] | pathogenic | 2 | 25246290 | 25246290 | Human | | name |
| 150412920 | CV1176140 | single nucleotide variant | NM_022552.5(DNMT3A):c.928A>G (p.Ile310Val) | not provided [RCV001547645] | uncertain significance | 2 | 25247677 | 25247677 | Human | | name |
| 150418686 | CV1179499 | single nucleotide variant | NM_022552.5(DNMT3A):c.835G>A (p.Asp279Asn) | Inborn genetic diseases [RCV002570687]|Tatton-Brown-Rahman overgrowth syndrome [RCV002568322]|not provided [RCV001550708] | likely benign|uncertain significance | 2 | 25248057 | 25248057 | Human | 2 | name |
| 150452349 | CV1275244 | single nucleotide variant | NM_022552.5(DNMT3A):c.890G>A (p.Trp297Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV001706757]|not provided [RCV003222340] | pathogenic|likely pathogenic | 2 | 25247715 | 25247715 | Human | 1 | name |
| 150529099 | CV1288656 | deletion | NM_022552.5(DNMT3A):c.1346del (p.Ala449fs) | not provided [RCV001727124] | pathogenic | 2 | 25246243 | 25246243 | Human | | name |
| 150533867 | CV1305970 | single nucleotide variant | NM_022552.5(DNMT3A):c.862C>T (p.Arg288Trp) | DNMT3A-related disorder [RCV004746447]|not provided [RCV001755373] | uncertain significance | 2 | 25247743 | 25247743 | Human | | name , trait , alternate_id |
| 150533947 | CV1307410 | single nucleotide variant | NM_022552.5(DNMT3A):c.656A>G (p.Lys219Arg) | Acute myeloid leukemia [RCV002482287]|Tatton-Brown-Rahman overgrowth syndrome [RCV003772097]|not provided [RCV001755546] | uncertain significance | 2 | 25248236 | 25248236 | Human | 3 | name |
| 150533077 | CV1308363 | single nucleotide variant | NM_022552.5(DNMT3A):c.899T>G (p.Leu300Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV005416127]|not provided [RCV001753354] | likely pathogenic|uncertain significance | 2 | 25247706 | 25247706 | Human | 1 | name |
| 150539287 | CV1308606 | single nucleotide variant | NM_022552.5(DNMT3A):c.893G>A (p.Gly298Glu) | not provided [RCV001766110] | uncertain significance | 2 | 25247712 | 25247712 | Human | | name |
| 150535977 | CV1309078 | single nucleotide variant | NM_022552.5(DNMT3A):c.899T>C (p.Leu300Pro) | not provided [RCV001759285] | uncertain significance | 2 | 25247706 | 25247706 | Human | | name |
| 151352236 | CV1322322 | single nucleotide variant | NM_022552.5(DNMT3A):c.875T>C (p.Ile292Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV002542370]|not provided [RCV001806945] | likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 2 | 25247730 | 25247730 | Human | 1 | name |
| 151663718 | CV1334184 | deletion | NM_022552.5(DNMT3A):c.1791del (p.Arg598fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV001839358] | pathogenic | 2 | 25244215 | 25244215 | Human | 1 | name |
| 8688714 | CV137723 | single nucleotide variant | NM_022552.5(DNMT3A):c.802G>A (p.Asp268Asn) | not specified [RCV000120653] | not provided | 2 | 25248090 | 25248090 | Human | | name |
| 8688715 | CV137724 | single nucleotide variant | NM_022552.5(DNMT3A):c.645G>C (p.Glu215Asp) | Tatton-Brown-Rahman overgrowth syndrome [RCV005055588]|not specified [RCV000120654] | uncertain significance|not provided | 2 | 25248247 | 25248247 | Human | 1 | name |
| 151840287 | CV1407850 | single nucleotide variant | NM_022552.5(DNMT3A):c.343C>G (p.Pro115Ala) | Tatton-Brown-Rahman overgrowth syndrome [RCV001881268] | uncertain significance | 2 | 25282546 | 25282546 | Human | 1 | name |
| 8696162 | CV143240 | single nucleotide variant | NM_022552.5(DNMT3A):c.929T>A (p.Ile310Asn) | Tatton-Brown-Rahman overgrowth syndrome [RCV000128560] | pathogenic | 2 | 25247676 | 25247676 | Human | 1 | name |
| 151751151 | CV1508357 | single nucleotide variant | NM_022552.5(DNMT3A):c.694G>A (p.Gly232Arg) | DNMT3A-related disorder [RCV004746570]|Tatton-Brown-Rahman overgrowth syndrome [RCV001986296] | uncertain significance | 2 | 25248198 | 25248198 | Human | 1 | name , trait , alternate_id |
| 153302266 | CV1688142 | single nucleotide variant | NM_022552.5(DNMT3A):c.626G>A (p.Arg209His) | not provided [RCV002265368] | uncertain significance | 2 | 25274954 | 25274954 | Human | | name |
| 153305259 | CV1688316 | single nucleotide variant | NM_022552.5(DNMT3A):c.905G>C (p.Gly302Ala) | Heyn-Sproul-Jackson syndrome [RCV003228061] | likely pathogenic | 2 | 25247700 | 25247700 | Human | 1 | name |
| 153346925 | CV1694277 | single nucleotide variant | NM_022552.5(DNMT3A):c.917G>A (p.Trp306Ter) | Neurodevelopmental disorder [RCV002277693] | pathogenic | 2 | 25247688 | 25247688 | Human | 1 | name |
| 155266653 | CV1699221 | single nucleotide variant | NM_022552.5(DNMT3A):c.505C>T (p.Arg169Trp) | not provided [RCV002283016] | uncertain significance | 2 | 25275075 | 25275075 | Human | | name |
| 155686496 | CV1777642 | single nucleotide variant | NM_022552.5(DNMT3A):c.625C>G (p.Arg209Gly) | Tatton-Brown-Rahman overgrowth syndrome [RCV002299024] | uncertain significance | 2 | 25274955 | 25274955 | Human | 1 | name |
| 155690637 | CV1777942 | single nucleotide variant | NM_022552.5(DNMT3A):c.374T>C (p.Leu125Pro) | Tatton-Brown-Rahman overgrowth syndrome [RCV002299267] | uncertain significance | 2 | 25282515 | 25282515 | Human | 1 | name |
| 155798859 | CV1862201 | single nucleotide variant | NM_022552.5(DNMT3A):c.460A>G (p.Lys154Glu) | Tatton-Brown-Rahman overgrowth syndrome [RCV002471605] | uncertain significance | 2 | 25275532 | 25275532 | Human | 1 | name |
| 155799999 | CV1862753 | deletion | NM_022552.5(DNMT3A):c.640-3826_640-3798del | Tatton-Brown-Rahman overgrowth syndrome [RCV002472160] | uncertain significance | 2 | 25252050 | 25252078 | Human | 1 | name |
| 156200297 | CV1916726 | single nucleotide variant | NM_022552.5(DNMT3A):c.751A>C (p.Thr251Pro) | DNMT3A-related disorder [RCV004747212]|Tatton-Brown-Rahman overgrowth syndrome [RCV002595679] | uncertain significance | 2 | 25248141 | 25248141 | Human | 1 | name , trait , alternate_id |
| 156173834 | CV1926824 | single nucleotide variant | NM_022552.5(DNMT3A):c.337G>A (p.Gly113Arg) | DNMT3A-related disorder [RCV003973718]|Tatton-Brown-Rahman overgrowth syndrome [RCV002624801]|not provided [RCV004721123] | likely benign|uncertain significance | 2 | 25282552 | 25282552 | Human | 1 | name , trait , alternate_id |
| 156449338 | CV1944606 | single nucleotide variant | NM_022552.5(DNMT3A):c.793G>A (p.Val265Met) | Tatton-Brown-Rahman overgrowth syndrome [RCV003121458] | uncertain significance | 2 | 25248099 | 25248099 | Human | 1 | name |
| 10401530 | CV205233 | single nucleotide variant | NM_022552.5(DNMT3A):c.892G>T (p.Gly298Trp) | Inborn genetic diseases [RCV000190731] | pathogenic | 2 | 25247713 | 25247713 | Human | 1 | name |
| 156311323 | CV2078665 | single nucleotide variant | NM_022552.5(DNMT3A):c.629G>A (p.Trp210Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV002898735] | pathogenic | 2 | 25274951 | 25274951 | Human | 1 | name |
| 156343471 | CV2124066 | single nucleotide variant | NM_022552.5(DNMT3A):c.428G>A (p.Arg143Gln) | DNMT3A-related disorder [RCV004747157]|Tatton-Brown-Rahman overgrowth syndrome [RCV002939030] | likely benign|uncertain significance | 2 | 25282461 | 25282461 | Human | 1 | name , trait , alternate_id |
| 156358512 | CV2162243 | single nucleotide variant | NM_022552.5(DNMT3A):c.853G>T (p.Glu285Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV003031398] | pathogenic | 2 | 25248039 | 25248039 | Human | 1 | name |
| 155980871 | CV2163067 | single nucleotide variant | NM_022552.5(DNMT3A):c.838G>T (p.Asp280Tyr) | Tatton-Brown-Rahman overgrowth syndrome [RCV003033872] | uncertain significance | 2 | 25248054 | 25248054 | Human | 1 | name |
| 156435273 | CV2403505 | single nucleotide variant | NM_022552.5(DNMT3A):c.745C>T (p.Gln249Ter) | Autism spectrum disorder [RCV003127441] | likely pathogenic | 2 | 25248147 | 25248147 | Human | 2 | name |
| 243057993 | CV2412266 | single nucleotide variant | NM_022552.5(DNMT3A):c.553A>G (p.Met185Val) | not provided [RCV003146808] | uncertain significance | 2 | 25275027 | 25275027 | Human | | name |
| 329349764 | CV2477187 | single nucleotide variant | NM_022552.5(DNMT3A):c.334G>A (p.Gly112Ser) | not provided [RCV003221512] | uncertain significance | 2 | 25282555 | 25282555 | Human | | name |
| 329848645 | CV2523392 | single nucleotide variant | NM_022552.5(DNMT3A):c.767C>T (p.Pro256Leu) | not provided [RCV003225406] | uncertain significance | 2 | 25248125 | 25248125 | Human | | name |
| 329848747 | CV2523495 | single nucleotide variant | NM_022552.5(DNMT3A):c.976C>T (p.Arg326Cys) | not provided [RCV003225509] | uncertain significance | 2 | 25247629 | 25247629 | Human | | name |
| 11558295 | CV260854 | single nucleotide variant | NM_022552.5(DNMT3A):c.895A>C (p.Lys299Gln) | Tatton-Brown-Rahman overgrowth syndrome [RCV000256441] | likely pathogenic | 2 | 25247710 | 25247710 | Human | 1 | name |
| 11632899 | CV264098 | deletion | NM_022552.5(DNMT3A):c.1374del (p.Lys459fs) | not provided [RCV000295479] | pathogenic | 2 | 25246215 | 25246215 | Human | | name |
| 401723724 | CV2737874 | single nucleotide variant | NM_022552.5(DNMT3A):c.547C>T (p.Arg183Trp) | not provided [RCV003315046] | uncertain significance | 2 | 25275033 | 25275033 | Human | | name |
| 401796596 | CV2740762 | single nucleotide variant | NM_022552.5(DNMT3A):c.413C>A (p.Thr138Asn) | not provided [RCV003321432] | uncertain significance | 2 | 25282476 | 25282476 | Human | | name |
| 401871495 | CV2749551 | single nucleotide variant | NM_022552.5(DNMT3A):c.322G>A (p.Gly108Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746675]|not provided [RCV003332679] | uncertain significance | 2 | 25282567 | 25282567 | Human | 1 | name |
| 401934571 | CV2800416 | single nucleotide variant | NM_022552.5(DNMT3A):c.481A>G (p.Met161Val) | DNMT3A-related disorder [RCV003411973]|Tatton-Brown-Rahman overgrowth syndrome [RCV005104294] | uncertain significance | 2 | 25275511 | 25275511 | Human | 1 | name , trait , alternate_id |
| 401936158 | CV2802739 | single nucleotide variant | NM_022552.5(DNMT3A):c.353G>C (p.Gly118Ala) | DNMT3A-related disorder [RCV003414129]|Tatton-Brown-Rahman overgrowth syndrome [RCV003746678]|not provided [RCV004723297] | uncertain significance | 2 | 25282536 | 25282536 | Human | 1 | name , trait , alternate_id |
| 405867557 | CV2842288 | deletion | NM_022552.5(DNMT3A):c.2250del (p.Phe751fs) | EBV-positive nodal T- and NK-cell lymphoma [RCV004560237] | pathogenic | 2 | 25240374 | 25240374 | Human | | name |
| 405150342 | CV2869948 | single nucleotide variant | NM_022552.5(DNMT3A):c.364G>A (p.Ala122Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV003585596] | uncertain significance | 2 | 25282525 | 25282525 | Human | 1 | name |
| 405149880 | CV2871975 | duplication | NM_022552.5(DNMT3A):c.1792dup (p.Arg598fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV003585556] | pathogenic | 2 | 25244213 | 25244214 | Human | 1 | name |
| 405150180 | CV2876653 | single nucleotide variant | NM_022552.5(DNMT3A):c.706T>C (p.Ser236Pro) | Inborn genetic diseases [RCV005333614]|Tatton-Brown-Rahman overgrowth syndrome [RCV003585582] | uncertain significance | 2 | 25248186 | 25248186 | Human | 2 | name |
| 405141007 | CV2894618 | single nucleotide variant | NM_022552.5(DNMT3A):c.371C>T (p.Thr124Ile) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584115] | uncertain significance | 2 | 25282518 | 25282518 | Human | 1 | name |
| 405142331 | CV2914286 | single nucleotide variant | NM_022552.5(DNMT3A):c.457C>T (p.Gln153Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584278] | pathogenic | 2 | 25275535 | 25275535 | Human | 1 | name |
| 405143428 | CV2918944 | deletion | NM_022552.5(DNMT3A):c.1151del (p.Phe384fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584227] | pathogenic | 2 | 25246748 | 25246748 | Human | 1 | name |
| 405248228 | CV2946775 | single nucleotide variant | NM_022552.5(DNMT3A):c.373C>G (p.Leu125Val) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746712] | uncertain significance | 2 | 25282516 | 25282516 | Human | 1 | name |
| 405248607 | CV2958806 | single nucleotide variant | NM_022552.5(DNMT3A):c.662T>C (p.Ile221Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746852] | uncertain significance | 2 | 25248230 | 25248230 | Human | 1 | name |
| 405249505 | CV2979100 | duplication | NM_022552.5(DNMT3A):c.1532dup (p.Gly512fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747155] | pathogenic | 2 | 25245274 | 25245275 | Human | 1 | name |
| 405249702 | CV2994977 | single nucleotide variant | NM_022552.5(DNMT3A):c.733C>A (p.Pro245Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747239] | uncertain significance | 2 | 25248159 | 25248159 | Human | 1 | name |
| 405249983 | CV3007977 | single nucleotide variant | NM_022552.5(DNMT3A):c.482T>A (p.Met161Lys) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747357] | uncertain significance | 2 | 25275510 | 25275510 | Human | 1 | name |
| 405246489 | CV3009502 | single nucleotide variant | NM_022552.5(DNMT3A):c.625C>T (p.Arg209Cys) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746013] | uncertain significance | 2 | 25274955 | 25274955 | Human | 1 | name |
| 405246553 | CV3016387 | single nucleotide variant | NM_022552.5(DNMT3A):c.721G>A (p.Glu241Lys) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746034] | uncertain significance | 2 | 25248171 | 25248171 | Human | 1 | name |
| 405246619 | CV3016961 | deletion | NM_022552.5(DNMT3A):c.2609del (p.Phe870fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746055] | pathogenic | 2 | 25234409 | 25234409 | Human | 1 | name |
| 405247262 | CV3035579 | single nucleotide variant | NM_022552.5(DNMT3A):c.838G>A (p.Asp280Asn) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746303] | uncertain significance | 2 | 25248054 | 25248054 | Human | 1 | name |
| 405247608 | CV3044697 | single nucleotide variant | NM_022552.5(DNMT3A):c.475G>A (p.Glu159Lys) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746437] | uncertain significance | 2 | 25275517 | 25275517 | Human | 1 | name |
| 405250388 | CV3068987 | single nucleotide variant | NM_022552.5(DNMT3A):c.367G>C (p.Glu123Gln) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747506] | uncertain significance | 2 | 25282522 | 25282522 | Human | 1 | name |
| 405079173 | CV3137081 | single nucleotide variant | NM_022552.5(DNMT3A):c.806C>G (p.Ala269Gly) | Tatton-Brown-Rahman overgrowth syndrome [RCV003833980] | uncertain significance | 2 | 25248086 | 25248086 | Human | 1 | name |
| 405253247 | CV3178240 | single nucleotide variant | NM_022552.5(DNMT3A):c.445G>A (p.Ala149Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV003871021] | uncertain significance | 2 | 25282444 | 25282444 | Human | 1 | name |
| 405268697 | CV3187105 | deletion | NM_022552.5(DNMT3A):c.1044del (p.Ser349fs) | not provided [RCV003887188] | pathogenic | 2 | 25247129 | 25247129 | Human | | name |
| 408368124 | CV3224477 | deletion | NM_022552.5(DNMT3A):c.1925del (p.Gly642fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV004723556] | likely pathogenic | 2 | 25243909 | 25243909 | Human | 1 | name |
| 405744754 | CV3226144 | single nucleotide variant | NM_022552.5(DNMT3A):c.916T>C (p.Trp306Arg) | Heyn-Sproul-Jackson syndrome [RCV003991135] | likely pathogenic | 2 | 25247689 | 25247689 | Human | 1 | name |
| 405853638 | CV3395072 | deletion | NM_022552.5(DNMT3A):c.2153del (p.Pro718fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV004555214] | likely pathogenic | 2 | 25240660 | 25240660 | Human | 1 | name |
| 407429461 | CV3413755 | deletion | NM_022552.5(DNMT3A):c.1367del (p.Lys456fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV004595164] | pathogenic | 2 | 25246222 | 25246222 | Human | 1 | name |
| 408377789 | CV3503127 | single nucleotide variant | NM_022552.5(DNMT3A):c.892G>C (p.Gly298Arg) | not provided [RCV004727698] | pathogenic | 2 | 25247713 | 25247713 | Human | | name |
| 408376142 | CV3505573 | single nucleotide variant | NM_022552.5(DNMT3A):c.981G>A (p.Trp327Ter) | DNMT3A-related disorder [RCV004726573] | likely pathogenic | 2 | 25247624 | 25247624 | Human | | name , trait , alternate_id |
| 408375637 | CV3506470 | single nucleotide variant | NM_022552.5(DNMT3A):c.483G>A (p.Met161Ile) | DNMT3A-related disorder [RCV004726315] | uncertain significance | 2 | 25275509 | 25275509 | Human | | name , trait , alternate_id |
| 408375069 | CV3509310 | single nucleotide variant | NM_022552.5(DNMT3A):c.602G>T (p.Arg201Leu) | DNMT3A-related disorder [RCV004747711] | uncertain significance | 2 | 25274978 | 25274978 | Human | | name , trait , alternate_id |
| 408374223 | CV3515241 | single nucleotide variant | NM_022552.5(DNMT3A):c.697C>G (p.Pro233Ala) | DNMT3A-related disorder [RCV004746098]|Inborn genetic diseases [RCV004981196] | uncertain significance | 2 | 25248195 | 25248195 | Human | 1 | name , trait , alternate_id |
| 408374473 | CV3516440 | single nucleotide variant | NM_022552.5(DNMT3A):c.398A>G (p.Glu133Gly) | DNMT3A-related disorder [RCV004746778] | uncertain significance | 2 | 25282491 | 25282491 | Human | | name , trait , alternate_id |
| 408393953 | CV3521646 | single nucleotide variant | NM_022552.5(DNMT3A):c.323G>C (p.Gly108Ala) | Tatton-Brown-Rahman overgrowth syndrome [RCV004764444] | uncertain significance | 2 | 25282566 | 25282566 | Human | 1 | name |
| 408392154 | CV3525124 | single nucleotide variant | NM_022552.5(DNMT3A):c.953G>A (p.Arg318Gln) | not provided [RCV004771010] | uncertain significance | 2 | 25247652 | 25247652 | Human | | name |
| 408393350 | CV3525494 | single nucleotide variant | NM_022552.5(DNMT3A):c.925C>T (p.Arg309Cys) | not provided [RCV004771380] | uncertain significance | 2 | 25247680 | 25247680 | Human | | name |
| 408391996 | CV3526424 | single nucleotide variant | NM_022552.5(DNMT3A):c.844C>A (p.Pro282Thr) | not provided [RCV004775673] | uncertain significance | 2 | 25248048 | 25248048 | Human | | name |
| 408393610 | CV3529528 | deletion | NM_022552.5(DNMT3A):c.2387del (p.Gly796fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV004776369] | pathogenic | 2 | 25239151 | 25239151 | Human | 1 | name |
| 597649436 | CV3659344 | single nucleotide variant | NM_022552.5(DNMT3A):c.730C>T (p.Pro244Ser) | Inborn genetic diseases [RCV004974375] | uncertain significance | 2 | 25248162 | 25248162 | Human | 1 | name |
| 597649558 | CV3659364 | single nucleotide variant | NM_022552.5(DNMT3A):c.817A>G (p.Asn273Asp) | Inborn genetic diseases [RCV004974394] | uncertain significance | 2 | 25248075 | 25248075 | Human | 1 | name |
| 597834417 | CV3735273 | single nucleotide variant | NM_022552.5(DNMT3A):c.364G>C (p.Ala122Pro) | Tatton-Brown-Rahman overgrowth syndrome [RCV005055005] | uncertain significance | 2 | 25282525 | 25282525 | Human | 1 | name |
| 597844050 | CV3736074 | single nucleotide variant | NM_022552.5(DNMT3A):c.742C>T (p.Gln248Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV005065422] | pathogenic | 2 | 25248150 | 25248150 | Human | 1 | name |
| 597916427 | CV3737409 | single nucleotide variant | NM_022552.5(DNMT3A):c.416C>G (p.Pro139Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV005074198] | uncertain significance | 2 | 25282473 | 25282473 | Human | 1 | name |
| 597849421 | CV3746698 | single nucleotide variant | NM_022552.5(DNMT3A):c.863G>A (p.Arg288Gln) | Tatton-Brown-Rahman overgrowth syndrome [RCV005066095] | uncertain significance | 2 | 25247742 | 25247742 | Human | 1 | name |
| 597946013 | CV3790026 | single nucleotide variant | NM_022552.5(DNMT3A):c.722A>C (p.Glu241Ala) | Tatton-Brown-Rahman overgrowth syndrome [RCV005134727] | uncertain significance | 2 | 25248170 | 25248170 | Human | 1 | name |
| 597883434 | CV3799493 | single nucleotide variant | NM_022552.5(DNMT3A):c.389G>T (p.Arg130Ile) | Tatton-Brown-Rahman overgrowth syndrome [RCV005150160] | uncertain significance | 2 | 25282500 | 25282500 | Human | 1 | name |
| 597956726 | CV3800274 | deletion | NM_022552.5(DNMT3A):c.1023del (p.Glu342fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV005137366] | pathogenic | 2 | 25247150 | 25247150 | Human | 1 | name |
| 597917361 | CV3811155 | deletion | NM_022552.5(DNMT3A):c.2671del (p.Arg891fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV005155190] | pathogenic | 2 | 25234347 | 25234347 | Human | 1 | name |
| 597877034 | CV3813335 | deletion | NM_022552.5(DNMT3A):c.1711del (p.Ala571fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV005149271] | pathogenic | 2 | 25244295 | 25244295 | Human | 1 | name |
| 597887414 | CV3839063 | single nucleotide variant | NM_022552.5(DNMT3A):c.690C>G (p.Asn230Lys) | Tatton-Brown-Rahman overgrowth syndrome [RCV005179148] | uncertain significance | 2 | 25248202 | 25248202 | Human | 1 | name |
| 597874115 | CV3846329 | single nucleotide variant | NM_022552.5(DNMT3A):c.631A>G (p.Lys211Glu) | Tatton-Brown-Rahman overgrowth syndrome [RCV005177212] | uncertain significance | 2 | 25274949 | 25274949 | Human | 1 | name |
| 597966745 | CV3855616 | single nucleotide variant | NM_022552.5(DNMT3A):c.731C>A (p.Pro244His) | Inborn genetic diseases [RCV005326059]|Tatton-Brown-Rahman overgrowth syndrome [RCV005194596] | uncertain significance | 2 | 25248161 | 25248161 | Human | 2 | name |
| 598125497 | CV3885787 | single nucleotide variant | NM_022552.5(DNMT3A):c.388A>G (p.Arg130Gly) | Tatton-Brown-Rahman overgrowth syndrome [RCV005241305] | uncertain significance | 2 | 25282501 | 25282501 | Human | 1 | name |
| 598127735 | CV3888305 | deletion | NM_022552.5(DNMT3A):c.1028del (p.Lys343fs) | not provided [RCV005242991] | pathogenic | 2 | 25247145 | 25247145 | Human | | name |
| 598123407 | CV3890327 | single nucleotide variant | NM_022552.5(DNMT3A):c.907T>C (p.Phe303Leu) | not provided [RCV005250846] | uncertain significance | 2 | 25247698 | 25247698 | Human | | name |
| 598164866 | CV3964245 | single nucleotide variant | NM_022552.5(DNMT3A):c.956G>A (p.Ser319Asn) | Inborn genetic diseases [RCV005329590] | uncertain significance | 2 | 25247649 | 25247649 | Human | 1 | name |
| 598164869 | CV3964246 | single nucleotide variant | NM_022552.5(DNMT3A):c.767C>G (p.Pro256Arg) | Inborn genetic diseases [RCV005329591] | uncertain significance | 2 | 25248125 | 25248125 | Human | 1 | name |
| 598165001 | CV3964275 | single nucleotide variant | NM_022552.5(DNMT3A):c.926G>C (p.Arg309Pro) | Inborn genetic diseases [RCV005329620] | uncertain significance | 2 | 25247679 | 25247679 | Human | 1 | name |
| 598165103 | CV3964296 | single nucleotide variant | NM_022552.5(DNMT3A):c.730C>A (p.Pro244Thr) | Inborn genetic diseases [RCV005329641] | uncertain significance | 2 | 25248162 | 25248162 | Human | 1 | name |
| 598165158 | CV3964308 | single nucleotide variant | NM_022552.5(DNMT3A):c.844C>G (p.Pro282Ala) | Inborn genetic diseases [RCV005329653] | uncertain significance | 2 | 25248048 | 25248048 | Human | 1 | name |
| 598165230 | CV3964324 | single nucleotide variant | NM_022552.5(DNMT3A):c.733C>T (p.Pro245Ser) | Inborn genetic diseases [RCV005329669] | uncertain significance | 2 | 25248159 | 25248159 | Human | 1 | name |
| 616935937 | CV4015916 | single nucleotide variant | NM_022552.5(DNMT3A):c.506G>T (p.Arg169Leu) | not provided [RCV005414780] | uncertain significance | 2 | 25275074 | 25275074 | Human | | name |
| 13212072 | CV425484 | single nucleotide variant | NM_022552.5(DNMT3A):c.901C>T (p.Arg301Trp) | Inborn genetic diseases [RCV000624203]|not provided [RCV000498296] | pathogenic|likely pathogenic|uncertain significance | 2 | 25247704 | 25247704 | Human | 1 | name |
| 13521158 | CV495148 | duplication | NM_022552.5(DNMT3A):c.1867dup (p.Tyr623fs) | not provided [RCV000599228] | likely pathogenic | 2 | 25243966 | 25243967 | Human | | name |
| 13624452 | CV517998 | deletion | NM_022552.5(DNMT3A):c.1510del (p.Leu504fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV000652288] | pathogenic | 2 | 25245297 | 25245297 | Human | 1 | name |
| 13790698 | CV550164 | duplication | NM_022552.5(DNMT3A):c.1628dup (p.Arg544fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV000677140] | pathogenic | 2 | 25244578 | 25244579 | Human | 1 | name |
| 13821585 | CV560553 | deletion | NM_022552.5(DNMT3A):c.1243del (p.Gln415fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV000696106] | pathogenic | 2 | 25246656 | 25246656 | Human | 1 | name |
| 13835937 | CV587200 | single nucleotide variant | NM_022552.5(DNMT3A):c.328C>G (p.Gln110Glu) | not provided [RCV000731871] | uncertain significance | 2 | 25282561 | 25282561 | Human | | name |
| 14395681 | CV611384 | single nucleotide variant | NM_022552.5(DNMT3A):c.920C>T (p.Pro307Leu) | Acute myeloid leukemia [RCV000760251] | likely pathogenic | 2 | 25247685 | 25247685 | Human | 2 | name |
| 14395893 | CV611568 | single nucleotide variant | NM_022552.5(DNMT3A):c.617G>A (p.Trp206Ter) | not provided [RCV000760611] | pathogenic | 2 | 25274963 | 25274963 | Human | | name |
| 14691273 | CV619907 | deletion | NM_022552.5(DNMT3A):c.1867del (p.Tyr623fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV000778096] | pathogenic | 2 | 25243967 | 25243967 | Human | 1 | name |
| 21072350 | CV789713 | single nucleotide variant | NM_022552.5(DNMT3A):c.988T>C (p.Trp330Arg) | Heyn-Sproul-Jackson syndrome [RCV000986095] | pathogenic | 2 | 25247617 | 25247617 | Human | 1 | name |
| 21072356 | CV789714 | single nucleotide variant | NM_022552.5(DNMT3A):c.997G>A (p.Asp333Asn) | Heyn-Sproul-Jackson syndrome [RCV000986096]|not provided [RCV003314654] | pathogenic|likely pathogenic | 2 | 25247608 | 25247608 | Human | 1 | name |
| 25319143 | CV805300 | deletion | NM_022552.5(DNMT3A):c.2657del (p.Gln886fs) | not provided [RCV001008921] | likely pathogenic | 2 | 25234361 | 25234361 | Human | | name |
| 25319684 | CV805301 | duplication | NM_022552.5(DNMT3A):c.2469dup (p.Ile824fs) | not provided [RCV001009039] | pathogenic | 2 | 25236944 | 25236945 | Human | | name |
| 26885907 | CV826114 | single nucleotide variant | NM_022552.5(DNMT3A):c.736G>A (p.Ala246Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV001043837] | uncertain significance | 2 | 25248156 | 25248156 | Human | 1 | name |
| 26917284 | CV826115 | single nucleotide variant | NM_022552.5(DNMT3A):c.700G>A (p.Gly234Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV001042541] | uncertain significance | 2 | 25248192 | 25248192 | Human | 1 | name |
| 38492018 | CV922677 | single nucleotide variant | NM_022552.5(DNMT3A):c.446C>T (p.Ala149Val) | Tatton-Brown-Rahman overgrowth syndrome [RCV001223254] | likely benign|uncertain significance | 2 | 25282443 | 25282443 | Human | 1 | name |
| 38498182 | CV942746 | single nucleotide variant | NM_022552.5(DNMT3A):c.958C>T (p.Arg320Ter) | EBV-positive nodal T- and NK-cell lymphoma [RCV004557460]|Tatton-Brown-Rahman overgrowth syndrome [RCV001227614]|not provided [RCV003321812] | pathogenic | 2 | 25247647 | 25247647 | Human | 1 | name |
| 38464017 | CV961260 | single nucleotide variant | NM_022552.5(DNMT3A):c.998A>T (p.Asp333Val) | DNMT3A-related disorder [RCV004545820] | not provided | 2 | 25247607 | 25247607 | Human | | name , trait , alternate_id |
| 40814403 | CV969342 | single nucleotide variant | NM_022552.5(DNMT3A):c.994G>A (p.Gly332Arg) | Intellectual disability [RCV001260609]|Tatton-Brown-Rahman overgrowth syndrome [RCV001879994] | conflicting interpretations of pathogenicity|uncertain significance | 2 | 25247611 | 25247611 | Human | 3 | name |
| 40887723 | CV973294 | deletion | NM_022552.5(DNMT3A):c.2037del (p.Lys680fs) | Inborn genetic diseases [RCV001267322] | pathogenic | 2 | 25241607 | 25241607 | Human | 1 | name |
| 40886844 | CV973296 | duplication | NM_022552.5(DNMT3A):c.1238dup (p.Phe414fs) | DNMT3A-related disorder [RCV004746302]|Inborn genetic diseases [RCV001266123]|Tatton-Brown-Rahman overgrowth syndrome [RCV003222290] | pathogenic|likely pathogenic | 2 | 25246660 | 25246661 | Human | 2 | name , trait , alternate_id |
| 40887628 | CV973297 | single nucleotide variant | NM_022552.5(DNMT3A):c.886G>C (p.Val296Leu) | Inborn genetic diseases [RCV001267236] | uncertain significance | 2 | 25247719 | 25247719 | Human | 1 | name |
| 126733874 | CV1000334 | single nucleotide variant | NM_022552.5(DNMT3A):c.2012C>T (p.Thr671Met) | not provided [RCV001311187] | likely pathogenic|uncertain significance | 2 | 25241632 | 25241632 | Human | | name |
| 127231467 | CV1053875 | single nucleotide variant | NM_022552.5(DNMT3A):c.1004A>G (p.Lys335Arg) | Autism spectrum disorder [RCV001871979]|Neonatal hypotonia [RCV001376132]|not provided [RCV002285481] | pathogenic|likely pathogenic|not provided | 2 | 25247601 | 25247601 | Human | 4 | name |
| 127237759 | CV1059268 | single nucleotide variant | NM_022552.5(DNMT3A):c.1792C>T (p.Arg598Ter) | See cases [RCV002252677]|Tatton-Brown-Rahman overgrowth syndrome [RCV001382894]|not provided [RCV002284489] | pathogenic|likely pathogenic | 2 | 25244214 | 25244214 | Human | 1 | name |
| 127230261 | CV1087032 | single nucleotide variant | NM_022552.5(DNMT3A):c.1490G>T (p.Cys497Phe) | See cases [RCV001420199] | likely pathogenic | 2 | 25245317 | 25245317 | Human | | name |
| 127296209 | CV1162240 | single nucleotide variant | NM_022552.5(DNMT3A):c.1757G>T (p.Cys586Phe) | Tatton-Brown-Rahman overgrowth syndrome [RCV001527373] | pathogenic | 2 | 25244249 | 25244249 | Human | 1 | name |
| 150414297 | CV1176138 | single nucleotide variant | NM_022552.5(DNMT3A):c.1648G>A (p.Gly550Arg) | not provided [RCV001548066] | pathogenic|uncertain significance | 2 | 25244559 | 25244559 | Human | | name |
| 150424863 | CV1183156 | single nucleotide variant | NM_022552.5(DNMT3A):c.2207G>A (p.Arg736His) | Tatton-Brown-Rahman overgrowth syndrome [RCV003227525]|not provided [RCV001557227] | pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 2 | 25240417 | 25240417 | Human | 1 | name |
| 150421872 | CV1196879 | single nucleotide variant | NM_022552.5(DNMT3A):c.1003A>G (p.Lys335Glu) | not provided [RCV001578215] | uncertain significance | 2 | 25247602 | 25247602 | Human | | name |
| 150476992 | CV1203123 | single nucleotide variant | NM_022552.5(DNMT3A):c.1907T>A (p.Val636Glu) | not provided [RCV001589717] | likely pathogenic | 2 | 25243927 | 25243927 | Human | | name |
| 150452984 | CV1203706 | single nucleotide variant | NM_022552.5(DNMT3A):c.2062C>T (p.Arg688Cys) | DNMT3A-related disorder [RCV004728779]|Tatton-Brown-Rahman overgrowth syndrome [RCV001591662] | uncertain significance | 2 | 25241582 | 25241582 | Human | 1 | name , trait , alternate_id |
| 150533848 | CV1305938 | single nucleotide variant | NM_022552.5(DNMT3A):c.2622T>A (p.Tyr874Ter) | not provided [RCV001755340] | uncertain significance | 2 | 25234396 | 25234396 | Human | | name |
| 150533926 | CV1306080 | single nucleotide variant | NM_022552.5(DNMT3A):c.2398G>A (p.Gly800Ser) | not provided [RCV001755484] | uncertain significance | 2 | 25239140 | 25239140 | Human | | name |
| 150534474 | CV1306166 | single nucleotide variant | NM_022552.5(DNMT3A):c.1631G>A (p.Arg544His) | not provided [RCV001757355] | uncertain significance | 2 | 25244576 | 25244576 | Human | | name |
| 150542868 | CV1306635 | single nucleotide variant | NM_022552.5(DNMT3A):c.1976G>A (p.Arg659His) | DNMT3A-related disorder [RCV004746450]|Inborn genetic diseases [RCV005330907]|Tatton-Brown-Rahman overgrowth syndrome [RCV004728802]|not provided [RCV001769699] | pathogenic|uncertain significance | 2 | 25241668 | 25241668 | Human | 2 | name , trait , alternate_id |
| 150535693 | CV1306992 | single nucleotide variant | NM_022552.5(DNMT3A):c.2027G>A (p.Arg676Gln) | Tatton-Brown-Rahman overgrowth syndrome [RCV005095071]|not provided [RCV001759046] | uncertain significance | 2 | 25241617 | 25241617 | Human | 1 | name |
| 150533968 | CV1307441 | single nucleotide variant | NM_022552.5(DNMT3A):c.2017G>A (p.Gly673Ser) | not provided [RCV001755578] | uncertain significance | 2 | 25241627 | 25241627 | Human | | name |
| 150531560 | CV1310987 | single nucleotide variant | NM_022552.5(DNMT3A):c.1061T>C (p.Phe354Ser) | not provided [RCV001776721] | uncertain significance | 2 | 25247112 | 25247112 | Human | | name |
| 150531720 | CV1311261 | single nucleotide variant | NM_022552.5(DNMT3A):c.2104G>A (p.Asp702Asn) | not provided [RCV001776996] | uncertain significance | 2 | 25240709 | 25240709 | Human | | name |
| 150536055 | CV1312245 | single nucleotide variant | NM_022552.5(DNMT3A):c.2693T>C (p.Ile898Thr) | Neurodevelopmental disorder [RCV001780007] | likely pathogenic | 2 | 25234325 | 25234325 | Human | 1 | name |
| 151351795 | CV1323637 | single nucleotide variant | NM_022552.5(DNMT3A):c.1647C>A (p.Cys549Ter) | Obesity [RCV001807541]|Tatton-Brown-Rahman overgrowth syndrome [RCV003772257] | pathogenic | 2 | 25244560 | 25244560 | Human | 8 | name |
| 151354949 | CV1328016 | single nucleotide variant | NM_022552.5(DNMT3A):c.1385C>T (p.Ala462Val) | DNMT3A-related disorder [RCV003968578]|Tatton-Brown-Rahman overgrowth syndrome [RCV002542576]|not specified [RCV001819492] | likely benign|uncertain significance | 2 | 25246204 | 25246204 | Human | 1 | name , trait , alternate_id |
| 151661993 | CV1330163 | single nucleotide variant | NM_022552.5(DNMT3A):c.2059G>A (p.Val687Ile) | DNMT3A-related disorder [RCV004728837]|Heyn-Sproul-Jackson syndrome [RCV001823574]|Tatton-Brown-Rahman overgrowth syndrome [RCV002542734] | uncertain significance | 2 | 25241585 | 25241585 | Human | 2 | name , trait , alternate_id |
| 8688716 | CV137725 | single nucleotide variant | NM_022552.5(DNMT3A):c.1502A>G (p.Asn501Ser) | DNMT3A-related disorder [RCV003925179]|Tatton-Brown-Rahman overgrowth syndrome [RCV000558524]|not provided [RCV001566672]|not specified [RCV000120655] | likely benign|uncertain significance|not provided | 2 | 25245305 | 25245305 | Human | 1 | name , trait , alternate_id |
| 151790235 | CV1393051 | single nucleotide variant | NM_022552.5(DNMT3A):c.1274C>T (p.Pro425Leu) | Tatton-Brown-Rahman overgrowth syndrome [RCV001931346] | uncertain significance | 2 | 25246625 | 25246625 | Human | 1 | name |
| 8696161 | CV143239 | single nucleotide variant | NM_022552.5(DNMT3A):c.1943T>C (p.Leu648Pro) | Tatton-Brown-Rahman overgrowth syndrome [RCV000128559] | pathogenic | 2 | 25241701 | 25241701 | Human | 1 | name |
| 8696163 | CV143241 | single nucleotide variant | NM_022552.5(DNMT3A):c.1643T>A (p.Met548Lys) | Tatton-Brown-Rahman overgrowth syndrome [RCV000128561] | pathogenic | 2 | 25244564 | 25244564 | Human | 1 | name |
| 8696164 | CV143242 | single nucleotide variant | NM_022552.5(DNMT3A):c.2705T>C (p.Phe902Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV000128562] | pathogenic | 2 | 25234313 | 25234313 | Human | 1 | name |
| 151816509 | CV1475983 | single nucleotide variant | NM_022552.5(DNMT3A):c.1057G>A (p.Ala353Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV001992342] | uncertain significance | 2 | 25247116 | 25247116 | Human | 1 | name |
| 151830154 | CV1491779 | single nucleotide variant | NM_022552.5(DNMT3A):c.2678G>A (p.Trp893Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV002030720] | pathogenic|likely pathogenic | 2 | 25234340 | 25234340 | Human | 1 | name |
| 151840389 | CV1508192 | single nucleotide variant | NM_022552.5(DNMT3A):c.1895A>G (p.Lys632Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV001956676] | uncertain significance | 2 | 25243939 | 25243939 | Human | 1 | name |
| 152155120 | CV1668045 | single nucleotide variant | NM_022552.5(DNMT3A):c.2504C>T (p.Thr835Met) | not provided [RCV002221939] | uncertain significance | 2 | 25235800 | 25235800 | Human | | name |
| 152059158 | CV1670895 | single nucleotide variant | NM_022552.5(DNMT3A):c.1978T>C (p.Tyr660His) | Acute myeloid leukemia [RCV005025733]|Autism spectrum disorder [RCV002226414]|not provided [RCV003238890] | likely pathogenic|not provided | 2 | 25241666 | 25241666 | Human | 4 | name |
| 152982384 | CV1677323 | single nucleotide variant | NM_022552.5(DNMT3A):c.1676G>A (p.Cys559Tyr) | Acute myeloid leukemia [RCV002249029] | likely pathogenic | 2 | 25244330 | 25244330 | Human | 2 | name |
| 153304935 | CV1687382 | single nucleotide variant | NM_022552.5(DNMT3A):c.1906G>A (p.Val636Met) | not provided [RCV002263200] | likely pathogenic | 2 | 25243928 | 25243928 | Human | | name |
| 153346519 | CV1691799 | single nucleotide variant | NM_022552.5(DNMT3A):c.1243C>T (p.Gln415Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV002273282] | pathogenic | 2 | 25246656 | 25246656 | Human | 1 | name |
| 153346578 | CV1691860 | single nucleotide variant | NM_022552.5(DNMT3A):c.2411C>A (p.Pro804Gln) | Tatton-Brown-Rahman overgrowth syndrome [RCV002273343] | uncertain significance | 2 | 25237003 | 25237003 | Human | 1 | name |
| 153347697 | CV1692213 | single nucleotide variant | NM_022552.5(DNMT3A):c.2337G>A (p.Met779Ile) | not provided [RCV002273698] | uncertain significance | 2 | 25239201 | 25239201 | Human | | name |
| 153349192 | CV1694043 | single nucleotide variant | NM_022552.5(DNMT3A):c.1787G>A (p.Arg596Gln) | DNMT3A-related disorder [RCV004747071]|Inborn genetic diseases [RCV003096221]|Tatton-Brown-Rahman overgrowth syndrome [RCV003585241]|not provided [RCV002275584] | uncertain significance | 2 | 25244219 | 25244219 | Human | 2 | name , trait , alternate_id |
| 155266645 | CV1699213 | single nucleotide variant | NM_022552.5(DNMT3A):c.2327A>C (p.Asn776Thr) | not provided [RCV002283008] | uncertain significance | 2 | 25239211 | 25239211 | Human | | name |
| 155265220 | CV1704679 | single nucleotide variant | NM_022552.5(DNMT3A):c.2729C>T (p.Ala910Val) | Tatton-Brown-Rahman overgrowth syndrome [RCV005096044]|not provided [RCV002284895] | uncertain significance | 2 | 25234289 | 25234289 | Human | 1 | name |
| 155643157 | CV1706573 | single nucleotide variant | NM_022552.5(DNMT3A):c.1585G>A (p.Asp529Asn) | See cases [RCV002287647] | likely pathogenic | 2 | 25244622 | 25244622 | Human | | name |
| 155643286 | CV1707767 | single nucleotide variant | NM_022552.5(DNMT3A):c.2311C>G (p.Arg771Gly) | Tatton-Brown-Rahman overgrowth syndrome [RCV002289228] | likely pathogenic | 2 | 25240313 | 25240313 | Human | 1 | name |
| 155643851 | CV1708161 | single nucleotide variant | NM_022552.5(DNMT3A):c.1550G>A (p.Cys517Tyr) | Tatton-Brown-Rahman overgrowth syndrome [RCV002290149] | uncertain significance | 2 | 25245257 | 25245257 | Human | 1 | name |
| 155645127 | CV1710607 | single nucleotide variant | NM_022552.5(DNMT3A):c.2185C>T (p.Arg729Trp) | Tatton-Brown-Rahman overgrowth syndrome [RCV005096090]|not provided [RCV002293903] | uncertain significance | 2 | 25240439 | 25240439 | Human | 1 | name |
| 155714078 | CV1760319 | single nucleotide variant | NM_022552.5(DNMT3A):c.2403G>A (p.Met801Ile) | not provided [RCV002300825] | uncertain significance | 2 | 25239135 | 25239135 | Human | | name |
| 155749778 | CV1772329 | single nucleotide variant | NM_022552.5(DNMT3A):c.1675T>C (p.Cys559Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV002305008] | uncertain significance | 2 | 25244331 | 25244331 | Human | 1 | name |
| 155748805 | CV1772394 | single nucleotide variant | NM_022552.5(DNMT3A):c.2009T>C (p.Ile670Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV002303937] | uncertain significance | 2 | 25241635 | 25241635 | Human | 1 | name |
| 155717588 | CV1780619 | single nucleotide variant | NM_022552.5(DNMT3A):c.2076G>C (p.Gln692His) | not provided [RCV002306224] | uncertain significance | 2 | 25241568 | 25241568 | Human | | name |
| 155794985 | CV1858657 | single nucleotide variant | NM_022552.5(DNMT3A):c.2186G>A (p.Arg729Gln) | Tatton-Brown-Rahman overgrowth syndrome [RCV002463468] | likely pathogenic | 2 | 25240438 | 25240438 | Human | 1 | name |
| 155796943 | CV1859184 | single nucleotide variant | NM_022552.5(DNMT3A):c.1714G>C (p.Ala572Pro) | not provided [RCV002464812] | uncertain significance | 2 | 25244292 | 25244292 | Human | | name |
| 156407964 | CV1873137 | single nucleotide variant | NM_022552.5(DNMT3A):c.2053G>A (p.Gly685Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV003071085] | uncertain significance | 2 | 25241591 | 25241591 | Human | 1 | name |
| 156326565 | CV1887273 | single nucleotide variant | NM_022552.5(DNMT3A):c.1790G>A (p.Arg597Gln) | Tatton-Brown-Rahman overgrowth syndrome [RCV003089526] | uncertain significance | 2 | 25244216 | 25244216 | Human | 1 | name |
| 156070320 | CV1893363 | single nucleotide variant | NM_022552.5(DNMT3A):c.1310C>T (p.Thr437Met) | DNMT3A-related disorder [RCV004747200]|Tatton-Brown-Rahman overgrowth syndrome [RCV003079518] | uncertain significance | 2 | 25246279 | 25246279 | Human | 1 | name , trait , alternate_id |
| 155952531 | CV1896322 | single nucleotide variant | NM_022552.5(DNMT3A):c.2287G>A (p.Val763Ile) | Tatton-Brown-Rahman overgrowth syndrome [RCV003095411] | uncertain significance | 2 | 25240337 | 25240337 | Human | 1 | name |
| 156059725 | CV1924283 | single nucleotide variant | NM_022552.5(DNMT3A):c.1446G>T (p.Glu482Asp) | Tatton-Brown-Rahman overgrowth syndrome [RCV002659651] | uncertain significance | 2 | 25246048 | 25246048 | Human | 1 | name |
| 156358204 | CV1925253 | single nucleotide variant | NM_022552.5(DNMT3A):c.2245C>T (p.Arg749Cys) | Melanoma [RCV003222461]|Tatton-Brown-Rahman overgrowth syndrome [RCV002651442] | pathogenic | 2 | 25240379 | 25240379 | Human | 3 | name |
| 156063946 | CV1925801 | single nucleotide variant | NM_022552.5(DNMT3A):c.1528G>A (p.Val510Ile) | Tatton-Brown-Rahman overgrowth syndrome [RCV002621039] | likely benign|uncertain significance | 2 | 25245279 | 25245279 | Human | 1 | name |
| 156419114 | CV1925964 | single nucleotide variant | NM_022552.5(DNMT3A):c.1148T>C (p.Leu383Pro) | Tatton-Brown-Rahman overgrowth syndrome [RCV002612332] | uncertain significance | 2 | 25246751 | 25246751 | Human | 1 | name |
| 156447425 | CV1945378 | single nucleotide variant | NM_022552.5(DNMT3A):c.2245C>A (p.Arg749Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV003118953] | uncertain significance | 2 | 25240379 | 25240379 | Human | 1 | name |
| 156227092 | CV2009546 | single nucleotide variant | NM_022552.5(DNMT3A):c.1910T>C (p.Leu637Pro) | Tatton-Brown-Rahman overgrowth syndrome [RCV002701222] | uncertain significance | 2 | 25243924 | 25243924 | Human | 1 | name |
| 156008161 | CV2034721 | single nucleotide variant | NM_022552.5(DNMT3A):c.1421G>A (p.Arg474His) | Tatton-Brown-Rahman overgrowth syndrome [RCV002779990] | uncertain significance | 2 | 25246168 | 25246168 | Human | 1 | name |
| 10398689 | CV204573 | single nucleotide variant | NM_022552.5(DNMT3A):c.1204C>T (p.Gln402Ter) | Early T cell progenitor acute lymphoblastic leukemia [RCV000190418] | pathogenic | 2 | 25246695 | 25246695 | Human | 1 | name |
| 156056318 | CV2050533 | single nucleotide variant | NM_022552.5(DNMT3A):c.1270C>T (p.Pro424Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV002796938] | uncertain significance | 2 | 25246629 | 25246629 | Human | 1 | name |
| 156323514 | CV2053912 | single nucleotide variant | NM_022552.5(DNMT3A):c.1817A>G (p.Gln606Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV002810238] | uncertain significance | 2 | 25244189 | 25244189 | Human | 1 | name |
| 156228433 | CV2115573 | single nucleotide variant | NM_022552.5(DNMT3A):c.1055G>A (p.Ser352Asn) | DNMT3A-related disorder [RCV004747152]|Tatton-Brown-Rahman overgrowth syndrome [RCV002918840] | uncertain significance | 2 | 25247118 | 25247118 | Human | 1 | name , trait , alternate_id |
| 156158875 | CV2118505 | single nucleotide variant | NM_022552.5(DNMT3A):c.1127C>A (p.Ala376Asp) | Tatton-Brown-Rahman overgrowth syndrome [RCV002929167] | uncertain significance | 2 | 25246772 | 25246772 | Human | 1 | name |
| 155958799 | CV2138162 | single nucleotide variant | NM_022552.5(DNMT3A):c.1114G>A (p.Val372Ile) | DNMT3A-related disorder [RCV004747167]|Inborn genetic diseases [RCV002979243]|Tatton-Brown-Rahman overgrowth syndrome [RCV002972277] | uncertain significance | 2 | 25247059 | 25247059 | Human | 2 | name , trait , alternate_id |
| 156001470 | CV2169985 | single nucleotide variant | NM_022552.5(DNMT3A):c.1102G>A (p.Ala368Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV003017293] | uncertain significance | 2 | 25247071 | 25247071 | Human | 1 | name |
| 156136762 | CV2239726 | single nucleotide variant | NM_022552.5(DNMT3A):c.1405G>T (p.Glu469Ter) | Inborn genetic diseases [RCV002763277] | pathogenic | 2 | 25246184 | 25246184 | Human | 1 | name |
| 156054339 | CV2388601 | single nucleotide variant | NM_022552.5(DNMT3A):c.1833T>A (p.Asn611Lys) | Inborn genetic diseases [RCV002759529] | uncertain significance | 2 | 25244173 | 25244173 | Human | 1 | name |
| 156435274 | CV2403506 | single nucleotide variant | NM_022552.5(DNMT3A):c.1280A>T (p.Glu427Val) | Autism spectrum disorder [RCV003127442] | likely benign | 2 | 25246309 | 25246309 | Human | 2 | name |
| 243062585 | CV2404989 | single nucleotide variant | NM_022552.5(DNMT3A):c.1627G>A (p.Gly543Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV003140539] | likely pathogenic | 2 | 25244580 | 25244580 | Human | 1 | name |
| 243057996 | CV2412267 | single nucleotide variant | NM_022552.5(DNMT3A):c.1138G>A (p.Ala380Thr) | DNMT3A-related disorder [RCV003966278]|Tatton-Brown-Rahman overgrowth syndrome [RCV003746659]|not provided [RCV003146809] | uncertain significance | 2 | 25246761 | 25246761 | Human | 1 | name , trait , alternate_id |
| 243052228 | CV2416114 | single nucleotide variant | NM_022552.5(DNMT3A):c.1165G>A (p.Asp389Asn) | not provided [RCV003149174] | uncertain significance | 2 | 25246734 | 25246734 | Human | | name |
| 329399847 | CV2467651 | single nucleotide variant | NM_022552.5(DNMT3A):c.1426A>G (p.Arg476Gly) | Inborn genetic diseases [RCV003221114] | uncertain significance | 2 | 25246163 | 25246163 | Human | 1 | name |
| 329352371 | CV2476782 | single nucleotide variant | NM_022552.5(DNMT3A):c.2629G>A (p.Val877Ile) | not provided [RCV003223014] | likely pathogenic|uncertain significance | 2 | 25234389 | 25234389 | Human | | name |
| 329847923 | CV2524637 | single nucleotide variant | NM_022552.5(DNMT3A):c.1481G>C (p.Cys494Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV003227566] | pathogenic | 2 | 25245326 | 25245326 | Human | 1 | name |
| 11588671 | CV264079 | single nucleotide variant | NM_022552.5(DNMT3A):c.1608C>G (p.Tyr536Ter) | not provided [RCV000304967] | pathogenic | 2 | 25244599 | 25244599 | Human | | name |
| 329951955 | CV2668289 | single nucleotide variant | NM_022552.5(DNMT3A):c.2666T>G (p.Leu889Arg) | Acute myeloid leukemia [RCV003229793] | uncertain significance | 2 | 25234352 | 25234352 | Human | 2 | name |
| 401723529 | CV2672139 | single nucleotide variant | NM_022552.5(DNMT3A):c.1300G>C (p.Glu434Gln) | not provided [RCV003239040] | uncertain significance | 2 | 25246289 | 25246289 | Human | | name |
| 11595136 | CV269141 | single nucleotide variant | NM_022552.5(DNMT3A):c.1903C>T (p.Arg635Trp) | Acute myeloid leukemia [RCV003883148]|Autism spectrum disorder [RCV003313065]|DNMT3A-related disorder [RCV004745319]|Inborn genetic diseases [RCV005328235]|Tatton-Brown-Rahman overgrowth syndrome [RCV000367312]|not provided [RCV000433567] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance|not provided | 2 | 25243931 | 25243931 | Human | 7 | name , trait , alternate_id |
| 401732739 | CV2736756 | single nucleotide variant | NM_022552.5(DNMT3A):c.1759G>T (p.Gly587Trp) | not provided [RCV003313518] | uncertain significance | 2 | 25244247 | 25244247 | Human | | name |
| 401796833 | CV2739808 | single nucleotide variant | NM_022552.5(DNMT3A):c.1787G>T (p.Arg596Leu) | not provided [RCV003319769] | uncertain significance | 2 | 25244219 | 25244219 | Human | | name |
| 401798230 | CV2740012 | single nucleotide variant | NM_022552.5(DNMT3A):c.1258A>T (p.Lys420Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV003320002] | pathogenic | 2 | 25246641 | 25246641 | Human | 1 | name |
| 401795703 | CV2740103 | single nucleotide variant | NM_022552.5(DNMT3A):c.1279G>T (p.Glu427Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV003320345] | pathogenic | 2 | 25246620 | 25246620 | Human | 1 | name |
| 401829525 | CV2743845 | single nucleotide variant | NM_022552.5(DNMT3A):c.1916T>C (p.Leu639Pro) | not provided [RCV003327022] | likely pathogenic | 2 | 25243918 | 25243918 | Human | | name |
| 401828298 | CV2744658 | single nucleotide variant | NM_022552.5(DNMT3A):c.2114T>C (p.Ile705Thr) | not provided [RCV003328057] | uncertain significance | 2 | 25240699 | 25240699 | Human | | name |
| 401830899 | CV2748523 | single nucleotide variant | NM_022552.5(DNMT3A):c.2177G>T (p.Gly726Val) | Tatton-Brown-Rahman overgrowth syndrome [RCV003330172] | pathogenic | 2 | 25240447 | 25240447 | Human | 1 | name |
| 401857060 | CV2752084 | single nucleotide variant | NM_022552.5(DNMT3A):c.1661G>C (p.Cys554Ser) | DNMT3A-related disorder [RCV004548607] | likely pathogenic | 2 | 25244546 | 25244546 | Human | | name , trait , alternate_id |
| 401891192 | CV2769132 | single nucleotide variant | NM_022552.5(DNMT3A):c.2580G>A (p.Trp860Ter) | Inborn genetic diseases [RCV003369319]|Intellectual disability [RCV004017987] | pathogenic|likely pathogenic | 2 | 25235724 | 25235724 | Human | 3 | name |
| 401915776 | CV2795347 | single nucleotide variant | NM_022552.5(DNMT3A):c.2390A>G (p.Asn797Ser) | Neurodevelopmental disorder [RCV003389182] | uncertain significance | 2 | 25239148 | 25239148 | Human | 1 | name |
| 401922919 | CV2796617 | single nucleotide variant | NM_022552.5(DNMT3A):c.2516C>T (p.Ser839Phe) | DNMT3A-related disorder [RCV003404236] | uncertain significance | 2 | 25235788 | 25235788 | Human | | name , trait , alternate_id |
| 401901648 | CV2797935 | single nucleotide variant | NM_022552.5(DNMT3A):c.1469T>C (p.Ile490Thr) | DNMT3A-related disorder [RCV003393079]|Inborn genetic diseases [RCV005333597]|Tatton-Brown-Rahman overgrowth syndrome [RCV005099970] | uncertain significance | 2 | 25246025 | 25246025 | Human | 2 | name , trait , alternate_id |
| 401923976 | CV2800981 | single nucleotide variant | NM_022552.5(DNMT3A):c.2626G>A (p.Asp876Asn) | DNMT3A-related disorder [RCV003404572] | uncertain significance | 2 | 25234392 | 25234392 | Human | | name , trait , alternate_id |
| 401933573 | CV2802079 | single nucleotide variant | NM_022552.5(DNMT3A):c.1803G>A (p.Trp601Ter) | DNMT3A-related disorder [RCV003410447] | pathogenic | 2 | 25244203 | 25244203 | Human | | name , trait , alternate_id |
| 401910884 | CV2815582 | single nucleotide variant | NM_022552.5(DNMT3A):c.1385C>A (p.Ala462Glu) | not provided [RCV003425530] | uncertain significance | 2 | 25246204 | 25246204 | Human | | name |
| 401929380 | CV2815583 | single nucleotide variant | NM_022552.5(DNMT3A):c.1273C>G (p.Pro425Ala) | not provided [RCV003407174] | uncertain significance | 2 | 25246626 | 25246626 | Human | | name |
| 401914330 | CV2830612 | single nucleotide variant | NM_022552.5(DNMT3A):c.2114T>G (p.Ile705Ser) | not provided [RCV003442350] | uncertain significance | 2 | 25240699 | 25240699 | Human | | name |
| 405867515 | CV2842290 | single nucleotide variant | NM_022552.5(DNMT3A):c.1319G>A (p.Trp440Ter) | EBV-positive nodal T- and NK-cell lymphoma [RCV004560239] | pathogenic | 2 | 25246270 | 25246270 | Human | | name |
| 405149308 | CV2856317 | single nucleotide variant | NM_022552.5(DNMT3A):c.1280A>G (p.Glu427Gly) | DNMT3A-related disorder [RCV003980975]|Inborn genetic diseases [RCV005333611]|Tatton-Brown-Rahman overgrowth syndrome [RCV003585505] | uncertain significance | 2 | 25246309 | 25246309 | Human | 2 | name , trait , alternate_id |
| 405149138 | CV2859423 | single nucleotide variant | NM_022552.5(DNMT3A):c.1006T>C (p.Phe336Leu) | Tatton-Brown-Rahman overgrowth syndrome [RCV003585491] | uncertain significance | 2 | 25247599 | 25247599 | Human | 1 | name |
| 405148450 | CV2860740 | single nucleotide variant | NM_022552.5(DNMT3A):c.1757G>A (p.Cys586Tyr) | Tatton-Brown-Rahman overgrowth syndrome [RCV003585432] | uncertain significance | 2 | 25244249 | 25244249 | Human | 1 | name |
| 405140775 | CV2883190 | single nucleotide variant | NM_022552.5(DNMT3A):c.2204A>C (p.Tyr735Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584092] | uncertain significance | 2 | 25240420 | 25240420 | Human | 1 | name |
| 405141595 | CV2903632 | single nucleotide variant | NM_022552.5(DNMT3A):c.2474C>T (p.Ala825Val) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584176] | uncertain significance | 2 | 25236940 | 25236940 | Human | 1 | name |
| 405142726 | CV2911137 | single nucleotide variant | NM_022552.5(DNMT3A):c.2416G>A (p.Ala806Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584320] | uncertain significance | 2 | 25236998 | 25236998 | Human | 1 | name |
| 405141939 | CV2918761 | single nucleotide variant | NM_022552.5(DNMT3A):c.1289A>G (p.Asn430Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584212] | uncertain significance | 2 | 25246300 | 25246300 | Human | 1 | name |
| 405142062 | CV2919990 | single nucleotide variant | NM_022552.5(DNMT3A):c.1778G>A (p.Gly593Glu) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584251] | uncertain significance | 2 | 25244228 | 25244228 | Human | 1 | name |
| 405142922 | CV2922268 | single nucleotide variant | NM_022552.5(DNMT3A):c.2707G>C (p.Ala903Pro) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584339] | uncertain significance | 2 | 25234311 | 25234311 | Human | 1 | name |
| 405143145 | CV2928927 | single nucleotide variant | NM_022552.5(DNMT3A):c.2446C>G (p.Gln816Glu) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584359] | uncertain significance | 2 | 25236968 | 25236968 | Human | 1 | name |
| 405248295 | CV2947608 | single nucleotide variant | NM_022552.5(DNMT3A):c.2259G>A (p.Trp753Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746731] | pathogenic | 2 | 25240365 | 25240365 | Human | 1 | name |
| 405250247 | CV3015278 | single nucleotide variant | NM_022552.5(DNMT3A):c.2438T>C (p.Leu813Pro) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747398] | uncertain significance | 2 | 25236976 | 25236976 | Human | 1 | name |
| 405246892 | CV3025363 | single nucleotide variant | NM_022552.5(DNMT3A):c.1934C>T (p.Thr645Ile) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746155] | uncertain significance | 2 | 25243900 | 25243900 | Human | 1 | name |
| 405247209 | CV3035116 | single nucleotide variant | NM_022552.5(DNMT3A):c.1810C>T (p.Arg604Trp) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746283] | uncertain significance | 2 | 25244196 | 25244196 | Human | 1 | name |
| 405247628 | CV3051378 | single nucleotide variant | NM_022552.5(DNMT3A):c.1154C>T (p.Pro385Leu) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746445] | uncertain significance | 2 | 25246745 | 25246745 | Human | 1 | name |
| 405250443 | CV3062460 | single nucleotide variant | NM_022552.5(DNMT3A):c.1523T>C (p.Leu508Pro) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747530] | likely pathogenic | 2 | 25245284 | 25245284 | Human | 1 | name |
| 405250597 | CV3070990 | single nucleotide variant | NM_022552.5(DNMT3A):c.1766A>G (p.Lys589Arg) | DNMT3A-related disorder [RCV004747369]|Tatton-Brown-Rahman overgrowth syndrome [RCV003747596] | uncertain significance | 2 | 25244240 | 25244240 | Human | 1 | name , trait , alternate_id |
| 405250508 | CV3075435 | duplication | NM_022552.5(DNMT3A):c.2196dup (p.Glu733Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV003747559] | pathogenic | 2 | 25240427 | 25240428 | Human | 1 | name |
| 405219153 | CV3135801 | single nucleotide variant | NM_022552.5(DNMT3A):c.2695C>T (p.Arg899Cys) | Tatton-Brown-Rahman overgrowth syndrome [RCV003824427] | uncertain significance | 2 | 25234323 | 25234323 | Human | 1 | name |
| 405223576 | CV3158438 | single nucleotide variant | NM_022552.5(DNMT3A):c.1317G>A (p.Met439Ile) | Tatton-Brown-Rahman overgrowth syndrome [RCV003863934] | uncertain significance | 2 | 25246272 | 25246272 | Human | 1 | name |
| 405255422 | CV3172403 | single nucleotide variant | NM_022552.5(DNMT3A):c.1000G>A (p.Gly334Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV003872341] | uncertain significance | 2 | 25247605 | 25247605 | Human | 1 | name |
| 405259454 | CV3186276 | single nucleotide variant | NM_022552.5(DNMT3A):c.1058C>T (p.Ala353Val) | not provided [RCV003884035] | uncertain significance | 2 | 25247115 | 25247115 | Human | | name |
| 405260003 | CV3186512 | single nucleotide variant | NM_022552.5(DNMT3A):c.1802G>A (p.Trp601Ter) | not provided [RCV003884271] | pathogenic | 2 | 25244204 | 25244204 | Human | | name |
| 405283003 | CV3191209 | single nucleotide variant | NM_022552.5(DNMT3A):c.1448T>C (p.Val483Ala) | DNMT3A-related disorder [RCV003921615] | uncertain significance | 2 | 25246046 | 25246046 | Human | | name , trait , alternate_id |
| 405257166 | CV3222456 | single nucleotide variant | NM_022552.5(DNMT3A):c.1627G>C (p.Gly543Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV003985952] | pathogenic | 2 | 25244580 | 25244580 | Human | 1 | name |
| 408368130 | CV3224478 | single nucleotide variant | NM_022552.5(DNMT3A):c.1684T>G (p.Cys562Gly) | Tatton-Brown-Rahman overgrowth syndrome [RCV004723557] | pathogenic | 2 | 25244322 | 25244322 | Human | 1 | name |
| 408368135 | CV3224479 | single nucleotide variant | NM_022552.5(DNMT3A):c.1925G>T (p.Gly642Val) | Tatton-Brown-Rahman overgrowth syndrome [RCV004723558] | likely pathogenic | 2 | 25243909 | 25243909 | Human | 1 | name |
| 408368762 | CV3224480 | single nucleotide variant | NM_022552.5(DNMT3A):c.1267G>T (p.Glu423Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV004723559] | likely pathogenic | 2 | 25246632 | 25246632 | Human | 1 | name |
| 405673680 | CV3380082 | single nucleotide variant | NM_022552.5(DNMT3A):c.2105A>G (p.Asp702Gly) | Tatton-Brown-Rahman overgrowth syndrome [RCV004515751] | likely pathogenic | 2 | 25240708 | 25240708 | Human | 1 | name |
| 407427048 | CV3409257 | single nucleotide variant | NM_022552.5(DNMT3A):c.1333G>A (p.Ala445Thr) | Heyn-Sproul-Jackson syndrome [RCV004585189] | uncertain significance | 2 | 25246256 | 25246256 | Human | 1 | name |
| 407428038 | CV3412315 | single nucleotide variant | NM_022552.5(DNMT3A):c.2173G>A (p.Glu725Lys) | not provided [RCV004593483] | uncertain significance | 2 | 25240640 | 25240640 | Human | | name |
| 407429460 | CV3413756 | single nucleotide variant | NM_022552.5(DNMT3A):c.1669T>C (p.Cys557Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV004595165] | likely pathogenic | 2 | 25244337 | 25244337 | Human | 1 | name |
| 407457953 | CV3416265 | single nucleotide variant | NM_022552.5(DNMT3A):c.1760G>A (p.Gly587Glu) | not provided [RCV004599143] | uncertain significance | 2 | 25244246 | 25244246 | Human | | name |
| 407505371 | CV3437693 | single nucleotide variant | NM_022552.5(DNMT3A):c.2606G>C (p.Gly869Ala) | Inborn genetic diseases [RCV004624337] | likely pathogenic | 2 | 25234412 | 25234412 | Human | 1 | name |
| 407502736 | CV3495709 | single nucleotide variant | NM_022552.5(DNMT3A):c.2330C>A (p.Pro777His) | not provided [RCV004697549] | likely pathogenic | 2 | 25239208 | 25239208 | Human | | name |
| 407460128 | CV3496962 | single nucleotide variant | NM_022552.5(DNMT3A):c.1759G>A (p.Gly587Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV004698776] | uncertain significance | 2 | 25244247 | 25244247 | Human | 1 | name |
| 408365346 | CV3499816 | single nucleotide variant | NM_022552.5(DNMT3A):c.2327A>G (p.Asn776Ser) | not provided [RCV004721858] | uncertain significance | 2 | 25239211 | 25239211 | Human | | name |
| 408374934 | CV3502550 | single nucleotide variant | NM_022552.5(DNMT3A):c.1981A>G (p.Ile661Val) | not provided [RCV004726137] | uncertain significance | 2 | 25241663 | 25241663 | Human | | name |
| 408379151 | CV3504002 | single nucleotide variant | NM_022552.5(DNMT3A):c.1502A>T (p.Asn501Ile) | DNMT3A-related disorder [RCV004728224]|Tatton-Brown-Rahman overgrowth syndrome [RCV005103662] | uncertain significance | 2 | 25245305 | 25245305 | Human | 1 | name , trait , alternate_id |
| 408379135 | CV3504101 | single nucleotide variant | NM_022552.5(DNMT3A):c.1361C>G (p.Ala454Gly) | DNMT3A-related disorder [RCV004728280] | uncertain significance | 2 | 25246228 | 25246228 | Human | | name , trait , alternate_id |
| 408382286 | CV3504397 | single nucleotide variant | NM_022552.5(DNMT3A):c.1606T>C (p.Tyr536His) | DNMT3A-related disorder [RCV004729740] | uncertain significance | 2 | 25244601 | 25244601 | Human | | name , trait , alternate_id |
| 408371191 | CV3504839 | single nucleotide variant | NM_022552.5(DNMT3A):c.1799A>G (p.Asp600Gly) | DNMT3A-related disorder [RCV004724486] | uncertain significance | 2 | 25244207 | 25244207 | Human | | name , trait , alternate_id |
| 408378233 | CV3505149 | single nucleotide variant | NM_022552.5(DNMT3A):c.1318T>A (p.Trp440Arg) | DNMT3A-related disorder [RCV004727902] | uncertain significance | 2 | 25246271 | 25246271 | Human | | name , trait , alternate_id |
| 408378597 | CV3505369 | single nucleotide variant | NM_022552.5(DNMT3A):c.1190A>C (p.Lys397Thr) | DNMT3A-related disorder [RCV004728042] | uncertain significance | 2 | 25246709 | 25246709 | Human | | name , trait , alternate_id |
| 408376287 | CV3505759 | single nucleotide variant | NM_022552.5(DNMT3A):c.1529T>C (p.Val510Ala) | DNMT3A-related disorder [RCV004726692] | uncertain significance | 2 | 25245278 | 25245278 | Human | | name , trait , alternate_id |
| 408374799 | CV3507713 | single nucleotide variant | NM_022552.5(DNMT3A):c.1959G>C (p.Leu653Phe) | Acute myeloid leukemia [RCV005410974]|DNMT3A-related disorder [RCV004747510] | uncertain significance | 2 | 25241685 | 25241685 | Human | 3 | name , trait , alternate_id |
| 408374840 | CV3508051 | single nucleotide variant | NM_022552.5(DNMT3A):c.1786C>T (p.Arg596Trp) | DNMT3A-related disorder [RCV004747546] | uncertain significance | 2 | 25244220 | 25244220 | Human | | name , trait , alternate_id |
| 408374863 | CV3508197 | single nucleotide variant | NM_022552.5(DNMT3A):c.1463G>A (p.Arg488Gln) | DNMT3A-related disorder [RCV004747566]|Tatton-Brown-Rahman overgrowth syndrome [RCV005059810] | uncertain significance | 2 | 25246031 | 25246031 | Human | 1 | name , trait , alternate_id |
| 408374976 | CV3509027 | single nucleotide variant | NM_022552.5(DNMT3A):c.1797G>T (p.Glu599Asp) | DNMT3A-related disorder [RCV004747672] | uncertain significance | 2 | 25244209 | 25244209 | Human | | name , trait , alternate_id |
| 408373791 | CV3512669 | single nucleotide variant | NM_022552.5(DNMT3A):c.1373G>A (p.Arg458Gln) | DNMT3A-related disorder [RCV004745726] | uncertain significance | 2 | 25246216 | 25246216 | Human | | name , trait , alternate_id |
| 408373899 | CV3513336 | single nucleotide variant | NM_022552.5(DNMT3A):c.2374C>T (p.Arg792Cys) | DNMT3A-related disorder [RCV004745830] | uncertain significance | 2 | 25239164 | 25239164 | Human | | name , trait , alternate_id |
| 408374187 | CV3515123 | single nucleotide variant | NM_022552.5(DNMT3A):c.1232T>A (p.Leu411Gln) | DNMT3A-related disorder [RCV004746073]|Inborn genetic diseases [RCV004981195] | uncertain significance | 2 | 25246667 | 25246667 | Human | 1 | name , trait , alternate_id |
| 408374569 | CV3517249 | single nucleotide variant | NM_022552.5(DNMT3A):c.1276G>A (p.Glu426Lys) | DNMT3A-related disorder [RCV004746901]|Tatton-Brown-Rahman overgrowth syndrome [RCV005103891] | uncertain significance | 2 | 25246623 | 25246623 | Human | 1 | name , trait , alternate_id |
| 408374688 | CV3518001 | single nucleotide variant | NM_022552.5(DNMT3A):c.1465A>C (p.Asn489His) | DNMT3A-related disorder [RCV004747014]|Inborn genetic diseases [RCV005325924]|Tatton-Brown-Rahman overgrowth syndrome [RCV005104904] | uncertain significance | 2 | 25246029 | 25246029 | Human | 2 | name , trait , alternate_id |
| 408389956 | CV3519154 | single nucleotide variant | NM_022552.5(DNMT3A):c.2411C>G (p.Pro804Arg) | not provided [RCV004762463] | uncertain significance | 2 | 25237003 | 25237003 | Human | | name |
| 408392560 | CV3528176 | single nucleotide variant | NM_022552.5(DNMT3A):c.2096G>A (p.Gly699Asp) | not provided [RCV004775944] | likely pathogenic | 2 | 25240717 | 25240717 | Human | | name |
| 596931019 | CV3529861 | single nucleotide variant | NM_022552.5(DNMT3A):c.1681G>A (p.Glu561Lys) | not provided [RCV004780911] | uncertain significance | 2 | 25244325 | 25244325 | Human | | name |
| 596922637 | CV3530023 | single nucleotide variant | NM_022552.5(DNMT3A):c.1897C>G (p.Pro633Ala) | not provided [RCV004776622] | uncertain significance | 2 | 25243937 | 25243937 | Human | | name |
| 596931633 | CV3531909 | single nucleotide variant | NM_022552.5(DNMT3A):c.1975C>T (p.Arg659Cys) | not provided [RCV004781471] | uncertain significance | 2 | 25241669 | 25241669 | Human | | name |
| 596922389 | CV3537189 | single nucleotide variant | NM_022552.5(DNMT3A):c.2410C>T (p.Pro804Ser) | not provided [RCV004786185] | uncertain significance | 2 | 25237004 | 25237004 | Human | | name |
| 596929208 | CV3540863 | single nucleotide variant | NM_022552.5(DNMT3A):c.1901T>C (p.Ile634Thr) | not provided [RCV004795192] | uncertain significance | 2 | 25243933 | 25243933 | Human | | name |
| 12742581 | CV359463 | single nucleotide variant | NM_022552.5(DNMT3A):c.2711C>T (p.Pro904Leu) | Autism spectrum disorder [RCV003233631]|EBV-positive nodal T- and NK-cell lymphoma [RCV004559047]|Tatton-Brown-Rahman overgrowth syndrome [RCV004725203]|not provided [RCV000413992] | pathogenic|likely pathogenic|not provided | 2 | 25234307 | 25234307 | Human | 3 | name |
| 12848691 | CV362758 | single nucleotide variant | NM_022552.5(DNMT3A):c.2645G>T (p.Arg882Leu) | Acute myeloid leukemia [RCV000445240] | pathogenic | 2 | 25234373 | 25234373 | Human | 1 | name |
| 12834487 | CV362759 | single nucleotide variant | NM_022552.5(DNMT3A):c.2645G>C (p.Arg882Pro) | Acute myeloid leukemia [RCV000436723]|Lung adenocarcinoma [RCV000419470]|Myelodysplastic syndrome [RCV000427788] | pathogenic|likely pathogenic | 2 | 25234373 | 25234373 | Human | 3 | name |
| 12834396 | CV362760 | single nucleotide variant | NM_022552.5(DNMT3A):c.2645G>A (p.Arg882His) | Abnormality of the nervous system [RCV001814155]|Acute myeloid leukemia [RCV000430182]|Clonal Cytopenia of Undetermined Significance [RCV003153242]|DNMT3A-related disorder [RCV004545768]|EBV-positive nodal T- and NK-cell lymphoma [RCV004559051]|Inborn genetic di seases [RCV000623601]|Intellectual disability [RCV004017608]|Tatton-Brown-Rahman overgrowth syndrome [RCV000524775]|not provided [RCV000485343]|not specified [RCV002248654] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance|not provided | 2 | 25234373 | 25234373 | Human | 8 | name , trait , alternate_id |
| 12845425 | CV362761 | single nucleotide variant | NM_022552.5(DNMT3A):c.2644C>T (p.Arg882Cys) | Acute myeloid leukemia [RCV000429128]|DNMT3A-related disorder [RCV004745372]|EBV-positive nodal T- and NK-cell lymphoma [RCV004559052]|Inborn genetic diseases [RCV001267371]|Neurodevelopmental disorder [RCV001374980]|Tatton-Brown-Rahman overgrowth syndrome [RCV0 00590987]|not provided [RCV001552894] | pathogenic|likely pathogenic | 2 | 25234374 | 25234374 | Human | 5 | name , trait , alternate_id |
| 12848651 | CV362762 | single nucleotide variant | NM_022552.5(DNMT3A):c.2644C>G (p.Arg882Gly) | Acute myeloid leukemia [RCV000427931] | pathogenic | 2 | 25234374 | 25234374 | Human | 1 | name |
| 12848673 | CV362763 | single nucleotide variant | NM_022552.5(DNMT3A):c.2644C>A (p.Arg882Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV003766178]|not provided [RCV001782899] | pathogenic|likely pathogenic|uncertain significance | 2 | 25234374 | 25234374 | Human | 1 | name |
| 597649355 | CV3659331 | single nucleotide variant | NM_022552.5(DNMT3A):c.2504C>G (p.Thr835Arg) | Inborn genetic diseases [RCV004974362] | uncertain significance | 2 | 25235800 | 25235800 | Human | 1 | name |
| 597649375 | CV3659334 | single nucleotide variant | NM_022552.5(DNMT3A):c.1249T>A (p.Ser417Thr) | Inborn genetic diseases [RCV004974365] | uncertain significance | 2 | 25246650 | 25246650 | Human | 1 | name |
| 597649410 | CV3659340 | single nucleotide variant | NM_022552.5(DNMT3A):c.1480T>A (p.Cys494Ser) | Inborn genetic diseases [RCV004974371] | uncertain significance | 2 | 25245327 | 25245327 | Human | 1 | name |
| 597649416 | CV3659341 | single nucleotide variant | NM_022552.5(DNMT3A):c.2654G>C (p.Arg885Thr) | Inborn genetic diseases [RCV004974372] | uncertain significance | 2 | 25234364 | 25234364 | Human | 1 | name |
| 597649421 | CV3659342 | single nucleotide variant | NM_022552.5(DNMT3A):c.1699G>T (p.Val567Leu) | Inborn genetic diseases [RCV004974373] | uncertain significance | 2 | 25244307 | 25244307 | Human | 1 | name |
| 597649457 | CV3659347 | single nucleotide variant | NM_022552.5(DNMT3A):c.1804C>A (p.Pro602Thr) | Inborn genetic diseases [RCV004974378] | uncertain significance | 2 | 25244202 | 25244202 | Human | 1 | name |
| 597649483 | CV3659351 | single nucleotide variant | NM_022552.5(DNMT3A):c.1327C>T (p.Pro443Ser) | Inborn genetic diseases [RCV004974382] | uncertain significance | 2 | 25246262 | 25246262 | Human | 1 | name |
| 597649514 | CV3659357 | single nucleotide variant | NM_022552.5(DNMT3A):c.1459T>C (p.Cys487Arg) | Inborn genetic diseases [RCV004974387] | uncertain significance | 2 | 25246035 | 25246035 | Human | 1 | name |
| 597649528 | CV3659359 | single nucleotide variant | NM_022552.5(DNMT3A):c.1769G>C (p.Gly590Ala) | Inborn genetic diseases [RCV004974389] | uncertain significance | 2 | 25244237 | 25244237 | Human | 1 | name |
| 597649547 | CV3659362 | single nucleotide variant | NM_022552.5(DNMT3A):c.1591G>C (p.Asp531His) | Inborn genetic diseases [RCV004974392] | uncertain significance | 2 | 25244616 | 25244616 | Human | 1 | name |
| 597649551 | CV3659363 | single nucleotide variant | NM_022552.5(DNMT3A):c.1376A>G (p.Lys459Arg) | Inborn genetic diseases [RCV004974393] | uncertain significance | 2 | 25246213 | 25246213 | Human | 1 | name |
| 597649562 | CV3659365 | single nucleotide variant | NM_022552.5(DNMT3A):c.1152C>G (p.Phe384Leu) | Inborn genetic diseases [RCV004974395] | uncertain significance | 2 | 25246747 | 25246747 | Human | 1 | name |
| 12849016 | CV366310 | single nucleotide variant | NM_022552.5(DNMT3A):c.2213T>G (p.Leu738Arg) | not provided [RCV000422670] | likely pathogenic | 2 | 25240411 | 25240411 | Human | | name |
| 12849997 | CV366311 | single nucleotide variant | NM_022552.5(DNMT3A):c.1684T>C (p.Cys562Arg) | Tatton-Brown-Rahman overgrowth syndrome [RCV000536842]|not provided [RCV000439792] | likely pathogenic|uncertain significance | 2 | 25244322 | 25244322 | Human | 1 | name |
| 12843655 | CV366533 | single nucleotide variant | NM_022552.5(DNMT3A):c.1743G>T (p.Trp581Cys) | Tatton-Brown-Rahman overgrowth syndrome [RCV000515481]|not provided [RCV000436598] | uncertain significance | 2 | 25244263 | 25244263 | Human | 1 | name |
| 597716972 | CV3733307 | single nucleotide variant | NM_022552.5(DNMT3A):c.2068G>A (p.Val690Ile) | not provided [RCV005052497] | uncertain significance | 2 | 25241576 | 25241576 | Human | | name |
| 597854015 | CV3747565 | single nucleotide variant | NM_022552.5(DNMT3A):c.1227G>A (p.Trp409Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV005066576] | pathogenic | 2 | 25246672 | 25246672 | Human | 1 | name |
| 597843828 | CV3752412 | single nucleotide variant | NM_022552.5(DNMT3A):c.1031T>C (p.Leu344Pro) | Tatton-Brown-Rahman overgrowth syndrome [RCV005086818] | uncertain significance | 2 | 25247142 | 25247142 | Human | 1 | name |
| 597875149 | CV3766272 | single nucleotide variant | NM_022552.5(DNMT3A):c.1124T>G (p.Val375Gly) | Tatton-Brown-Rahman overgrowth syndrome [RCV005108404] | uncertain significance | 2 | 25246775 | 25246775 | Human | 1 | name |
| 597925189 | CV3778151 | single nucleotide variant | NM_022552.5(DNMT3A):c.1647C>G (p.Cys549Trp) | Tatton-Brown-Rahman overgrowth syndrome [RCV005130875] | uncertain significance | 2 | 25244560 | 25244560 | Human | 1 | name |
| 597927484 | CV3783470 | duplication | NM_022552.5(DNMT3A):c.1577dup (p.Tyr526Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV005116157] | pathogenic | 2 | 25244629 | 25244630 | Human | 1 | name |
| 597946499 | CV3790146 | single nucleotide variant | NM_022552.5(DNMT3A):c.1711G>A (p.Ala571Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV005134847] | uncertain significance | 2 | 25244295 | 25244295 | Human | 1 | name |
| 597952083 | CV3798483 | single nucleotide variant | NM_022552.5(DNMT3A):c.2405A>G (p.Asn802Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV005136264] | uncertain significance | 2 | 25239133 | 25239133 | Human | 1 | name |
| 597937918 | CV3807948 | single nucleotide variant | NM_022552.5(DNMT3A):c.1668G>T (p.Arg556Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV005158327] | uncertain significance | 2 | 25244338 | 25244338 | Human | 1 | name |
| 597920824 | CV3807986 | single nucleotide variant | NM_022552.5(DNMT3A):c.1945G>A (p.Val649Met) | Tatton-Brown-Rahman overgrowth syndrome [RCV005155694] | uncertain significance | 2 | 25241699 | 25241699 | Human | 1 | name |
| 597875292 | CV3813099 | single nucleotide variant | NM_022552.5(DNMT3A):c.2384G>A (p.Trp795Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV005149035] | pathogenic | 2 | 25239154 | 25239154 | Human | 1 | name |
| 597929215 | CV3816050 | single nucleotide variant | NM_022552.5(DNMT3A):c.2259G>T (p.Trp753Cys) | Tatton-Brown-Rahman overgrowth syndrome [RCV005156631] | uncertain significance | 2 | 25240365 | 25240365 | Human | 1 | name |
| 597970328 | CV3832437 | single nucleotide variant | NM_022552.5(DNMT3A):c.2093G>A (p.Trp698Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV005166516] | pathogenic | 2 | 25240720 | 25240720 | Human | 1 | name |
| 597947183 | CV3841835 | single nucleotide variant | NM_022552.5(DNMT3A):c.1066C>T (p.Gln356Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV005189269] | pathogenic | 2 | 25247107 | 25247107 | Human | 1 | name |
| 597871761 | CV3849376 | single nucleotide variant | NM_022552.5(DNMT3A):c.1420C>T (p.Arg474Cys) | Tatton-Brown-Rahman overgrowth syndrome [RCV005197557] | uncertain significance | 2 | 25246169 | 25246169 | Human | 1 | name |
| 598126891 | CV3882350 | single nucleotide variant | NM_022552.5(DNMT3A):c.1919T>C (p.Phe640Ser) | not provided [RCV005233901] | uncertain significance | 2 | 25243915 | 25243915 | Human | | name |
| 598201151 | CV3892749 | single nucleotide variant | NM_022552.5(DNMT3A):c.2598G>C (p.Arg866Ser) | not provided [RCV005254582] | uncertain significance | 2 | 25234420 | 25234420 | Human | | name |
| 598203277 | CV3892869 | single nucleotide variant | NM_022552.5(DNMT3A):c.2320G>A (p.Glu774Lys) | not provided [RCV005255199] | uncertain significance | 2 | 25240304 | 25240304 | Human | | name |
| 598238587 | CV3893316 | single nucleotide variant | NM_022552.5(DNMT3A):c.1094A>G (p.Tyr365Cys) | not provided [RCV005256049] | uncertain significance | 2 | 25247079 | 25247079 | Human | | name |
| 598225953 | CV3894319 | single nucleotide variant | NM_022552.5(DNMT3A):c.2129G>A (p.Cys710Tyr) | not provided [RCV005257562] | uncertain significance | 2 | 25240684 | 25240684 | Human | | name |
| 598216874 | CV3895263 | single nucleotide variant | NM_022552.5(DNMT3A):c.1776C>A (p.Tyr592Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV005360161] | uncertain significance | 2 | 25244230 | 25244230 | Human | 1 | name |
| 598164877 | CV3964248 | single nucleotide variant | NM_022552.5(DNMT3A):c.2021T>G (p.Met674Arg) | Inborn genetic diseases [RCV005329593] | uncertain significance | 2 | 25241623 | 25241623 | Human | 1 | name |
| 598164882 | CV3964249 | single nucleotide variant | NM_022552.5(DNMT3A):c.1304T>C (p.Val435Ala) | Inborn genetic diseases [RCV005329594] | uncertain significance | 2 | 25246285 | 25246285 | Human | 1 | name |
| 598164934 | CV3964260 | single nucleotide variant | NM_022552.5(DNMT3A):c.1303G>T (p.Val435Leu) | Inborn genetic diseases [RCV005329605] | uncertain significance | 2 | 25246286 | 25246286 | Human | 1 | name |
| 598164954 | CV3964265 | single nucleotide variant | NM_022552.5(DNMT3A):c.1295A>G (p.Tyr432Cys) | Inborn genetic diseases [RCV005329610] | uncertain significance | 2 | 25246294 | 25246294 | Human | 1 | name |
| 598164974 | CV3964269 | single nucleotide variant | NM_022552.5(DNMT3A):c.1406A>C (p.Glu469Ala) | Inborn genetic diseases [RCV005329614] | uncertain significance | 2 | 25246183 | 25246183 | Human | 1 | name |
| 598164983 | CV3964271 | single nucleotide variant | NM_022552.5(DNMT3A):c.1402A>G (p.Lys468Glu) | Inborn genetic diseases [RCV005329616] | uncertain significance | 2 | 25246187 | 25246187 | Human | 1 | name |
| 598164997 | CV3964274 | single nucleotide variant | NM_022552.5(DNMT3A):c.2419T>A (p.Ser807Thr) | Inborn genetic diseases [RCV005329619] | uncertain significance | 2 | 25236995 | 25236995 | Human | 1 | name |
| 598165011 | CV3964277 | single nucleotide variant | NM_022552.5(DNMT3A):c.1719G>T (p.Gln573His) | Inborn genetic diseases [RCV005329622] | uncertain significance | 2 | 25244287 | 25244287 | Human | 1 | name |
| 598165021 | CV3964279 | single nucleotide variant | NM_022552.5(DNMT3A):c.1547A>C (p.Asn516Thr) | Inborn genetic diseases [RCV005329624] | uncertain significance | 2 | 25245260 | 25245260 | Human | 1 | name |
| 598165025 | CV3964280 | single nucleotide variant | NM_022552.5(DNMT3A):c.1692C>A (p.Asp564Glu) | Inborn genetic diseases [RCV005329625] | uncertain significance | 2 | 25244314 | 25244314 | Human | 1 | name |
| 598165055 | CV3964286 | single nucleotide variant | NM_022552.5(DNMT3A):c.2426T>C (p.Val809Ala) | Inborn genetic diseases [RCV005329631] | uncertain significance | 2 | 25236988 | 25236988 | Human | 1 | name |
| 598165137 | CV3964303 | single nucleotide variant | NM_022552.5(DNMT3A):c.1087C>A (p.Pro363Thr) | Inborn genetic diseases [RCV005329648] | uncertain significance | 2 | 25247086 | 25247086 | Human | 1 | name |
| 598165180 | CV3964312 | single nucleotide variant | NM_022552.5(DNMT3A):c.2231A>C (p.Lys744Thr) | Inborn genetic diseases [RCV005329657] | uncertain significance | 2 | 25240393 | 25240393 | Human | 1 | name |
| 598165197 | CV3964316 | single nucleotide variant | NM_022552.5(DNMT3A):c.1893G>T (p.Arg631Ser) | Inborn genetic diseases [RCV005329661] | uncertain significance | 2 | 25243941 | 25243941 | Human | 1 | name |
| 598165216 | CV3964320 | single nucleotide variant | NM_022552.5(DNMT3A):c.1178G>A (p.Ser393Asn) | Inborn genetic diseases [RCV005329665] | uncertain significance | 2 | 25246721 | 25246721 | Human | 1 | name |
| 598165218 | CV3964321 | single nucleotide variant | NM_022552.5(DNMT3A):c.1796A>C (p.Glu599Ala) | Inborn genetic diseases [RCV005329666] | uncertain significance | 2 | 25244210 | 25244210 | Human | 1 | name |
| 598165223 | CV3964322 | single nucleotide variant | NM_022552.5(DNMT3A):c.1369C>T (p.Pro457Ser) | Inborn genetic diseases [RCV005329667] | uncertain significance | 2 | 25246220 | 25246220 | Human | 1 | name |
| 598165241 | CV3964326 | single nucleotide variant | NM_022552.5(DNMT3A):c.2386G>T (p.Gly796Cys) | Inborn genetic diseases [RCV005329671] | likely pathogenic | 2 | 25239152 | 25239152 | Human | 1 | name |
| 598165250 | CV3964328 | single nucleotide variant | NM_022552.5(DNMT3A):c.1372C>T (p.Arg458Trp) | Inborn genetic diseases [RCV005329673] | uncertain significance | 2 | 25246217 | 25246217 | Human | 1 | name |
| 616938277 | CV4013045 | single nucleotide variant | NM_022552.5(DNMT3A):c.1906G>T (p.Val636Leu) | not provided [RCV005410512] | likely pathogenic | 2 | 25243928 | 25243928 | Human | | name |
| 616933386 | CV4013726 | single nucleotide variant | NM_022552.5(DNMT3A):c.1988C>A (p.Ser663Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV005411211] | likely pathogenic | 2 | 25241656 | 25241656 | Human | 1 | name |
| 616938422 | CV4014960 | single nucleotide variant | NM_022552.5(DNMT3A):c.1588G>A (p.Asp530Asn) | not provided [RCV005411976] | uncertain significance | 2 | 25244619 | 25244619 | Human | | name |
| 617153712 | CV4016787 | single nucleotide variant | NM_022552.5(DNMT3A):c.1600C>T (p.Gln534Ter) | not provided [RCV005415884] | uncertain significance | 2 | 25244607 | 25244607 | Human | | name |
| 12895365 | CV405690 | single nucleotide variant | NM_022552.5(DNMT3A):c.2311C>T (p.Arg771Ter) | Acute myeloid leukemia [RCV003338604]|Tatton-Brown-Rahman overgrowth syndrome [RCV001237885]|not provided [RCV000486209] | pathogenic | 2 | 25240313 | 25240313 | Human | 3 | name |
| 12894511 | CV405691 | single nucleotide variant | NM_022552.5(DNMT3A):c.1748G>A (p.Cys583Tyr) | not provided [RCV000483070] | pathogenic|likely pathogenic | 2 | 25244258 | 25244258 | Human | | name |
| 12895550 | CV405692 | single nucleotide variant | NM_022552.5(DNMT3A):c.1628G>A (p.Gly543Asp) | not provided [RCV000486870] | pathogenic|likely pathogenic | 2 | 25244579 | 25244579 | Human | | name |
| 13213971 | CV428048 | single nucleotide variant | NM_022552.5(DNMT3A):c.1135C>T (p.Arg379Cys) | DNMT3A-related disorder [RCV003403163]|Tatton-Brown-Rahman overgrowth syndrome [RCV005091091]|not provided [RCV002275043]|not specified [RCV000500674] | uncertain significance | 2 | 25246764 | 25246764 | Human | 1 | name , trait , alternate_id |
| 13435448 | CV431903 | single nucleotide variant | NM_022552.5(DNMT3A):c.2312G>A (p.Arg771Gln) | Acute myeloid leukemia [RCV004796213]|Inborn genetic diseases [RCV000624769]|Tatton-Brown-Rahman overgrowth syndrome [RCV000505187] | pathogenic|likely pathogenic | 2 | 25240312 | 25240312 | Human | 4 | name |
| 13485659 | CV443220 | single nucleotide variant | NM_022552.5(DNMT3A):c.1063C>T (p.His355Tyr) | not provided [RCV000522668] | uncertain significance | 2 | 25247110 | 25247110 | Human | | name |
| 13521294 | CV495150 | indel | NM_022552.5(DNMT3A):c.1015-3_1015-1delinsAA | not provided [RCV000599335] | pathogenic | 2 | 25247159 | 25247161 | Human | | name |
| 13592890 | CV511415 | single nucleotide variant | NM_022552.5(DNMT3A):c.2536C>T (p.Gln846Ter) | Inborn genetic diseases [RCV000624328] | pathogenic | 2 | 25235768 | 25235768 | Human | 1 | name |
| 13530872 | CV511416 | single nucleotide variant | NM_022552.5(DNMT3A):c.2312G>T (p.Arg771Leu) | Inborn genetic diseases [RCV000622849] | uncertain significance | 2 | 25240312 | 25240312 | Human | 1 | name |
| 13703146 | CV537347 | single nucleotide variant | NM_022552.5(DNMT3A):c.2141C>G (p.Ser714Cys) | Tatton-Brown-Rahman overgrowth syndrome [RCV001251185]|not provided [RCV000658860] | likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 2 | 25240672 | 25240672 | Human | 1 | name |
| 13786260 | CV550351 | single nucleotide variant | NM_022552.5(DNMT3A):c.2086C>T (p.Gln696Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV000677427] | likely pathogenic | 2 | 25240727 | 25240727 | Human | 1 | name |
| 13783997 | CV550586 | single nucleotide variant | NM_022552.5(DNMT3A):c.1634A>G (p.Glu545Gly) | Tatton-Brown-Rahman overgrowth syndrome [RCV000677682] | likely pathogenic | 2 | 25244573 | 25244573 | Human | 1 | name |
| 13820851 | CV576102 | single nucleotide variant | NM_022552.5(DNMT3A):c.1913C>G (p.Ser638Cys) | Tatton-Brown-Rahman overgrowth syndrome [RCV000709939] | not provided | 2 | 25243921 | 25243921 | Human | | name |
| 14395680 | CV611383 | single nucleotide variant | NM_022552.5(DNMT3A):c.2525A>G (p.Gln842Arg) | Acute myeloid leukemia [RCV000760250] | likely pathogenic | 2 | 25235779 | 25235779 | Human | 2 | name |
| 14696635 | CV622947 | single nucleotide variant | NM_022552.5(DNMT3A):c.2710C>T (p.Pro904Ser) | Glioblastoma [RCV000785978] | likely pathogenic | 2 | 25234308 | 25234308 | Human | 2 | name |
| 14736208 | CV629751 | single nucleotide variant | NM_022552.5(DNMT3A):c.2495C>T (p.Thr832Ile) | Tatton-Brown-Rahman overgrowth syndrome [RCV000803514] | likely pathogenic | 2 | 25235809 | 25235809 | Human | 1 | name |
| 14720086 | CV629752 | single nucleotide variant | NM_022552.5(DNMT3A):c.2385G>A (p.Trp795Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV000812887] | pathogenic | 2 | 25239153 | 25239153 | Human | 1 | name |
| 14724541 | CV629753 | single nucleotide variant | NM_022552.5(DNMT3A):c.2309C>T (p.Ser770Leu) | Tatton-Brown-Rahman overgrowth syndrome [RCV000798433]|not provided [RCV001585724] | pathogenic|uncertain significance | 2 | 25240315 | 25240315 | Human | 1 | name |
| 14741697 | CV629754 | single nucleotide variant | NM_022552.5(DNMT3A):c.2063G>A (p.Arg688His) | Inborn genetic diseases [RCV001267190]|Tatton-Brown-Rahman overgrowth syndrome [RCV000805932]|not provided [RCV001567102] | pathogenic|uncertain significance | 2 | 25241581 | 25241581 | Human | 2 | name |
| 14727347 | CV629755 | single nucleotide variant | NM_022552.5(DNMT3A):c.1490G>C (p.Cys497Ser) | Tatton-Brown-Rahman overgrowth syndrome [RCV000816045] | uncertain significance | 2 | 25245317 | 25245317 | Human | 1 | name |
| 21066911 | CV795203 | single nucleotide variant | NM_022552.5(DNMT3A):c.1840G>A (p.Asp614Asn) | not provided [RCV000997083] | uncertain significance | 2 | 25244166 | 25244166 | Human | | name |
| 21404859 | CV801063 | single nucleotide variant | NM_022552.5(DNMT3A):c.2204A>G (p.Tyr735Cys) | DNMT3A-related disorder [RCV004746194]|Malignant lymphoma, large B-cell, diffuse [RCV003448984]|Myeloproliferative disorder [RCV001003798]|Tatton-Brown-Rahman overgrowth syndrome [RCV002471010]|not provided [RCV001776076]|not specified [RCV002249617] | pathogenic|likely pathogenic|uncertain significance | 2 | 25240420 | 25240420 | Human | 4 | name , trait , alternate_id |
| 26898946 | CV826112 | single nucleotide variant | NM_022552.5(DNMT3A):c.2546C>A (p.Pro849His) | Tatton-Brown-Rahman overgrowth syndrome [RCV001034840] | uncertain significance | 2 | 25235758 | 25235758 | Human | 1 | name |
| 26920853 | CV826113 | single nucleotide variant | NM_022552.5(DNMT3A):c.1706C>T (p.Pro569Leu) | DNMT3A-related disorder [RCV004746225]|Tatton-Brown-Rahman overgrowth syndrome [RCV001060402]|not provided [RCV001776115] | uncertain significance | 2 | 25244300 | 25244300 | Human | 1 | name , trait , alternate_id |
| 28907523 | CV859151 | single nucleotide variant | NM_022552.5(DNMT3A):c.1904G>A (p.Arg635Gln) | Tatton-Brown-Rahman overgrowth syndrome [RCV001384970]|not provided [RCV001093354] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 2 | 25243930 | 25243930 | Human | 1 | name |
| 28907569 | CV859153 | single nucleotide variant | NM_022552.5(DNMT3A):c.1443C>A (p.Tyr481Ter) | not provided [RCV001093356] | likely pathogenic | 2 | 25246051 | 25246051 | Human | | name |
| 38500088 | CV953021 | single nucleotide variant | NM_022552.5(DNMT3A):c.1363A>T (p.Lys455Ter) | Tatton-Brown-Rahman overgrowth syndrome [RCV001245491] | pathogenic | 2 | 25246226 | 25246226 | Human | 1 | name |
| 38597609 | CV965326 | single nucleotide variant | NM_022552.5(DNMT3A):c.2146G>A (p.Val716Ile) | not provided [RCV001254801] | pathogenic | 2 | 25240667 | 25240667 | Human | | name |
| 39456282 | CV966508 | single nucleotide variant | NM_022552.5(DNMT3A):c.1668G>C (p.Arg556Ser) | Rare genetic intellectual disability [RCV001256990] | likely pathogenic | 2 | 25244338 | 25244338 | Human | | name |
| 40814405 | CV969340 | single nucleotide variant | NM_022552.5(DNMT3A):c.2722T>A (p.Tyr908Asn) | Intellectual disability [RCV001260611] | likely pathogenic | 2 | 25234296 | 25234296 | Human | 2 | name |
| 40814404 | CV969341 | single nucleotide variant | NM_022552.5(DNMT3A):c.2206C>T (p.Arg736Cys) | Intellectual disability [RCV001260610]|Tatton-Brown-Rahman overgrowth syndrome [RCV001340498]|not provided [RCV003319458] | pathogenic|likely pathogenic|uncertain significance | 2 | 25240418 | 25240418 | Human | 3 | name |
| 40886877 | CV973295 | single nucleotide variant | NM_022552.5(DNMT3A):c.1643T>C (p.Met548Thr) | Inborn genetic diseases [RCV001266174]|not provided [RCV004720833] | pathogenic|likely pathogenic | 2 | 25244564 | 25244564 | Human | 1 | name |
| 40904023 | CV976226 | single nucleotide variant | NM_022552.5(DNMT3A):c.1097G>A (p.Arg366His) | Tatton-Brown-Rahman overgrowth syndrome [RCV003746587]|not provided [RCV001269839] | likely pathogenic|uncertain significance | 2 | 25247076 | 25247076 | Human | 1 | name |
| 41406128 | CV980225 | single nucleotide variant | NM_022552.5(DNMT3A):c.2726T>C (p.Phe909Ser) | DNMT3A-related disorder [RCV004746305]|not provided [RCV001280739] | pathogenic|uncertain significance | 2 | 25234292 | 25234292 | Human | | name , trait , alternate_id |
| 41408065 | CV980675 | single nucleotide variant | NM_022552.5(DNMT3A):c.1345G>A (p.Ala449Thr) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584877] | uncertain significance | 2 | 25246244 | 25246244 | Human | 1 | name |
| 126733991 | CV988570 | single nucleotide variant | NM_022552.5(DNMT3A):c.2026C>T (p.Arg676Trp) | Tatton-Brown-Rahman overgrowth syndrome [RCV001294838] | uncertain significance | 2 | 25241618 | 25241618 | Human | 1 | name |
| 12895554 | CV405696 | duplication | NM_022552.5(DNMT3A):c.130_131dup (p.Ala45fs) | not provided [RCV000486884] | likely pathogenic | 2 | 25300184 | 25300185 | Human | | name |
| 405867508 | CV2842287 | duplication | NM_022552.5(DNMT3A):c.754_760dup (p.Ala254fs) | EBV-positive nodal T- and NK-cell lymphoma [RCV004560236] | pathogenic | 2 | 25248131 | 25248132 | Human | | name |
| 405142792 | CV2931046 | deletion | NM_022552.5(DNMT3A):c.867_870del (p.Phe290fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV003584327] | pathogenic | 2 | 25247735 | 25247738 | Human | 1 | name |
| 404993504 | CV3132484 | indel | NM_022552.5(DNMT3A):c.1937-18_1937-17delinsTC | Tatton-Brown-Rahman overgrowth syndrome [RCV003827423] | uncertain significance | 2 | 25241724 | 25241725 | Human | | name |
| 597883025 | CV3784191 | deletion | NM_022552.5(DNMT3A):c.663_675del (p.Ile221fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV005124480] | pathogenic | 2 | 25248217 | 25248229 | Human | 1 | name |
| 598232948 | CV3886499 | deletion | NM_022552.5(DNMT3A):c.760_767del (p.Ala254fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV005255943] | pathogenic | 2 | 25248125 | 25248132 | Human | 1 | name |
| 12895245 | CV405694 | deletion | NM_022552.5(DNMT3A):c.700_709del (p.Gly234fs) | not provided [RCV000485726] | likely pathogenic | 2 | 25248183 | 25248192 | Human | | name |
| 8696160 | CV143238 | deletion | NM_022552.5(DNMT3A):c.889_891del (p.Trp297del) | Tatton-Brown-Rahman overgrowth syndrome [RCV000128558] | pathogenic | 2 | 25247714 | 25247716 | Human | 1 | name |
| 243057989 | CV2412265 | microsatellite | NM_022552.5(DNMT3A):c.1077CAA[1] (p.Asn360del) | not provided [RCV003146807] | uncertain significance | 2 | 25247091 | 25247093 | Human | | name |
| 401936113 | CV2796255 | microsatellite | NM_022552.5(DNMT3A):c.2190CTT[1] (p.Phe732del) | DNMT3A-related disorder [RCV003414084]|Tatton-Brown-Rahman overgrowth syndrome [RCV003585390] | uncertain significance | 2 | 25240429 | 25240431 | Human | | name , trait , alternate_id |
| 407574638 | CV3499649 | microsatellite | NM_022552.5(DNMT3A):c.2252TCT[1] (p.Phe752del) | not provided [RCV004720142] | likely pathogenic | 2 | 25240367 | 25240369 | Human | | name |
| 597648888 | CV3551694 | microsatellite | NM_022552.5(DNMT3A):c.1583ACG[3] (p.Asp531del) | not provided [RCV004820407] | uncertain significance | 2 | 25244613 | 25244615 | Human | | name |
| 34890526 | CV904282 | deletion | NM_022552.5(DNMT3A):c.911_913del (p.Ser304del) | Heyn-Sproul-Jackson syndrome [RCV002510586]|Inborn genetic diseases [RCV001266051]|Tatton-Brown-Rahman overgrowth syndrome [RCV002558718]|not provided [RCV001171613] | pathogenic|likely pathogenic|uncertain significance | 2 | 25247692 | 25247694 | Human | 3 | name |
| 156251266 | CV2082606 | deletion | NM_022552.5(DNMT3A):c.1004_1011del (p.Lys335fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV002876950] | pathogenic | 2 | 25247594 | 25247601 | Human | 1 | name |
| 155950325 | CV2123450 | duplication | NM_022552.5(DNMT3A):c.1342_1343dup (p.Ala449fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV002971830] | pathogenic | 2 | 25246245 | 25246246 | Human | 1 | name |
| 243055028 | CV2407251 | deletion | NM_022552.5(DNMT3A):c.2051_2055del (p.Val684fs) | not provided [RCV003144801] | likely pathogenic | 2 | 25241589 | 25241593 | Human | | name |
| 329846550 | CV2523778 | duplication | NM_022552.5(DNMT3A):c.1353_1356dup (p.Pro453fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV003226068] | uncertain significance | 2 | 25246232 | 25246233 | Human | 1 | name |
| 408374803 | CV3507726 | duplication | NM_022552.5(DNMT3A):c.1761_1762dup (p.His588fs) | DNMT3A-related disorder [RCV004747513] | likely pathogenic | 2 | 25244243 | 25244244 | Human | | name , trait , alternate_id |
| 408375017 | CV3508927 | duplication | NM_022552.5(DNMT3A):c.1602_1615dup (p.Ile539fs) | DNMT3A-related disorder [RCV004747659] | likely pathogenic | 2 | 25244591 | 25244592 | Human | | name , trait , alternate_id |
| 408393538 | CV3526182 | deletion | NM_022552.5(DNMT3A):c.2593_2594del (p.Glu865fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV004771614] | pathogenic | 2 | 25235710 | 25235711 | Human | 1 | name |
| 596925031 | CV3541790 | deletion | NM_022552.5(DNMT3A):c.1935_1936del (p.Gly646fs) | Acute myeloid leukemia [RCV004795501] | pathogenic | 2 | 25243898 | 25243899 | Human | 2 | name |
| 597885062 | CV3854763 | deletion | NM_022552.5(DNMT3A):c.1778_1793del (p.Gly593fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV005199608] | pathogenic | 2 | 25244213 | 25244228 | Human | 1 | name |
| 598244311 | CV3895559 | deletion | NM_022552.5(DNMT3A):c.1036_1040del (p.Pro346fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV005365657] | uncertain significance | 2 | 25247133 | 25247137 | Human | 1 | name |
| 12913520 | CV421376 | duplication | NM_022552.5(DNMT3A):c.1450_1451dup (p.Gln485fs) | not provided [RCV000493919] | likely pathogenic | 2 | 25246042 | 25246043 | Human | | name |
| 13813910 | CV557984 | deletion | NM_022552.5(DNMT3A):c.1060_1069del (p.Phe354fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV000690485] | pathogenic | 2 | 25247104 | 25247113 | Human | 1 | name |
| 13805544 | CV558336 | deletion | NM_022552.5(DNMT3A):c.2540_2541del (p.His847fs) | Tatton-Brown-Rahman overgrowth syndrome [RCV000700133] | likely pathogenic | 2 | 25235763 | 25235764 | Human | 1 | name |
| 21404862 | CV801064 | deletion | NM_022552.5(DNMT3A):c.1035_1045del (p.Met345fs) | Acute myeloid leukemia [RCV001003799] | likely pathogenic | 2 | 25247128 | 25247138 | Human | 2 | name |
| 25317749 | CV805302 | deletion | NM_022552.5(DNMT3A):c.2162_2168del (p.Lys721fs) | not provided [RCV001008212] | pathogenic | 2 | 25240645 | 25240651 | Human | | name |
| 150332844 | CV1168906 | deletion | NM_022552.5(DNMT3A):c.1582_1584del (p.Tyr528del) | not provided [RCV001537045] | uncertain significance | 2 | 25244623 | 25244625 | Human | | name |
| 408381306 | CV3501461 | indel | NM_022552.5(DNMT3A):c.2048_2053delinsC (p.Tyr683fs) | not provided [RCV004727550] | pathogenic | 2 | 25241591 | 25241596 | Human | | name |
| 597964421 | CV3792261 | deletion | NM_022552.5(DNMT3A):c.2401del (p.Gly800_Met801insTer) | Tatton-Brown-Rahman overgrowth syndrome [RCV005139819] | pathogenic | 2 | 25239137 | 25239137 | Human | 1 | name |
| 150539415 | CV1308791 | microsatellite | NM_022552.5(DNMT3A):c.2736_2737del (p.Ter913ArgextTer?) | not provided [RCV001766295] | uncertain significance | 2 | 25234281 | 25234282 | Human | | name |
| 329847955 | CV2667574 | duplication | NM_022552.5(DNMT3A):c.2716_2718dup (p.Lys906_Glu907insLys) | not provided [RCV003229141] | uncertain significance | 2 | 25234299 | 25234300 | Human | | name |
| 408377948 | CV3224482 | duplication | NM_022552.5(DNMT3A):c.1078_1095dup (p.Tyr365_Arg366insAsnLysGlnProMetTyr) | Tatton-Brown-Rahman overgrowth syndrome [RCV004723561]|not provided [RCV004767514] | likely pathogenic|uncertain significance | 2 | 25247077 | 25247078 | Human | 1 | name |